Unnamed: 0,title,date,stock,sentiment
42841.0,FDA Issues Warning Letter To Allergan For Failing To Comply With Requirements  Under 2 Separate Premarket Approval Orders,2020-05-14 15:35:00-04:00,AGN,negative
42842.0,"The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500",2020-05-07 07:41:00-04:00,AGN,negative
42843.0,"The Daily Biotech Pulse: FDA Nod For AstraZeneca, AbbVie-Allergan Deal Clears Antitrust Hurdle",2020-05-06 08:42:00-04:00,AGN,positive
42844.0,"AbbVie, Allergan Report FTC Clearance For Deal",2020-05-05 17:52:00-04:00,AGN,neutral
42845.0,"Abbvie Purchase Of Allergan FTC Approval Is Imminent, Mlex Says",2020-05-05 15:03:00-04:00,AGN,positive
42846.0,"Ironwood, Allergan Receive Notices Of Allowance For Patent Applications Covering 72 mcg Dose Of LINZESS",2020-04-28 16:07:00-04:00,AGN,neutral
42847.0,"Benzinga's Top Upgrades, Downgrades For April 21, 2020",2020-04-21 09:35:00-04:00,AGN,positive
42848.0,"SunTrust Robinson Humphrey Downgrades Allergan to Hold, Raises Price Target to $193",2020-04-21 07:46:00-04:00,AGN,neutral
42849.0,"AbbVie Analyst Upgrades Stock To Outperform, Looks Forward To 2021",2020-04-20 12:50:00-04:00,AGN,neutral
42850.0,"Shares of several healthcare companies are trading higher following Senate passage of a $2 trillion economic stimulus package, which has lifted stocks across sectors.",2020-03-26 11:49:00-04:00,AGN,positive
42851.0,CFRA Downgrades Allergan to Hold,2020-03-25 12:43:00-04:00,AGN,neutral
42852.0,"Shares of several healthcare companies are trading higher as equities gain amid hopes of a US stimulus agreement. Additionally, the coronavirus outbreak has increased demand for certain medical supplies.",2020-03-24 12:20:00-04:00,AGN,positive
42853.0,Shares of several healthcare companies are trading lower amid market volatility. Sunday's fiscal stimulus bill failed a procedural senate vote while the Fed Monday morning announced further stimulus measures to support liquidity.,2020-03-23 11:31:00-04:00,AGN,negative
42854.0,"The Daily Biotech Pulse: AbbVie, Allergan Agree On Divestments, Obalon Stops Obesity Balloon Sale, COVID-19 Updates",2020-03-18 07:36:00-04:00,AGN,positive
42855.0,"AbbVie, Allergan Report Signing Of Consent Decree Deal With FTC Staff Related To Deal",2020-03-17 16:31:00-04:00,AGN,positive
42856.0,CTFN Says AbbVie/Allergan Deal A Top Priority At FTC,2020-03-17 15:40:00-04:00,AGN,positive
42857.0,"Dept. Of Justice, FTC Could Seek Extensions To Complete Probes For Merger Reviews, Allergan, Raytheon, Google Deals Mentioned",2020-03-17 13:14:00-04:00,AGN,positive
42858.0,"Shares of several healthcare companies are trading lower as the coronavirus outbreak continues to cause economic disruption around the globe, leading to a steep selloff in equities across sectors.",2020-03-16 10:50:00-04:00,AGN,negative
42859.0,Shares of several healthcare companies are trading higher as the market rebounds following Thursday's selloff. NOTE: Since the coronavirus outbreak the healthcare sector has been extremely volatile.,2020-03-13 09:29:00-04:00,AGN,positive
42860.0,Shares of several healthcare companies are trading lower as equities sell off amid continued global coronavirus concerns. The virus has caused global economic disruption and negatively impacted stocks across sectors.,2020-03-12 09:26:00-04:00,AGN,negative
42861.0,Shares of several healthcare companies are trading lower. Movement appears market related amid selloff in equities. The global coronavirus outbreak has caused volatility in global markets and impacted stocks across sectors.,2020-03-11 07:15:00-04:00,AGN,neutral
42862.0,Allergan Receives FDA Approval For DURYSTA,2020-03-05 09:45:00-05:00,AGN,positive
42863.0,"Allergan, Editas Medicine Announce Dosing of First Patient in Landmark Phase 1/2 Clinical Trial of CRISPR Medicine AGN-151587 (EDIT-101) for the Treatment of LCA10",2020-03-04 05:12:00-05:00,AGN,positive
42864.0,"AbbVie, Allergan Receive Final Europan Approval To Close Deal",2020-03-03 08:03:00-05:00,AGN,positive
42865.0,"The Daily Biotech Pulse: Deciphera Cancer Drug Gets Priority Review, Fast Track Designation For Soligenix, Revolution Medicines IPO",2020-02-13 08:05:00-05:00,AGN,negative
42866.0,"The Daily Biotech Pulse: J&J Intensifies Efforts On COVID-19 Cure, Adamas Reports Positive, Long-Term Gocovri Data",2020-02-12 09:18:00-05:00,AGN,positive
42867.0,Stocks That Hit 52-Week Highs On Tuesday,2020-02-11 10:17:00-05:00,AGN,neutral
42868.0,"SunTrust Robinson Humphrey Maintains Buy on Allergan, Raises Price Target to $202",2020-02-11 09:50:00-05:00,AGN,neutral
42869.0,"The Daily Biotech Pulse: LogicBio Slapped With Clinical Hold, Agile Inks Debt Deal Ahead of Twirla Approval, Gilead Builds Stake In Sierra Oncology",2020-02-11 07:23:00-05:00,AGN,positive
42870.0,Mid-Afternoon Market Update: Dow Rises 70 Points; vTv Therapeutics Shares Jump,2020-02-10 14:48:00-05:00,AGN,positive
42871.0,Mid-Day Market Update: Crude Oil Down Over 1%; Taubman Centers Shares Spike Higher,2020-02-10 12:23:00-05:00,AGN,negative
42872.0,Here's How Much Investing $100 In Allergan Stock Back In 2010 Would Be Worth Today,2020-02-10 11:48:00-05:00,AGN,positive
42873.0,Stocks That Hit 52-Week Highs On Monday,2020-02-10 10:25:00-05:00,AGN,neutral
42874.0,Mid-Morning Market Update: Markets Open Higher; Allergan Tops Q4 Expectations,2020-02-10 10:13:00-05:00,AGN,positive
42875.0,Allergan Reports Q4 Earnings Beat,2020-02-10 09:00:00-05:00,AGN,neutral
42876.0,"Benzinga Pro's Top 5 Stocks To Watch For Mon., Feb. 10, 2020: NIO, SPG, AGN, LB, UA",2020-02-10 07:44:00-05:00,AGN,positive
42877.0,"Allergan Q4 Adj. EPS $5.22 Beats $4.57 Estimate, Sales $4.351B Beat $4.09B Estimate",2020-02-10 07:03:00-05:00,AGN,neutral
42878.0,"7 Stocks To Watch For February 10, 2020",2020-02-10 04:48:00-05:00,AGN,neutral
42879.0,"Earnings Scheduled For February 10, 2020",2020-02-10 04:09:00-05:00,AGN,neutral
42880.0,The Week Ahead In Biotech: SMID-Cap Earnings In The Spotlight,2020-02-09 15:22:00-05:00,AGN,neutral
42881.0,"Job Market Heats Up In January, As Warmer Weather Might Have Helped Add Positions",2020-02-07 09:41:00-05:00,AGN,positive
42882.0,13 Key NASH Drug Candidates To Watch For In A Potential $30-Billion Market,2020-02-05 16:11:00-05:00,AGN,neutral
42883.0,Endo Begins Shipment Of Authorized Generic Version Of Carafate Oral Suspension In Yhe United States,2020-01-27 16:21:00-05:00,AGN,positive
42884.0,Nestlé Acquires Zenpep; Financial Details Not Disclosed,2020-01-27 05:18:00-05:00,AGN,neutral
42885.0,AstraZeneca to Recover the Global Rights to Brazikumab from Allergan,2020-01-27 05:13:00-05:00,AGN,neutral
42886.0,"Benzinga's Top Upgrades, Downgrades For January 22, 2020",2020-01-22 09:51:00-05:00,AGN,positive
42887.0,"Ironwood And Allergan Announce Settlement With Teva Resolving LINZESS Patent Litigation; Settlement Does Not Grant License To Teva With Regard To 72 mcg Generic Version Of LINZESS, Grants Teva License To Market 145 mcg And 290 mcg Generics Starting 2029",2020-01-22 09:27:00-05:00,AGN,positive
42888.0,"Wells Fargo Downgrades Allergan to Equal-Weight, Announces $198 Price Target",2020-01-22 07:02:00-05:00,AGN,positive
42889.0,"The Daily Biotech Pulse: Osmotica Soars On Insider Buys, Ultragenyx's Partnered Rare Disease Drug Moves Into Clinics",2020-01-16 07:22:00-05:00,AGN,neutral
42890.0,Stocks That Hit 52-Week Highs On Wednesday,2020-01-15 13:14:00-05:00,AGN,neutral
42891.0,Stocks That Hit 52-Week Highs On Friday,2020-01-10 12:18:00-05:00,AGN,neutral
42892.0,"EU Commission Approves Abbvie's Acquisition Of Allergan, Subject To Conditions",2020-01-10 09:11:00-05:00,AGN,positive
42893.0,"The Daily Biotech Pulse: Positive Data Readouts To Spur Aclaris, Moderna And Ultragenyx",2020-01-10 07:13:00-05:00,AGN,positive
42894.0,Stocks That Hit 52-Week Highs On Thursday,2020-01-09 15:15:00-05:00,AGN,neutral
42895.0,"The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, DBV Announces Positive Peanut Allergy Study Findings, Applied Genetic Soars On Trial Results",2020-01-09 08:39:00-05:00,AGN,positive
42896.0,Ironwood Pharma and Allergan Resolve Patent Litigation in Response to Sandoz's New Drug Application,2020-01-06 08:06:00-05:00,AGN,positive
42897.0,Allergan Subsidiaries Warner Chilcott and Watson Settle Antitrust Class Action Litigation for $300M,2020-01-06 07:16:00-05:00,AGN,negative
42898.0,Attention Biotech Investors: Mark Your Calendar For These January PDUFA Dates,2020-01-01 18:00:00-05:00,AGN,neutral
42899.0,Axsome Shares Target New Highs After Migraine Drug Aces Late-Stage Trial,2019-12-30 09:21:00-05:00,AGN,positive
42900.0,"Week Ahead In Biotech: PDUFA Date Ahead For Astra Zeneca, Merck's Lynparza, Pending Clinical Readouts In Focus",2019-12-29 18:38:00-05:00,AGN,neutral
42901.0,BTL Aesthetics Reports Its US Affiliate Filed Suit Against Allergan And Zimmer MedizinSystem Related To Emsculpt,2019-12-27 11:09:00-05:00,AGN,neutral
42902.0,"The Daily Biotech Pulse: Flexion Receives FDA Nod For Zilretta Label Expansion, Astellas Goes Shopping",2019-12-27 07:59:00-05:00,AGN,neutral
42903.0,Allergan Receives US FDA Approval For UBRELVY For The Acute Treatment Of Migraine With Or Without Aura In Adults,2019-12-23 15:18:00-05:00,AGN,positive
42904.0,Allergan Shares Tick Slightly Higher Over $191 Level; Traders Circulate FDA News Release From Late Sun. Afternoon 'FDA approves new treatment for adults with migraine',2019-12-23 14:37:00-05:00,AGN,positive
42905.0,Stocks That Hit 52-Week Highs On Friday,2019-12-20 11:59:00-05:00,AGN,neutral
42906.0,"The Daily Biotech Pulse: Axovant Surges On Gene Therapy Study Results, FDA Approves Merck's Ebola Vaccine, Abeona Announces Offering",2019-12-20 08:12:00-05:00,AGN,positive
42907.0,"Amgen And Allergan Submit Biologics License Application For ABP 798, Biosimilar Candidate To Rituxan, To U.S. Food And Drug Administration",2019-12-19 16:45:00-05:00,AGN,neutral
42908.0,Minerva Neurosciences Shelves Depression Drug Study After Failed Mid-Stage Trial,2019-12-19 09:35:00-05:00,AGN,negative
42909.0,"The Daily Biotech Pulse: Seattle Genetics' Bladder Cancer Drug Gets FDA Nod, Paratek Wins Contract For Antibiotic",2019-12-19 07:52:00-05:00,AGN,negative
42910.0,Stocks That Hit 52-Week Highs On Wednesday,2019-12-18 10:43:00-05:00,AGN,neutral
42911.0,"The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data",2019-12-18 07:23:00-05:00,AGN,positive
42912.0,Stocks That Hit 52-Week Highs On Tuesday,2019-12-17 11:19:00-05:00,AGN,neutral
42913.0,Stocks That Hit 52-Week Highs On Friday,2019-12-13 11:19:00-05:00,AGN,neutral
42914.0,Watching Allergan Shares AS Hearing Co. Deal With AbbVie To Receive US Regulatory Approval In Jan. 2020,2019-12-13 09:44:00-05:00,AGN,positive
42915.0,"The Daily Biotech Pulse: Second Time's The Charm For Sarepta, Pfizer's Xeljanz Snags Third Approval, NewLink Genetics Rejects Competing Offer",2019-12-13 08:10:00-05:00,AGN,positive
42916.0,Stocks That Hit 52-Week Highs On Thursday,2019-12-12 10:21:00-05:00,AGN,neutral
42918.0,"The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend",2019-12-06 07:39:00-05:00,AGN,positive
42919.0,"The Daily Biotech Pulse: Aurinia Rips Higher On Positive Readout, Sesen Bio On Track For Vicinium BLA Submission",2019-12-05 07:14:00-05:00,AGN,positive
42920.0,Allergan Highlights Phase 3 ACHIEVE I Trial Results For Ubrogepant Published In New England Journal Of Medicine,2019-12-04 17:30:00-05:00,AGN,neutral
42921.0,Stocks That Hit 52-Week Highs On Wednesday,2019-12-04 10:30:00-05:00,AGN,neutral
42922.0,Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates,2019-11-29 08:13:00-05:00,AGN,neutral
42923.0,"The Daily Biotech Pulse: Endo's Cellulite Treatment Accepted For Review, Diffusion Pharma Reports Positive Glioblastoma Data",2019-11-20 07:25:00-05:00,AGN,positive
42924.0,Allergan Highlights Phase 3 ACHIEVE II Trial Results From Ubrogepant Published In Journal Of American Medical Association,2019-11-19 11:23:00-05:00,AGN,neutral
42925.0,Stocks That Hit 52-Week Highs On Tuesday,2019-11-19 10:21:00-05:00,AGN,neutral
42926.0,"Benzinga's Top Upgrades, Downgrades For November 19, 2019",2019-11-19 09:57:00-05:00,AGN,positive
42927.0,10 Biggest Price Target Changes For Tuesday,2019-11-19 08:31:00-05:00,AGN,neutral
42928.0,"UBS Downgrades Allergan to Neutral, Raises Price Target to $203",2019-11-19 06:16:00-05:00,AGN,neutral
42929.0,Stocks That Hit 52-Week Highs On Monday,2019-11-18 11:01:00-05:00,AGN,neutral
42930.0,Allergan Announces First Annual National BOTOX Cosmetic Day,2019-11-18 07:31:00-05:00,AGN,neutral
42931.0,Third Point 13F Shows New 3.6M Share Stake In Allergan,2019-11-14 16:26:00-05:00,AGN,positive
42932.0,"Allergan, Exicure Strike Collaboration Agreement For Hair Loss Disorder Drugs",2019-11-14 10:05:00-05:00,AGN,negative
42933.0,"UPDATE: Exicure To Receive $25M Upfront Payment, Up To $275M In Potential Milestone Payments From Allergan",2019-11-14 07:02:00-05:00,AGN,neutral
42934.0,"Exicure, Allergan Report Collaboration, Option, License Deal To Discover, Develop Spherical Nucleic Acid-Based Treatments For Hair Loss Disorders",2019-11-14 07:02:00-05:00,AGN,negative
42935.0,"The Daily Biotech Pulse: Merck Goes Shopping, Nuvectra Files For Bankruptcy Protection, Opiant Rips Higher",2019-11-13 07:10:00-05:00,AGN,neutral
42936.0,Stocks That Hit 52-Week Highs On Tuesday,2019-11-12 10:11:00-05:00,AGN,neutral
42937.0,"The Daily Biotech Pulse: Reata, Kadmon Clinical Readouts, Apyx Medical's Earnings Beat",2019-11-12 07:20:00-05:00,AGN,neutral
42938.0,Allergan Receives FDA Qualified Infectious Disease Product Designation And Fast Track Designation For ATM-AVI For Antibiotic-Resistant Gram-Negative Infections,2019-11-11 07:32:00-05:00,AGN,neutral
42939.0,"The Week Ahead In Biotech: Adcom Test For Amarin's Fish Oil Pill, Agile Awaits FDA Verdict",2019-11-10 16:08:00-05:00,AGN,positive
42940.0,Stocks That Hit 52-Week Highs On Friday,2019-11-08 10:30:00-05:00,AGN,neutral
42941.0,Stocks That Hit 52-Week Highs On Tuesday,2019-11-05 11:12:00-05:00,AGN,neutral
42942.0,Allergan's Q3 Sales Get A Facelift From Botox; AbbVie Deal On Track,2019-11-05 10:48:00-05:00,AGN,neutral
42943.0,Allergan And Abbvie Continue To Expect To Close The Transaction In Early 2020,2019-11-05 07:16:00-05:00,AGN,neutral
42944.0,Allergan Raises FY19 Sales Guidance From $15.40B-$15.60B To $15.60B-$15.80B vs $15.56B Est.,2019-11-05 07:04:00-05:00,AGN,neutral
42945.0,"Allergan Q3 Adj. EPS $4.25 Beats $4.22 Estimate, Adj. Sales $4.025B Beat $3.88B Estimate",2019-11-05 07:02:00-05:00,AGN,neutral
42946.0,"Earnings Scheduled For November 5, 2019",2019-11-05 04:14:00-05:00,AGN,neutral
42947.0,Stocks That Hit 52-Week Highs On Monday,2019-11-04 14:43:00-05:00,AGN,neutral
42948.0,Allergan Q3 Earnings Preview,2019-11-04 13:08:00-05:00,AGN,neutral
42949.0,Stocks That Hit 52-Week Highs On Friday,2019-11-01 10:31:00-04:00,AGN,neutral
42950.0,From AbbVie Earnings Conference Call: Co. Notified FTC It Plans To Divest 2 Assets For Allergan Deal To Go Through,2019-11-01 09:37:00-04:00,AGN,positive
42951.0,Attention Biotech Investors: Mark Your Calendar For These November PDUFA Dates,2019-11-01 08:05:00-04:00,AGN,neutral
42952.0,"The Daily Biotech Pulse: Amgen Takes 20.5% Stake In BeiGene, Paratek's Mixed Clinical Readout, CareDx Slips On Guidance",2019-11-01 07:38:00-04:00,AGN,neutral
42953.0,"The Daily Biotech Pulse: Agile Receives Favorable Adcom Verdict, Merit Medical Tumbles On Earnings, 2 Biotechs To Debut",2019-10-31 08:08:00-04:00,AGN,positive
42954.0,Wells Fargo Turns Bullish On Revance Therapeutics After Meeting With Management,2019-10-30 13:09:00-04:00,AGN,positive
42955.0,FDA Approves Allergan And Medicines360's LILETTA To Prevent Pregnancy,2019-10-28 09:01:00-04:00,AGN,positive
42956.0,"FDA Approves Allergan''s Supplemental Biologics License Application For BOTOX In Pediatric Patients With Lower Limb Spasticity, Excluding Spasticity Caused By Cerebral Palsy",2019-10-24 07:33:00-04:00,AGN,positive
42957.0,16 Stocks With The Highest Long-Term Sales Growth Rate,2019-10-23 15:26:00-04:00,AGN,positive
42958.0,"4 Pharma Companies Settle Opioid Lawsuits Ahead Of Trial With Ohio Counties; 2,300 Cases Remain",2019-10-21 09:08:00-04:00,AGN,negative
42959.0,Allergan Reports Shareholders Have Approved Deal By AbbVie,2019-10-14 09:16:00-04:00,AGN,positive
42960.0,Allergan and Molecular Partners Late Friday Presented Late-Breaking Data From Phase 3 Studies Of Investigational Abicipar Pegol In Neovascular Wet Age-Related Macular Degeneration,2019-10-14 09:07:00-04:00,AGN,neutral
42961.0,"The Daily Biotech Pulse: FDA Approves Clinuvel Drug, Aclaris Files Patent Lawsuit Against Taro, Viela Out-Licenses Autoimmune Disorder Drug",2019-10-09 07:58:00-04:00,AGN,negative
42962.0,Investors Sell FANG To Buy IPOs In September's IMX,2019-10-07 16:54:00-04:00,AGN,neutral
42963.0,Investor Movement Index Summary: September 2019,2019-10-07 13:18:00-04:00,AGN,neutral
42964.0,Allergan Launches Three Over-The-Counter Products for Eye Care,2019-10-07 07:39:00-04:00,AGN,positive
42965.0,Allergan Partner Molecular Partners Announces Late-Stage Data from Abicipar in Age-Related Macular Degeneration to be Showcased at American Academy of Ophthalmology (AAO) Annual Meeting,2019-10-04 04:33:00-04:00,AGN,neutral
42966.0,"Allergan Reports Will Highlight Late-Stage Data In Age-Related Macular Degeneration, Glaucoma At American Academy of Ophthalmology Annual Meeting",2019-10-03 07:39:00-04:00,AGN,positive
42967.0,Abbvie Inc Co And Allergan Are Cooperating Fully With FTC And Continue To Expect To Close Transaction In Early 2020,2019-09-27 16:15:00-04:00,AGN,neutral
42968.0,Citi Bullish On AbbVie As Allergan Deal Provides An Earnings Floor,2019-09-26 13:46:00-04:00,AGN,neutral
42969.0,"Biotech Stock On The Radar: Anavex, A Neurology-Focused Precision Medicine Company",2019-09-25 17:32:00-04:00,AGN,neutral
42970.0,11 Most Aggressively Shorted Stocks,2019-09-19 11:15:00-04:00,AGN,negative
42971.0,FDA Says Allergan Recalled Natrelle Biocell Textured Breast Implants Due To Risk Of BIA-ALCL Cancer,2019-09-12 14:00:00-04:00,AGN,negative
42972.0,"UPDATE: UBS Maintains Buy On Allergan, Raises Tgt To $189 'based on ABBV Target Price of $79 and assuming deal closes' In 1Q'20;Firm Notes 'ABBV/AGN has sufficiently addressed possible anti-trust issues with the announced divestitures of Zenpep and Creon'",2019-09-12 10:37:00-04:00,AGN,neutral
42973.0,"UBS Maintains Buy on Allergan, Raises Price Target to $189",2019-09-12 09:18:00-04:00,AGN,neutral
42974.0,Allergan and Molecular Partners Announce FDA Acceptance of a Biologics License Application and Validation of a European Marketing Authorization for Abicipar Pegol,2019-09-09 07:44:00-04:00,AGN,positive
42975.0,Mallinckrodt Eyes Restructuring Ahead Of Cleveland Opioid Trial: 'Bankruptcy A Real Option',2019-09-05 10:39:00-04:00,AGN,neutral
42976.0,Biotech Stock On The Radar: Ardelyx Gears Up For FDA Decision Day,2019-09-04 16:42:00-04:00,AGN,neutral
42977.0,Allergan Receives FDA Approval Of Juvéderm VOLUMA XC For Mid-Face Injection Via Cannula,2019-09-03 07:30:00-04:00,AGN,positive
42978.0,Allergan Announces Settlement With Two Ohio Plaintiffs In Federal Opioid Litigation; Co. To Pay $5M Total To Resolve Claims In Two Counties,2019-08-30 07:01:00-04:00,AGN,positive
42979.0,Amgen And Allergan Announce Results Of Comparative Clinical Study Of ABP 798,2019-08-22 09:02:00-04:00,AGN,neutral
42980.0,"Endo, Allergan in Talks to Avoid Trial Over Opioid Crisis",2019-08-20 04:38:00-04:00,AGN,negative
42981.0,"Q2 13F Roundup: How Buffett, Einhorn, Ackman And Others Adjusted Their Portfolios",2019-08-15 13:40:00-04:00,AGN,neutral
42982.0,"Soros 13F Just Out; Shows New Stake In Allergan, Liquidated Stake In Adobe",2019-08-14 16:17:00-04:00,AGN,neutral
42983.0,﻿Shares of several healthcare companies are trading higher with the overall market after the U.S. announced it is excluding and delaying the additional 10% tariff on certain products.,2019-08-13 11:53:00-04:00,AGN,positive
42984.0,"Benzinga's Top Upgrades, Downgrades For August 7, 2019",2019-08-07 09:48:00-04:00,AGN,positive
42985.0,Guggenheim Downgrades Allergan to Neutral,2019-08-07 06:57:00-04:00,AGN,neutral
42986.0,"Allergan Reports Q2 Earnings Beat, Reaffirms Guidance",2019-08-06 07:32:00-04:00,AGN,neutral
42987.0,"Allergan Reaffirms FY19 Adj. EPS Guidance Of $16.55+ vs $16.72 Est., Raises Sales Guidance From $15.1B-$15.4B To $15.4B-$15.6B vs $15.34B Est.",2019-08-06 07:07:00-04:00,AGN,neutral
42988.0,"Allergan Q2 Adj. EPS $4.38 Beats $4.34 Estimate, Sales $4.09B Beat $3.93B Estimate",2019-08-06 07:06:00-04:00,AGN,neutral
42989.0,"Earnings Scheduled For August 6, 2019",2019-08-06 04:00:00-04:00,AGN,neutral
42990.0,Investor Movement Index Summary: July 2019,2019-08-05 14:22:00-04:00,AGN,neutral
42991.0,Allergan and Editas Medicine Initiate Brilliance Phase 1/2 Clinical Trial Of AGN-151587 (EDIT-101) For Treatment Of LCA10,2019-07-25 09:02:00-04:00,AGN,positive
42992.0,Allergan Voluntarily Recalls BIOCELL Textured Breast Implants And Tissue Expanders,2019-07-24 08:31:00-04:00,AGN,neutral
42993.0,Amgen and Allergan's MVASI and KANJINTI Now Available in the U.S.,2019-07-19 04:02:00-04:00,AGN,neutral
42994.0,10 Biggest Price Target Changes For Thursday,2019-07-18 09:54:00-04:00,AGN,neutral
42995.0,"Benzinga's Top Upgrades, Downgrades For July 18, 2019",2019-07-18 09:18:00-04:00,AGN,positive
42996.0,"SVB Leerink Downgrades Allergan to Market Perform, Lowers Price Target to $188",2019-07-18 06:48:00-04:00,AGN,negative
42997.0,FDA Accepts Allergan's New Drug Application For Bimatoprost Sustained-Release In Patients With Open-Angle Glaucoma Or Ocular Hypertension,2019-07-17 07:31:00-04:00,AGN,positive
42998.0,"Benzinga's Top Upgrades, Downgrades For July 16, 2019",2019-07-16 09:05:00-04:00,AGN,positive
42999.0,Bernstein Downgrades Allergan to Market Perform,2019-07-16 07:19:00-04:00,AGN,neutral
43000.0,Allergan To Present 29 Abstracts At 61st American Headache Society Meetings On Jul. 13,2019-07-09 07:43:00-04:00,AGN,neutral
43001.0,"Shares of several healthcare companies are trading lower after Trump on Friday said he was preparing an executive order declaring a 'favored nations clause' for drug prices, lowering the price that consumers will pay prescription drugs.",2019-07-08 12:55:00-04:00,AGN,positive
43002.0,"Notable Insider Buys This Past Week: AbbVie, MGM and More",2019-06-30 10:09:00-04:00,AGN,neutral
43003.0,"Barron's Picks And Pans: AbbVie, Crocs, RealReal, Roku And More",2019-06-30 10:00:00-04:00,AGN,neutral
43004.0,"A Look At Benzinga Pro's Most-Searched Tickers For June 26, 2019",2019-06-26 11:22:00-04:00,AGN,neutral
43005.0,Hearing Elliott Had Built A Stake In Allergan And Was Advocating For Break Up Of Co. Prior To Purchase By AbbVie; Allergan Shares Not Moving,2019-06-26 10:49:00-04:00,AGN,positive
43006.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Wednesday, June 26, 2019",2019-06-26 10:13:00-04:00,AGN,positive
43007.0,A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street,2019-06-26 07:43:00-04:00,AGN,neutral
43008.0,"The Daily Biotech Pulse: Decision Day For Regeneron-Sanofi, Vermillion Offering, PDL BioPharma CFO to Depart",2019-06-26 07:19:00-04:00,AGN,neutral
43009.0,"Mizuho Downgrades Allergan to Neutral, Raises Price Target to $188",2019-06-26 06:30:00-04:00,AGN,neutral
43010.0,51 Biggest Movers From Yesterday,2019-06-26 05:53:00-04:00,AGN,neutral
43011.0,Hearing Raymond James Downgrades Allergan From Outperform To Market Perform,2019-06-25 17:57:00-04:00,AGN,neutral
43012.0,Mid-Afternoon Market Update: NASDAQ Down 1.5%; Acer Therapeutics Shares Slide,2019-06-25 14:54:00-04:00,AGN,positive
43013.0,"UPDATE: Mizuho Cuts Target On Allergan, Sees 'lowered estimates for Botox Cosmetic and CoolSculpt following our survey work'",2019-06-25 14:09:00-04:00,AGN,negative
43014.0,Mid-Day Market Update: Allergan Jumps On Acquisition News; Conatus Pharmaceuticals Shares Plunge,2019-06-25 12:56:00-04:00,AGN,positive
43015.0,42 Stocks Moving In Tuesday's Mid-Day Session,2019-06-25 12:44:00-04:00,AGN,neutral
43016.0,"A Look At Benzinga Pro's Most-Searched Tickers For June 25, 2019",2019-06-25 12:07:00-04:00,AGN,neutral
43017.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Tuesday, June 25 2019",2019-06-25 10:26:00-04:00,AGN,positive
43018.0,Mid-Morning Market Update: Markets Open Lower; Lennar Tops Q2 Estimates,2019-06-25 10:15:00-04:00,AGN,positive
43019.0,"Anticipation Of Powell Speech, G20 Summit Has Market In Wait-And-See Mode",2019-06-25 10:00:00-04:00,AGN,positive
43020.0,8 Biggest Price Target Changes For Tuesday,2019-06-25 09:53:00-04:00,AGN,neutral
43021.0,AbbVie CEO Says Feels Comfortable With Risk Related To Allergan's Opioid Exposure,2019-06-25 08:58:00-04:00,AGN,positive
43022.0,Abbvie CEO Says Believes It Is Highly Unlikely There Will Be A Botox Biosimilar For A Long Time,2019-06-25 08:57:00-04:00,AGN,neutral
43023.0,"Mizuho Maintains Buy on Allergan, Lowers Price Target to $171",2019-06-25 08:52:00-04:00,AGN,negative
43024.0,30 Stocks Moving In Tuesday's Pre-Market Session,2019-06-25 08:04:00-04:00,AGN,neutral
43025.0,AbbVie To Acquire Allergan In $63B Deal,2019-06-25 07:29:00-04:00,AGN,neutral
43026.0,AbbVie Says Allergan Deal Mitigates Impact Of 2023 US Humira Loss Of Exclusivity,2019-06-25 07:17:00-04:00,AGN,negative
43027.0,A Peek Into The Markets: US Stock Futures Down Ahead Of Economic Data,2019-06-25 06:47:00-04:00,AGN,neutral
43028.0,Allergan shares are trading higher after AbbVie announced it will acquire the company for $188.24 per share in cash and stock.,2019-06-25 06:46:00-04:00,AGN,positive
43029.0,AbbVie To Acquire Allergan For $188.24/Share In Cash And Stock,2019-06-25 06:45:00-04:00,AGN,neutral
43030.0,Allergan shares are trading higher following rumors indicating AbbVie may be near a deal to acquire the company for $188 per share in cash and stock.,2019-06-25 06:38:00-04:00,AGN,positive
43031.0,"UPDATE: AbbVie Would Pay $188/Share In Cash And Stock For Allergan, Representing 45% Premium To Allergan's Monday Close, According To Sources Cited By WSJ",2019-06-25 06:33:00-04:00,AGN,negative
43032.0,"'AbbVie Nears Deal to Buy Allergan for More Than $60 Billion' -WSJ, Citing Sources",2019-06-25 06:31:00-04:00,AGN,neutral
43033.0,Allergan Receives FDA Clearance For CoolTone Device,2019-06-24 07:38:00-04:00,AGN,neutral
43034.0,FDA Approves Allergan's BOTOX For Pediatric Patients With Upper Limb Spasticity,2019-06-21 07:30:00-04:00,AGN,positive
43035.0,"Russian Parliament OKs Cannabis, Psychotropic Cultivation For Pharmaceutical Reasons",2019-06-19 16:05:00-04:00,AGN,neutral
43036.0,"Allergan shares trading higher following news the company and Irownwood Pharma reported topline data from a LINZESS trial. A JP Morgan analyst called the recent selloff in Allergan shares ""very much overdone.""",2019-06-19 11:30:00-04:00,AGN,positive
43037.0,"Ironwood, Allergan Investors React Positively After Duo's Constipation Drug Found Effective",2019-06-19 10:22:00-04:00,AGN,positive
43038.0,"The Daily Biotech Pulse: Positive Readouts From Adamas And Ironwood, Sesen Bio To Offer Shares, Stoke Therapeutics Debut",2019-06-19 07:51:00-04:00,AGN,positive
43039.0,"Ironwood, Allergan Report Topline Data From Phase IIIb Trial of LINZESS® (linaclotide) in Adults with Irritable Bowel Syndrome with Constipation: Met All Primary, Secondary Endpoints",2019-06-18 16:10:00-04:00,AGN,negative
43040.0,Allergan shares are trading higher after an Evercore ISI analyst reportedly said the company could be headed towards a split of its aesthetics and therapeutics business.,2019-06-18 14:21:00-04:00,AGN,positive
43041.0,"Rising Pharmaceuticals Announces US Launch & Commercial Shipment Of A Generic Version Of CANASA, (Mesalamine) Suppository, In 1,000 Mg Strength; CANASA Is A Registered Trademark Of Allergan Affiliate  Aptalis Pharma Canada",2019-06-18 14:14:00-04:00,AGN,positive
43042.0,"'""I walked away with the sense that Allergan is heading towards a split and may likely lay out timelines. We may get an update in 'next couple of months,' Evercore ISI analyst Umer Raffat writes on $AGN after talking with the pharma's...'",2019-06-18 13:16:00-04:00,AGN,neutral
43043.0,"The Daily Biotech Pulse:  Hematology And Rheumatology Conference Presentations Take The Spotlight, Eton In-Licenses Epilepsy Drug NDA",2019-06-14 08:47:00-04:00,AGN,neutral
43044.0,"FDA Approves Amgen And Allergan's KANJINTI, Biosimilar to Herceptin",2019-06-14 04:21:00-04:00,AGN,positive
43045.0,"Benzinga's Top Upgrades, Downgrades For June 11, 2019",2019-06-11 09:19:00-04:00,AGN,positive
43046.0,"Barclays Initiates Coverage On Allergan with Underweight Rating, Announces $133 Price Target",2019-06-11 07:24:00-04:00,AGN,neutral
43047.0,Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico has renewed trade optimism and lifted economic outlook.,2019-06-04 13:07:00-04:00,AGN,positive
43048.0,"Ironwood Pharma, Allergan Report Initiation Of Patient Dosing In Phase II Trial Of MD-7246 In Patients With Abdominal Pain Associated With IBS-D",2019-06-03 08:32:00-04:00,AGN,negative
43049.0,"The Daily Biotech Pulse: Unity Biotech Licenses Anti-Aging Protein, Strong Results For Mereo's Brittle Bone Disease Drug",2019-05-30 07:33:00-04:00,AGN,positive
43050.0,Shares of several healthcare companies are trading lower after the US state of Oklahoma filed a multi-billion dollar lawsuit against Johnson & Johnson relating to opioid abuse; Oklahoma settled an opioid lawsuit with Teva Pharmaceuticals earlier this week,2019-05-29 10:47:00-04:00,AGN,negative
43051.0,Allergan PLC shares are trading lower after the company announced it would voluntarily recall textured breast implants in Canada.,2019-05-28 17:21:00-04:00,AGN,neutral
43052.0,Allergan To Voluntarily Recall Textured Breast Implants In Canada; Natrelle Smooth Implants And Tissue Expanders Are Not Impacted By Licence Suspension And Voluntary Recall,2019-05-28 15:52:00-04:00,AGN,neutral
43053.0,Allergan And Gedeon Richter Receive FDA Approval For Expanded Use Of VRAYLAR In The Treatment Of Bipolar Depression,2019-05-28 07:39:00-04:00,AGN,negative
43054.0,"Goldman Sachs Initiates Coverage On Allergan with Neutral Rating, Announces $154 Price Target",2019-05-28 07:37:00-04:00,AGN,neutral
43055.0,The Week Ahead In Biotech: ASCO Presentations In The Spotlight,2019-05-26 17:03:00-04:00,AGN,neutral
43056.0,"David Tepper To Turn Appaloosa Into A Family Office, Focus On Family And Panthers",2019-05-23 10:54:00-04:00,AGN,neutral
43057.0,Allergan Reports Expansion Of PLEDGE Program With Fifth Study Now Evaluating Relamorelin For Treatment Of Diabetic Gastroparesis,2019-05-17 07:32:00-04:00,AGN,neutral
43058.0,Allergan Highlights Will Present VRAYLAR Data At American Psychiatric Association,2019-05-15 07:47:00-04:00,AGN,neutral
43059.0,"Raymond James Maintains Outperform on Allergan plc Ordinary Shares, Lowers Price Target to $166",2019-05-09 10:04:00-04:00,AGN,positive
43060.0,"UBS Maintains Buy on Allergan plc Ordinary Shares, Lowers Price Target to $172",2019-05-09 08:44:00-04:00,AGN,positive
43061.0,"RBC Capital Maintains Sector Perform on Allergan plc Ordinary Shares, Lowers Price Target to $140",2019-05-08 11:54:00-04:00,AGN,positive
43062.0,"Wells Fargo Maintains Outperform on Allergan plc Ordinary Shares, Lowers Price Target to $188",2019-05-08 08:36:00-04:00,AGN,positive
43063.0,Shares of several healthcare companies are trading lower after several companies in the space reported weak earnings with Mylan leading the selloff.,2019-05-07 10:25:00-04:00,AGN,negative
43064.0,"The Daily Biotech Pulse: Osmotica Flies, Catalyst Plummets, GW Pharma On Track To File For Expanded Use Of Epidiolex",2019-05-07 08:20:00-04:00,AGN,neutral
43065.0,"Allergan Sees Q2 Adj. EPS $4.20-$4.40 vs $4.20 Est., Sales $3.85B-$4.00B vs $3.87B Est.",2019-05-07 07:03:00-04:00,AGN,neutral
43066.0,Allergan Raises FY19 Sales Guidance From $15.0B-$15.30B To $15.10B-$15.40B vs $15.2B Est.,2019-05-07 07:03:00-04:00,AGN,neutral
43067.0,"Allergan Q1 Adj. EPS $3.79 Beats $3.55 Estimate, Sales $3.6B Beat $3.54B Estimate",2019-05-07 07:01:00-04:00,AGN,neutral
43068.0,"Earnings Scheduled For May 7, 2019",2019-05-07 05:03:00-04:00,AGN,neutral
43069.0,"Medicines360, Allergan Report Presentation Of New 6-Year Data From Co.'s Ongoing Multi-Center US-Based Pivotal Clinical Trial On LILETTA At American College of Obstetricians and Gynecologists",2019-05-06 08:52:00-04:00,AGN,neutral
43070.0,"Jim Cramer Weighs In On Exxon, Delta Air Lines And More",2019-05-02 07:46:00-04:00,AGN,neutral
43071.0,Appaloosa Issues Statement Saying Allergan Shareholders Are 'Clearly dissatisfied' With Management's Performance,2019-05-01 11:12:00-04:00,AGN,neutral
43072.0,Allergan shares are trading lower after shareholders rejected the proposal to immediately separate the Chairman and CEO roles held by Brent Saunders.,2019-05-01 10:12:00-04:00,AGN,negative
43073.0,Allergan  Says Shareholders Approved All Allergan Proposals,2019-05-01 06:38:00-04:00,AGN,positive
43074.0,Attention Biotech Investors: Mark Your Calendar For These May PDUFA Dates,2019-04-30 13:00:00-04:00,AGN,neutral
43075.0,Shares of several healthcare companies are trading lower on continued weakness over concerns of 'Medicare for all' support within 2020 presidential candidates and the uncertainty over healthcare policy going into the election.,2019-04-18 10:42:00-04:00,AGN,negative
43076.0,Shares of several healthcare companies are trading lower after Trump renewed his efforts to repeal and replace the Affordable Care Act; the Department of Justice moved to accelerate the appeal process in hopes to invalidate the ACA as unconstitutional.,2019-04-17 10:38:00-04:00,AGN,positive
43077.0,US Supreme Court Rejects Allergan's Bid to Protect Patents From Review by Transferring Them to Native American Tribe,2019-04-15 09:34:00-04:00,AGN,positive
43078.0,"Benzinga's Top Upgrades, Downgrades For April 15, 2019",2019-04-15 09:27:00-04:00,AGN,positive
43079.0,Jefferies Initiates Coverage On Allergan with Hold Rating,2019-04-15 08:39:00-04:00,AGN,neutral
43080.0,Allergan Says Currently Reviewing April 4 Health Canada Notice Of Its Intent To Suspend Co.'s Licences For Biocell Breast Implants; Says Intends To Respond Within The Deadline Provided By Health Canada,2019-04-04 15:26:00-04:00,AGN,negative
43081.0,Appaloosa Says Filed Supplemental Presentation On Allergan,2019-04-04 14:31:00-04:00,AGN,neutral
43082.0,"Health Canada Reviewing Information On Safety Of Textured Breast Implants, Includes Any New Evidence Provided By Allergan In Next 15 Calendar Days",2019-04-04 13:52:00-04:00,AGN,positive
43083.0,"As Of April 4, Been Notified Of 28 Confirmed Canadian Cases Of Bia-Alcl, Of Which 24 (86%) Involve Allergan's Biocell Breast Implant",2019-04-04 13:51:00-04:00,AGN,neutral
43084.0,Health Canada Advises Allergan Of Its Intent To Suspend Its Licences For Biocell Breast Implants As A Precautionary Measure,2019-04-04 13:51:00-04:00,AGN,negative
43085.0,"UBS Maintains Buy on Allergan, Lowers Price Target to $173",2019-04-03 09:15:00-04:00,AGN,negative
43086.0,Allergan And Molecular Partners Announce Topline Safety Results From MAPLE Study Of Abicipar pegol,2019-04-02 07:08:00-04:00,AGN,positive
43087.0,"Allergan Reports Purchase Of Envy Medical, No Terms Disclosed",2019-03-26 09:05:00-04:00,AGN,negative
43088.0,Hedge Fund Appaloosa Issues a Statement on Allergan's Proxy Filing,2019-03-25 07:34:00-04:00,AGN,neutral
43089.0,"SunTrust Robinson Humphrey Initiates Coverage On Allergan with Buy Rating, Announces $178 Price Target",2019-03-20 07:22:00-04:00,AGN,neutral
43090.0,Allergan Announces FDA Approval Of AVYCAZ For Pediatric Patients,2019-03-18 07:31:00-04:00,AGN,positive
43091.0,Allergan Highlights Will Present New Data 'Extended Duration of Intraocular Pressure (IOP) Control with Intracameral Bimatoprost Sustained-Release Implant' At Upcoming Meeting,2019-03-14 07:42:00-04:00,AGN,negative
43092.0,Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for the Acute Treatment of Migraine,2019-03-11 07:31:00-04:00,AGN,positive
43093.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Earnings, IPOs",2019-03-10 14:32:00-04:00,AGN,neutral
43094.0,"The Daily Biotech Pulse: Tonix Gets European Patent, EC Nod For Roche, Insys Earnings",2019-03-08 07:38:00-05:00,AGN,neutral
43095.0,UPDATE: Appaloosa Urges Allergan To Name Independent Chair,2019-03-07 10:57:00-05:00,AGN,neutral
43096.0,David Tepper's Appaloosa Sends Statement Related To Allergan's Failed Anti-Depression Study,2019-03-07 10:56:00-05:00,AGN,negative
43097.0,Allergan's Depression Drug Letdown Largely Expected: Analysts Focus On Remainder Of Pipeline,2019-03-07 10:54:00-05:00,AGN,negative
43098.0,Allergan shares are trading higher after the FDA accepted the company's application for expanded use of Botox for pediatric patients with upper and lower limb spasticity.,2019-03-07 10:32:00-05:00,AGN,positive
43099.0,7 Biggest Price Target Changes For Thursday,2019-03-07 09:57:00-05:00,AGN,neutral
43100.0,"Credit Suisse Maintains Neutral on Allergan, Lowers Price Target to $155",2019-03-07 09:05:00-05:00,AGN,positive
43101.0,26 Stocks Moving In Thursday's Pre-Market Session,2019-03-07 08:01:00-05:00,AGN,neutral
43102.0,"Daily Biotech Pulse: Allergan's Depression Drug Flunks Late-Stage Trial, Apellis Offering, ShockWave Medical IPO",2019-03-07 07:48:00-05:00,AGN,negative
43103.0,5 Stocks Moving In Wednesday's After-Hours Session,2019-03-06 16:41:00-05:00,AGN,neutral
43105.0,Allergan Announces Phase 3 Results For Rapastinel; Three Acute Pivotal Studies Did Not Meet Primary Endpoint,2019-03-06 16:18:00-05:00,AGN,neutral
43106.0,'ITC agrees to investigate Allergan claims that Botox rivals stole secrets' - STAT News,2019-03-04 15:59:00-05:00,AGN,positive
43107.0,"Mylan's Disappointing Outlook Rattles Analysts, Investors",2019-02-27 16:04:00-05:00,AGN,negative
43108.0,Allergan Responds To Appaloosa Letter Says 'we strongly disagree that an immediate separation of the CEO and Chair positions is warranted...',2019-02-19 13:04:00-05:00,AGN,negative
43109.0,UPDATE: Appaloosa Highlights 5 'Status Quo' Items Allergan Board Is Responsible For,2019-02-19 10:58:00-05:00,AGN,positive
43110.0,Appaloosa Sends Letter To Allergan Board,2019-02-19 10:57:00-05:00,AGN,neutral
43111.0,"Stocks Trading Ex Dividend For Thurs., Feb. 14, 2019",2019-02-14 11:29:00-05:00,AGN,neutral
43112.0,FDA Panel Reviews Johnson & Johnson's Treatment-Resistant Depression Candidate: What To Expect,2019-02-11 16:00:00-05:00,AGN,negative
43113.0,Appaloosa Sends Letter To Allergan's Board Of Directors Urging Them To Separate The Roles Of Chairman And CEO And Take Meaningful Steps To Address Allergan's Chronic Underperformance,2019-02-05 09:16:00-05:00,AGN,positive
43114.0,'Allergan asks the ITC to investigate its new Botox rivals for stealing secrets' -STAT News,2019-02-04 15:00:00-05:00,AGN,negative
43115.0,Attention Biotech Investors: Mark Your Calendar For These February PDUFA Dates,2019-02-01 13:30:00-05:00,AGN,neutral
43116.0,7 Biggest Price Target Changes For Thursday,2019-01-31 09:53:00-05:00,AGN,neutral
43117.0,"UPDATE: Credit Suisse On Allergan Notes 'Company commentary also leaves us more cautious on pipeline depression
drug rapastinel (which we had viewed as a key 2019 catalyst to regenerate interest in the stock)'",2019-01-31 09:22:00-05:00,AGN,positive
43118.0,UPDATE: Credit Suisse Downgrades Allergan 'following underwhelming 2019 guidance and additional questions we have on the strength of their business',2019-01-31 09:20:00-05:00,AGN,positive
43119.0,"Benzinga's Top Upgrades, Downgrades For January 31, 2019",2019-01-31 09:11:00-05:00,AGN,positive
43120.0,"Credit Suisse Downgrades Allergan to Neutral, Lowers Price Target to $161",2019-01-31 06:51:00-05:00,AGN,positive
43121.0,Morgan Stanley Loses Confidence In Allergan's Pipeline Optionality,2019-01-30 10:18:00-05:00,AGN,positive
43122.0,Hearing Thedeal.com Reported A 'Large Activist' Is Said To Be Targeting Allergan; Unconfirmed,2019-01-30 09:59:00-05:00,AGN,negative
43123.0,"Benzinga's Top Upgrades, Downgrades For January 30, 2019",2019-01-30 09:17:00-05:00,AGN,positive
43124.0,UPDATE: Morgan Stanley Downgrades Allergan As Firm Believes 'pipeline and growth uncertainty will continue to constrain stock valuation',2019-01-30 08:41:00-05:00,AGN,positive
43125.0,"Morgan Stanley Downgrades Allergan to Equal-Weight, Announces $156 Price Target",2019-01-30 06:24:00-05:00,AGN,neutral
43126.0,"RBC Capital Downgrades Allergan to Sector Perform, Announces $165 Price Target",2019-01-30 06:22:00-05:00,AGN,neutral
43127.0,58 Biggest Movers From Yesterday,2019-01-30 04:53:00-05:00,AGN,neutral
43128.0,46 Stocks Moving In Tuesday's Mid-Day Session,2019-01-29 13:02:00-05:00,AGN,neutral
43129.0,Allergan shares are trading lower after the company said it expects Q1 EPS of $3.40 to $3.60 versus the $3.75 analyst estimate. The company also expects revenue below analyst expectations.,2019-01-29 08:28:00-05:00,AGN,neutral
43130.0,"The Daily Biotech Pulse: Big Pharma Earnings, Kiniksa Offering, FDA Decision Day For Aquestive",2019-01-29 07:25:00-05:00,AGN,neutral
43131.0,"Allergan Sees Q1 Adj. EPS $3.40-$3.60 vs $3.75 Est., Sales $15.0B-$15.3B vs $15.39B Est.",2019-01-29 07:04:00-05:00,AGN,neutral
43132.0,Allergan Reports $2B Buyback,2019-01-29 07:03:00-05:00,AGN,neutral
43133.0,"Allergan Q4 Adj. EPS $4.29 Beats $4.15 Estimate, Sales $4.08B Beat $4B Estimate",2019-01-29 07:02:00-05:00,AGN,neutral
43134.0,"Earnings Scheduled For January 29, 2019",2019-01-29 04:13:00-05:00,AGN,neutral
43135.0,'We're announcing today that we plan to hold a public meeting of our General and Plastic Surgery Devices Panel on March 25-26 at #FDA headquarters to discuss a range of topics concerning the benefit-risk profile of breast implants.' -FDA's Gottlieb,2019-01-28 14:56:00-05:00,AGN,neutral
43136.0,Allergan Q4 Earnings Preview,2019-01-28 13:19:00-05:00,AGN,neutral
43137.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings",2019-01-27 16:07:00-05:00,AGN,neutral
43138.0,Allergan Raises Qtr. Dividend From $0.72 To $0.74/Share,2019-01-25 07:31:00-05:00,AGN,neutral
43139.0,UPDATE: Amgen And Allergan Announce ABP 798 Met Its Primary Endpoint Of Pharmacokinetic Similarity,2019-01-24 09:05:00-05:00,AGN,neutral
43140.0,"Amgen And Allergan Announce Positive Top-line Results From Phase 1/ Phase 3 Study Of Abp 798, Biosimilar Candidate To Rituximab",2019-01-24 09:04:00-05:00,AGN,positive
43141.0,Editas Medicine Tumbles 20% After CEO Steps Down,2019-01-22 12:39:00-05:00,AGN,neutral
43142.0,Aurinia's Dry Eye Syndrome Drug Produces Mixed Results In Mid-Stage Trial,2019-01-22 09:09:00-05:00,AGN,neutral
43143.0,Searching For A Treatment: NASH Investigational Drugs With Catalysts This Year,2019-01-18 09:15:00-05:00,AGN,neutral
43144.0,Health Canada Says Initiated Safety Review Of Fibristal After Receiving 4 Int'l. Reports Of Liver Injury From Transplants,2019-01-11 10:03:00-05:00,AGN,neutral
43145.0,Allergan Announces 'Positive' 3-Month Topline Results from Second Phase 3 Study of Bimatoprost SR Implant for Lowering Intraocular Pressure in Patients with Open-Angle Glaucoma or Ocular Hypertension,2019-01-07 07:50:00-05:00,AGN,negative
43146.0,Allergan Highlights New Data Published In International Journal of Neuropsychopharmacology Support that Rapastinel May Produce Rapid and Sustained Antidepressant Effects Through a Potentially Novel Mechanism of Action,2019-01-03 07:45:00-05:00,AGN,positive
43147.0,"The Daily Biotech Pulse: Aevi's ADHD Drug Flunks Mid-Stage Trial, Bristol-Myers To Buy Celgene, Teva Settles With Amgen",2019-01-03 07:36:00-05:00,AGN,negative
43148.0,Ironwood And Allergan Announce Settlement With Mylan Resolving LINZESS Patent Litigation; Additional Details Not Disclosed,2019-01-02 16:03:00-05:00,AGN,positive
43149.0,"Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 20, 2018",2018-12-20 11:33:00-05:00,AGN,negative
43150.0,"UPDATE: Bank Of America On Allergan Notes Textured Breast Implants Accounted For Less Than Approx. 0.4% Of Total Sales In FY18; Reiterates Buy, $212 Target",2018-12-20 09:00:00-05:00,AGN,neutral
43151.0,Bank Of America On Allergan: Notes Textured Breast European Implant Recall 'is specific to textured breast implants in EU markets and has no impact on US sales',2018-12-20 08:59:00-05:00,AGN,negative
43152.0,"Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018",2018-12-19 12:43:00-05:00,AGN,negative
43153.0,"UPDATE: JP Morgan Notes Allergan's Textured Breast Implant Product Has Annual Sales ~$60M, Or Less THan 1% Of Total Co. Sales This Year)",2018-12-19 11:28:00-05:00,AGN,positive
43154.0,Allergan shares are trading down after the company suspended sales and withdrew its supply of textured breast implants in European markets due to the expiration of the company's CE mark for these products.,2018-12-19 11:25:00-05:00,AGN,negative
43155.0,"Allergan Shares Down 6%; Co. Earlier Issued Release Highlighting Suspension Of Sales, Withdrawal Of Supply Of Textured Breast Implants In Europe; Hearing JP Morgan Issued Report 'Breast Implant Related Sell-off Appears Overdone'",2018-12-19 11:24:00-05:00,AGN,positive
43156.0,"Allergan Suspends Sales And Withdraws Supply Of Textured Breast Implants In European Markets, Stemming From Expiration Of Co.'s CE Mark For These Products",2018-12-19 08:34:00-05:00,AGN,neutral
43157.0,Allergan Announces FDA Acceptance Of Supplemental New Drug Application For AVYCAZ,2018-11-20 07:30:00-05:00,AGN,positive
43158.0,13F For Appaloosa Shows Cut Stake In Allergan From ~3.4M Shares To ~1.9M Shares,2018-11-14 16:09:00-05:00,AGN,positive
43159.0,"Leerink Swann Initiates Coverage On Allergan with Outperform Rating, Announces $220 Price Target",2018-11-13 08:33:00-05:00,AGN,neutral
43160.0,"Stocks Trading Ex Dividend For Fri. Nov. 9, 2018",2018-11-09 09:36:00-05:00,AGN,neutral
43161.0,"Stocks That Will Trade Ex Dividend Fri., Nov. 9th, 2018",2018-11-08 10:59:00-05:00,AGN,neutral
43162.0,"Raymond James Maintains Outperform on Allergan, Lowers Price Target to $198",2018-10-31 11:15:00-04:00,AGN,negative
43163.0,"The Daily Biotech Pulse: Pfizer And Allergan Earnings, CFO Departures At Acadia And Assertio",2018-10-30 08:00:00-04:00,AGN,neutral
43164.0,UPDATE: Allergan Raises FY18 Adj. Sales From $15.45B-$15.6B To $15.55B-$15.7B vs $15.61B Estimate,2018-10-30 06:34:00-04:00,AGN,neutral
43165.0,Allergan Raises Guidance,2018-10-30 06:33:00-04:00,AGN,neutral
43166.0,"Allergan, Inc. Q3 EPS $4.25 Beats $4.02 Estimate, Sales $3.91B Beat $3.86B Estimate",2018-10-30 06:31:00-04:00,AGN,neutral
43167.0,"Earnings Scheduled For October 30, 2018",2018-10-30 04:01:00-04:00,AGN,neutral
43168.0,Allergan's Q3 Earnings Outlook,2018-10-29 14:16:00-04:00,AGN,neutral
43169.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs",2018-10-27 10:23:00-04:00,AGN,neutral
43170.0,"The Daily Biotech Pulse: Eiger's Lymphoedema Drug Study Fails, Roche's Sales Rise",2018-10-17 08:15:00-04:00,AGN,negative
43171.0,UPDATE: Allergan Says US New Drug Application Filing For Ubrogepant On Track For Early 2019,2018-10-17 07:31:00-04:00,AGN,neutral
43172.0,UPDATE: Allergan On Ubrogepant Highlights 'Two-month hepatic safety study in healthy volunteers demonstrated no signal of drug-induced liver injury',2018-10-17 07:31:00-04:00,AGN,positive
43173.0,Allergan Reports Completion Of 2 Safety Studies For Ubrogepant For Acute Treatment Of Migraine: 'One-year study continues to support positive safety and tolerability profile for ubrogepant',2018-10-17 07:31:00-04:00,AGN,positive
43174.0,Medicines360 And Allergan Announce FDA Approval Of sNDA For LILETTA 52mg To Prevent Pregnancy For Up To Five Years,2018-10-16 09:06:00-04:00,AGN,positive
43175.0,"UPDATE: Aclaris Entered Loan, Security Deal With Oxford Finance For $30M Loan Made Available Until Oct. 31, 2018, Remaining $35M Upon Closing Of RHOFADE Deal Until Mar. 31, 2019",2018-10-15 16:02:00-04:00,AGN,positive
43176.0,"UPDATE: Aclaris Will Also Pay 'a development milestone payment related to the potential development of an additional dermatology product, and tiered royalties on net sales'",2018-10-15 16:02:00-04:00,AGN,negative
43177.0,Aclaris Therapeutics Reports Purchase Of Global Rights To RHOFADE From Allergan For Upfront Cash Payment Of $65M,2018-10-15 16:01:00-04:00,AGN,neutral
43178.0,Akorn's Generic Drug For Inadequate Eye Lashes Receives FDA Nod,2018-10-10 09:43:00-04:00,AGN,negative
43179.0,FDA Commissioner Scott Gottlieb Issues Statement On 'new efforts to advance the development of generic copies of complex drugs to improve patient access to medicines',2018-10-09 11:19:00-04:00,AGN,positive
43180.0,Allergan Reports Launch Of Personalized Study Approach For Clinical Research Programs In Inflammatory Bowel Disease,2018-10-05 07:30:00-04:00,AGN,neutral
43181.0,Allergan Reports Received FDA Clearance To Treat Area Below The Jawline With CoolSculpting,2018-10-04 07:43:00-04:00,AGN,positive
43182.0,Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates,2018-09-26 16:41:00-04:00,AGN,neutral
43183.0,Allergan Reports FDA Acceptance Of Supplemental New Drug Application For VRAYLAR,2018-09-26 07:30:00-04:00,AGN,positive
43184.0,Allergan Shares Spike ~0.5% As Bloomberg Highlights Questionable Activist/Takeover Chatter,2018-09-21 10:11:00-04:00,AGN,neutral
43185.0,"FDA Issues New Safety Measures For Immediate-Release, Extended-Release, and Long-Acting Opioid Analgesics",2018-09-18 15:17:00-04:00,AGN,positive
43186.0,JMP: Changing Competitive Landscape Makes Revance Less Appealing,2018-09-17 16:11:00-04:00,AGN,positive
43187.0,Mid-Afternoon Market Update: Dow Falls Over 50 Points; Select Income REIT Shares Spike Higher,2018-09-17 14:36:00-04:00,AGN,positive
43188.0,Mid-Day Market Update: Senomyx Climbs Following Acquisition News; Government Properties Income Trust Shares Fall,2018-09-17 12:08:00-04:00,AGN,positive
43189.0,Mid-Morning Market Update: Markets Mostly Lower; Teva's Preventive Migraine Treatment Approved By FDA,2018-09-17 10:20:00-04:00,AGN,positive
43190.0,10 Biggest Price Target Changes For Monday,2018-09-17 09:50:00-04:00,AGN,neutral
43191.0,Teva's Preventive Migraine Treatment Approved By FDA,2018-09-17 09:08:00-04:00,AGN,positive
43192.0,"Raymond James Maintains Outperform on Allergan, Raises Price Target to $232",2018-09-17 08:23:00-04:00,AGN,neutral
43193.0,Allergan Reports Results Of Higher Dose BOTOX For Treatment Of Moderate To Severe Glabellar Lines: Met Primary Endpoint,2018-09-14 16:18:00-04:00,AGN,negative
43194.0,"Allergan Press Release Highlights Medical Aesthetics Business, Sees Potential For It To Double By 2025, See 8-10% CAGR From 2017-2025 and Generate Sales of $7B-$8B by 2025",2018-09-14 15:02:00-04:00,AGN,neutral
43195.0,"FDA Says Believes Currently Available Scientific Evidence Does Not Conclusively Demonstrate Association Between Breast Implants And Connective Tissue Diseases, Says More Evaluation Is Required",2018-09-14 12:12:00-04:00,AGN,neutral
43196.0,Allergan To Acquire Bonti For An Upfront Payment Of $195M Plus Additional Potential Commercial Milestone Payments,2018-09-14 09:15:00-04:00,AGN,neutral
43197.0,"Insider Buys Of The Week: Allergan, American Homes 4 Rent, Tiffany",2018-09-09 18:13:00-04:00,AGN,neutral
43198.0,Health Care Has Been On Fire. Will The Uptrend Continue?,2018-09-07 14:40:00-04:00,AGN,positive
43199.0,New Class of Migraine Drug Creates Four-Way Pharma Development Race,2018-09-06 15:58:00-04:00,AGN,positive
43200.0,"Wells Fargo Maintains Outperform on Allergan, Lowers Price Target to $232",2018-08-23 08:03:00-04:00,AGN,positive
43201.0,"Morgan Stanley Maintains Overweight on Allergan, Raises Price Target to $202",2018-08-23 07:40:00-04:00,AGN,negative
43202.0,"The Daily Biotech Pulse: FDA Snub For Allergan, Myriad's Q4 Beat, Mallinckrodt's Stannsoporfin",2018-08-22 08:20:00-04:00,AGN,negative
43203.0,UPDATE: FDA Said It Is Not Able To Approve Ulipristal Acetate NDA In Its Current Form; Agency Cited Safety Concerns Regarding ESMYA Post-Marketing Reports Outside US,2018-08-21 17:02:00-04:00,AGN,positive
43204.0,Allergan Receives Complete Response Letter From U.S. Food And Drug Administration For Ulipristal Acetate New Drug Application,2018-08-21 17:00:00-04:00,AGN,neutral
43205.0,"Stocks Trading Ex Dividend Today, August 16th",2018-08-16 09:18:00-04:00,AGN,neutral
43206.0,Allergan Option Alert: Fri $170 Calls at the Bid: 500 @ $13.85 vs 4801 OI; Ref=$183.83,2018-08-15 12:09:00-04:00,AGN,positive
43207.0,"Stocks That Will Be Trading Ex Dividend Tomorrow, August 16th",2018-08-15 11:36:00-04:00,AGN,neutral
43208.0,"13F From David Tepper's Appaloosa Late Tuesday Showed Cut Stake In Alibaba, Allergan, Alphabet, Altaba, Dollar General, Facebook, & MGM Resorts; Raised Stake In Caesars Entertainment, Micron, Western Digital, & Wells Fargo",2018-08-15 11:30:00-04:00,AGN,positive
43209.0,Jana Partners 13F Shows Dissolved 12K Shares Stake In Allergan,2018-08-14 10:06:00-04:00,AGN,positive
43210.0,United Therapeutics Announces Settlement of Patent Litigation With Watson Laboratories  Relating to Tyvaso,2018-08-08 20:08:00-04:00,AGN,positive
43211.0,Allergan and Editas Medicine Announce Exercise of Options To Jointly Develop CRISPR Genome Editing Medicine EDIT-101,2018-08-06 16:03:00-04:00,AGN,neutral
43212.0,Almirall to Acquire U.S. Dermatology Portfolio from Allergan for $550M,2018-08-03 04:08:00-04:00,AGN,neutral
43213.0,Attention Biotech Investors: Mark Your Calendar For These August PDUFA Dates,2018-08-01 07:38:00-04:00,AGN,neutral
43214.0,"Jim Cramer Weighs In On Allergan, Procter & Gamble And More",2018-07-31 07:24:00-04:00,AGN,neutral
43215.0,Shares Of Allergan Up 1.7% As Dealreporter Speculates Activist Interest In The Co.,2018-07-27 09:53:00-04:00,AGN,positive
43216.0,"Nasdaq, Tech Names Might Come Under Pressure Following Facebook's Weak Results",2018-07-26 10:06:00-04:00,AGN,negative
43217.0,"'""The days of driving growth through large price increases is coming to an end in our industry,"" $AGN CEO @brentlsaunders says on earnings call' -Tweet From CNBC's Meg Tirrell",2018-07-26 09:17:00-04:00,AGN,positive
43218.0,"Benzinga's Daily Biotech Pulse: Biogen, AC Immune Slip Despite Positive Trials, Sarepta Slapped With Clinical Hold",2018-07-26 08:40:00-04:00,AGN,negative
43219.0,UPDATE: Allergan Sees FY18 Net Income Of $16.00-$16.50 vs $16.08 Est.,2018-07-26 06:34:00-04:00,AGN,neutral
43220.0,Allergan Sees Q3 Adj. EPS $3.80-$4.10 vs $3.90 Est.,2018-07-26 06:33:00-04:00,AGN,neutral
43221.0,Allergan Raises FY18 Sales From $15.15-$15.35B To $15.45-$15.60B,2018-07-26 06:33:00-04:00,AGN,neutral
43222.0,Allergan Authorizes New $2B Buyback,2018-07-26 06:31:00-04:00,AGN,neutral
43223.0,"Allergan Q2 EPS $4.42 Beats $4.12 Estimate, Sales $4.124B Beat $3.91B Estimate",2018-07-26 06:31:00-04:00,AGN,neutral
43224.0,"Earnings Scheduled For July 26, 2018",2018-07-26 04:20:00-04:00,AGN,neutral
43225.0,Allergan's Q2 Earnings Preview,2018-07-25 14:30:00-04:00,AGN,neutral
43226.0,Allergan Receives FDA Fast Track Designation for AGN-241751,2018-07-23 08:00:00-04:00,AGN,neutral
43227.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Results, Earnings And IPOs",2018-07-22 17:03:00-04:00,AGN,neutral
43228.0,Mylan Press Release Highlights Earlier Report Court Denied Allergan's Attempt To Protect Its Drug Patents Through A Deal With A Native American Tribe,2018-07-20 16:12:00-04:00,AGN,negative
43229.0,"U.S. Appeals Court Rejects Allergan Bid To Protect Drug Patents Through Deal With Native America Tribe, Court Says Tribal Sovereign Immunity Can't Be Used To Prevent Govt. Review of Patents",2018-07-20 12:28:00-04:00,AGN,negative
43230.0,"Appeals Court Has Ruled Allergan, Mohawks Can't Assert Tribal Immunity, Co. Must Face Patent Review Board",2018-07-20 10:27:00-04:00,AGN,neutral
43231.0,"Allergan, Molecular Partners Reports Two Positive Phase 3 Clinical Trials for Abicipar pegol 8 and 12-week Regimens for the Treatment in Patients with Neovascular Age-Related Macular Degeneration",2018-07-19 08:04:00-04:00,AGN,positive
43232.0,Cantor Fitzgerald Makes An Uber-Bullish Call On Galmed Pharmaceuticals,2018-07-12 12:11:00-04:00,AGN,neutral
43233.0,"Allergan To Report Q2 Earnings On Thurs., Jul. 26 Before Market Open",2018-06-26 08:11:00-04:00,AGN,neutral
43234.0,"The IPO Outlook For The Week Of June 18: Pharma, Pharma And More Pharma",2018-06-17 16:22:00-04:00,AGN,neutral
43235.0,Allergan Shares Spike ~$2 Higher Over Last Min.; Traders Circulating Speculation Carl Icahn Could Push For Sale,2018-06-14 09:44:00-04:00,AGN,positive
43236.0,Allergan Announces Topline Phase 3 Clinical Data for Bimatoprost SR Implant for IOP Lowering in Patients with Open-Angle Glaucoma or Ocular Hypertension,2018-06-13 08:02:00-04:00,AGN,negative
43237.0,Galmed Shares More Than Double As It Hits Bullseye With Fatty Liver Candidate,2018-06-12 11:47:00-04:00,AGN,positive
43238.0,"Bank of America Maintains Buy on Allergan, Raises Price Target to $213",2018-06-12 07:44:00-04:00,AGN,neutral
43239.0,10 Biggest Price Target Changes For Monday,2018-06-11 10:00:00-04:00,AGN,neutral
43240.0,Allergan's Oral CGRP Receptor Antagonist Atogepant Demonstrates Robust Efficacy And Safety In Episodic Migraine Prevention In Phase 2b/3 Clinical Trial,2018-06-11 08:04:00-04:00,AGN,positive
43241.0,"Mizuho Maintains Neutral on Allergan, Raises Price Target to $176",2018-06-11 07:35:00-04:00,AGN,neutral
43242.0,"Pharma Stock Roundup: Merck, Eli Lilly, AbbVie And More",2018-06-08 16:33:00-04:00,AGN,neutral
43243.0,Bernstein: What Activism Means For Allergan Shareholders,2018-06-08 09:45:00-04:00,AGN,neutral
43244.0,Allergan Shares Up 5.6% After Bloomberg Reported Possible Carl Icahn Stake,2018-06-07 12:18:00-04:00,AGN,positive
43245.0,"The Market In 5 Minutes: Allergan, Solars, Jobless Claims And More",2018-06-07 09:05:00-04:00,AGN,neutral
43246.0,"'Allergan jumps after-hours; Carl Icahn has built a small position in the company, a report says.'",2018-06-06 16:51:00-04:00,AGN,neutral
43247.0,"Watching Shares of Allergan As Traders In Chatrooms Circulate Chatter Of A Potential Bid From Pfizer, Unconfirmed",2018-06-05 14:15:00-04:00,AGN,positive
43248.0,"Allergan Issues Response Following Appaloosa, Senator Investment Group Letters To Board",2018-06-05 13:44:00-04:00,AGN,neutral
43249.0,"Appaloosa, Senator Investment Group Push For Management Changes At Allergan",2018-06-05 11:22:00-04:00,AGN,neutral
43250.0,Allergan Option Alert: Jul 20 $160 Calls Sweep (9) at the Ask: 500 @ $3.75 vs 232 OI; Earnings 8/2 Before Open [est] Ref=$154.19,2018-06-05 10:56:00-04:00,AGN,positive
43251.0,"Allergan Shares Now Up 1.8% Following Letters From Appaloosa, Senator Investment Group To Co. Board",2018-06-05 10:49:00-04:00,AGN,positive
43252.0,"Allergan Shares Spike 0.5% Over Last Few Mins, Now Up ~0.6% For Session",2018-06-05 10:34:00-04:00,AGN,positive
43253.0,"UPDATE: Appaloosa, Senator Investment Says 'we believe Allergan should publicly disavow large-scale ""transformative"" acquisitions as an element of its strategic review and commit to rationalizing its disparate business units'",2018-06-05 10:33:00-04:00,AGN,positive
43254.0,"UPDATE: Appaloosa, Senator Investment Letter To Allergan Board Includes Comment 'We wish to play a constructive role in this process and, accordingly, request an in-person meeting in the coming days with Chairman, President and CEO...'",2018-06-05 10:33:00-04:00,AGN,positive
43255.0,"UPDATE: Appaloosa, Senator Investment Says Message To Allergan 'remains consistent – become a more focused and nimble enterprise by concentrating on the core therapeutic areas of Medical Aesthetics, Neuroscience and Ophthalmology'",2018-06-05 10:32:00-04:00,AGN,positive
43256.0,"UPDATE: Appaloosa, Senator Investment Group On Allergan: '...the entire exercise with Shire was a waste of valuable time and corporate resources, as well as a distraction from the Company's much needed strategic review'",2018-06-05 10:31:00-04:00,AGN,negative
43257.0,"UPDATE: Appaloosa Says Half-Hearted Strategic Review Represents Continuation of Untenable Status Quo, Renews Calls For Co. To Stop Hiding Behind An Arbitrary Debt Reduction Target As An Excuse To Preserve Means  To Pursue M&A",2018-06-05 10:31:00-04:00,AGN,negative
43258.0,"Appaloosa, Senator Investment Group Send Letters To Allergan Board",2018-06-05 10:30:00-04:00,AGN,neutral
43259.0,Hearing RBC Says Allergan And Biogen Are Two Companies That Could Be Interested In Either Partnering Or Acquiring Alder Biophamraceuticals,2018-05-31 13:35:00-04:00,AGN,positive
43260.0,"Allergan Looks To Sell Women's Health, Infectious Disease Businesses",2018-05-30 11:41:00-04:00,AGN,neutral
43261.0,"Allergan CEO Says Co. Plans Sale Of Women's Health, Infection Disease Businesses",2018-05-30 10:06:00-04:00,AGN,neutral
43262.0,'BREAKING: Allergan to sell women's health and infectious disease units after strategic review – sources '-CNBC Now,2018-05-30 09:40:00-04:00,AGN,neutral
43263.0,"Bernstein Strategic Decisions Conference Begins Today, Presenters Include: Domino's Pizza, Juniper, US Bancorp, Delta Air Lines, Allergan, Clorox, Mastercard, Citigroup, Softbank, McDonald's, Bank of America, and Las Vegas Sands",2018-05-30 06:50:00-04:00,AGN,neutral
43264.0,Allergan Shares Down Around 2.3% As Stat News Reports 'Allergan recalls birth-control pill packs with out-of-order placebos',2018-05-29 13:29:00-04:00,AGN,positive
43265.0,Allergan Exercises Option To Acquire Drug Candidate AGN-241751 From Aptinyx Discovery Platform Under Ongoing Research Collaboration,2018-05-22 08:03:00-04:00,AGN,neutral
43266.0,"Jim Cramer Weighs In On Royal Caribbean Cruises, Allergan And More",2018-05-22 07:38:00-04:00,AGN,neutral
43267.0,Cantor Fitzgerald: 18 Drug Companies With Catalysts Worth Watching,2018-05-19 16:10:00-04:00,AGN,positive
43268.0,13F From David Tepper's Appaloosa Shows Increased Stake In Allergan From ~3.47M Shares To 3.7M Shares,2018-05-15 16:12:00-04:00,AGN,positive
43269.0,"Allergan Shares Up 2.7% Over Last 40 Mins., Up 3.9% For Session; Traders Attributing Volume, Price Spike To Earlier Questionable Takeover Chatter",2018-05-10 10:49:00-04:00,AGN,neutral
43270.0,Hearing Teva Canada Launches A Generic Version Of Allergan's Restasis,2018-05-10 09:33:00-04:00,AGN,neutral
43271.0,"Morgan Stanley Turns Bearish On Ironwood Pharma, Lowers Linzess Sales Estimate",2018-05-09 10:13:00-04:00,AGN,negative
43272.0,Ironwood and Allergan Announce Settlement With Aurobindo Pharma Over LINZESS Patent Litigation,2018-05-03 17:08:00-04:00,AGN,negative
43273.0,"Credit Suisse Maintains Outperform on Allergan, Lowers Price Target to $213.00",2018-05-03 10:53:00-04:00,AGN,positive
43274.0,"Benzinga's Top Analyst Calls From May 1, 2018",2018-05-01 14:31:00-04:00,AGN,positive
43275.0,"Bank of America Maintains Buy on Allergan, Lowers Price Target to $209.00",2018-05-01 11:27:00-04:00,AGN,negative
43276.0,8 Biggest Price Target Changes For Tuesday,2018-05-01 11:11:00-04:00,AGN,neutral
43277.0,"Deutsche Bank Says They Continue To Like Allergan's Setup  In The Event Of Possible Pipeline News, But That The Co.'s Strong Q1 Results Were Overshadowed By The Ongoing Strategic Review Which Didn't Provide Specifics On Strategy Or Timing",2018-05-01 09:35:00-04:00,AGN,positive
43278.0,"Cantor Fitzgerald Maintains Neutral on Allergan, Lowers Price Target to $180.00",2018-05-01 08:41:00-04:00,AGN,negative
43279.0,"Wells Fargo Maintains Outperform on Allergan, Lowers Price Target to $240.00",2018-05-01 08:11:00-04:00,AGN,positive
43280.0,"Benzinga Pro's Most-Searched Tickers For Morning Of Mon., Apr. 30, 2018",2018-04-30 10:15:00-04:00,AGN,neutral
43281.0,Benzinga Pro's 6 Stocks To Watch Today,2018-04-30 08:41:00-04:00,AGN,neutral
43282.0,"Allergan's CEO Says a Large M&A Deal is Low Priority and Unlikely; Focused on Buybacks, Divestitures, Breaking Up the Company, Acquisitions",2018-04-30 08:24:00-04:00,AGN,positive
43283.0,A Peek Into The Markets: US Stock Futures Up Ahead Of Economic Data,2018-04-30 07:16:00-04:00,AGN,neutral
43284.0,"Allergan Raises FY18 Sales $15-$15.3B To $15.15-$15.35B, EPS $15.65-$16.25 vs $15.65 Est.; Q2 Sales $3.85-$4.00B vs $3.84B Est., EPS $4.00-$4.20 vs $3.94 Est.",2018-04-30 07:04:00-04:00,AGN,neutral
43285.0,"Allergan Q1 EPS $3.74 Beats $3.35 Est., Sales $3.67B Beats $3.59B Est.",2018-04-30 07:02:00-04:00,AGN,neutral
43286.0,"10 Stocks To Watch For April 30, 2018",2018-04-30 06:00:00-04:00,AGN,neutral
43287.0,"Earnings Scheduled For April 30, 2018",2018-04-30 05:48:00-04:00,AGN,neutral
43288.0,"The Week Ahead In Biotech: PDUFA Dates, Clinical Trials, Merck And Pfizer Earnings On Tap",2018-04-29 08:11:00-04:00,AGN,neutral
43289.0,UPDATE: Allergan Says Planning US NDA Filing For Ubrogepant In '19,2018-04-27 08:05:00-04:00,AGN,neutral
43290.0,UPDATE: Allergan Says Ubrogepant Study Met Co-Primary Endpoints At 50 mg,2018-04-27 08:04:00-04:00,AGN,neutral
43291.0,"Allergan Reports On Second Phase 3 Trial For Ubrogepant: ACHIEVE II Study Showed efficacy, Safety, Tolerability",2018-04-27 08:04:00-04:00,AGN,positive
43292.0,"Watching Mylan, Allergan, Valeant Shares Amid Report Generic-Drug Cos. Facing First Charges In US Probe",2018-04-24 15:59:00-04:00,AGN,neutral
43293.0,"Citigroup Maintains Buy on Allergan, Lowers Price Target to $200.00",2018-04-24 08:41:00-04:00,AGN,negative
43294.0,"Citigroup Reinstates Buy on Allergan, Announces $200.00",2018-04-24 07:59:00-04:00,AGN,neutral
43295.0,Allergan Press Release Confirms Co. Does Not Intend To Make Offer For Shire,2018-04-19 14:21:00-04:00,AGN,neutral
43296.0,CNBC: Allergan-Shire Deal Is DOA,2018-04-19 13:41:00-04:00,AGN,negative
43297.0,Allergan Shares Up ~3.2% Over Last Few Mins. Amid Report Co. Will Not Bid For Shire,2018-04-19 12:32:00-04:00,AGN,positive
43298.0,CNBC's Faber Reports Allergan Will Not Bid For Shire,2018-04-19 12:28:00-04:00,AGN,neutral
43299.0,Allergan Confirms Consideration Of Shire Bid,2018-04-19 11:27:00-04:00,AGN,neutral
43300.0,UPDATE: Allergan Says Has Til May 17 To Confirm Intentions With Shire,2018-04-19 10:27:00-04:00,AGN,neutral
43301.0,"Allergan's Full Statement On Strategic Review, Talks With Shire",2018-04-19 10:26:00-04:00,AGN,neutral
43302.0,UPDATE: Allergan Says Is Considering Possible Offer For Shire,2018-04-19 10:22:00-04:00,AGN,neutral
43303.0,Allergan Issues Response Related To Strategic Review,2018-04-19 10:22:00-04:00,AGN,neutral
43304.0,UPDATE: Source Says 'It's Not Clear' Whether Allergan Submitted Offer For Shire,2018-04-19 10:14:00-04:00,AGN,negative
43305.0,"Allergan Shares Now Selling Off, Now Down 3.8% From Session Highs, Down 3% For Session",2018-04-19 09:51:00-04:00,AGN,positive
43306.0,Allergan Shares Spike ~1% Following Report Co. In Talks To Buy Shire; Shire Shares Spike ~1.7%,2018-04-19 09:49:00-04:00,AGN,positive
43307.0,Allergan Shares Fall Amid Report Co. In Talks To Buy Shire,2018-04-19 09:48:00-04:00,AGN,positive
43308.0,"Stifel Says Allergan Could Use A Face-Lift, Initiates Coverage With Hold",2018-04-17 11:51:00-04:00,AGN,neutral
43309.0,"Benzinga's Top Upgrades, Downgrades For April 17, 2018",2018-04-17 09:24:00-04:00,AGN,positive
43310.0,"Stifel Nicolaus Initiates Coverage On Allergan with Hold Rating, Announces $192.00 Price Target",2018-04-17 06:42:00-04:00,AGN,neutral
43311.0,"Allergan And Richter Report That Cariprazine Met Primary And Secondary Endpoints For The 1.5 mg Dose Group, But Did Not Reach Statistical Significance For 3 mg Group",2018-04-03 08:09:00-04:00,AGN,negative
43312.0,UPDATE: Adviser Working With Allergan On Possible Sale Of Women's Health Unit Sees Value At $5B+,2018-04-02 15:32:00-04:00,AGN,positive
43313.0,Allergan Shares Spike ~$3 Amid Report Co. Considering Options For Women's Health Unit,2018-04-02 15:32:00-04:00,AGN,positive
43314.0,Canaccord Sees An 'Intriguing Setup' In Biohaven Following Reaction To Phase 3 News,2018-03-27 16:34:00-04:00,AGN,neutral
43315.0,"Amgen, Allergan Report CHMP Recommended Approval Of ABP 980 For Treatment Of 3 Types Of Cancer",2018-03-23 08:43:00-04:00,AGN,negative
43316.0,"Watch Stocks Mentioned In Barron's Over The Weekend; Gap, Allergan, Xilinx, Micron, Marvell, Maxim Integrated, Microchip Technology, and Analog Devices All Received Positive Mention",2018-03-19 07:38:00-04:00,AGN,positive
43317.0,"Barron's Picks And Pans: Allergan, Broadcom, Gap And More",2018-03-18 15:00:00-04:00,AGN,neutral
43318.0,Allergan Considering All Strategic Options 'With A Sense Of Urgency',2018-03-15 09:05:00-04:00,AGN,neutral
43319.0,"UPDATE: RBC On Allergan Says Mgmt. Made Clear 'all strategic options are being evaluated and ""with a sense of urgency""'",2018-03-14 14:51:00-04:00,AGN,positive
43320.0,Allergan Shares Rally ~$0.90 Over Last Few Mins. As Hearing Traders Circulating Recent Mid-Day Comments From RBC Suggesting Co. Is Exploring Strategic Alternatives,2018-03-14 14:49:00-04:00,AGN,positive
43321.0,Cantor Fitzgerald Names 8 Upcoming Biotech Catalysts,2018-03-13 16:32:00-04:00,AGN,neutral
43322.0,Goldman Sachs Sees 100% Upside In This Biopharma Company,2018-03-05 15:30:00-05:00,AGN,neutral
43323.0,Allergan Says FDA Extended Ulipristal Acetate NDA Review Period To Aug. '18,2018-02-28 16:31:00-05:00,AGN,neutral
43324.0,Jim Cramer Shares His Thoughts On STMicroelectronics And Allergan,2018-02-27 07:22:00-05:00,AGN,positive
43325.0,Mylan Announces the US Patent and Trial Appeal Board Has Denied the St. Regis Mohawk Tribe's Motion to Terminate Mylan's Patent Challenge for 6 Allergan Patents Related to Restasis,2018-02-26 08:14:00-05:00,AGN,negative
43326.0,"Benzinga's Insider Buys Of The Week: Allergan, HCA, Opko And More",2018-02-25 17:01:00-05:00,AGN,neutral
43327.0,"Allergan Shares Tick Toward Session Highs, Now Up 1.8%; Traders Circulating Chatter Of Corporate Split",2018-02-23 11:39:00-05:00,AGN,positive
43328.0,"Benzinga's Top Upgrades, Downgrades For February 23, 2018",2018-02-23 09:44:00-05:00,AGN,positive
43329.0,"SunTrust Robinson Humphrey Initiates Coverage On Allergan with Buy Rating, Announces $200.00 Price Target",2018-02-23 07:47:00-05:00,AGN,neutral
43330.0,"Allergan Announces FDA Acceptance Of Medicines360's Filing For Supplemental New Drug Application For LILETTA, Application Seeks to Extend Duration of Use Up to 5 Years for LILETTA",2018-02-22 08:04:00-05:00,AGN,positive
43331.0,13F From Tepper's Appaloosa Shows Raised Stake In Allergan,2018-02-14 17:00:00-05:00,AGN,neutral
43332.0,BZ NOTE: Allergan Has Now Made a New 52-Wk Low In 3 Times Since Feb. 9th,2018-02-14 12:52:00-05:00,AGN,neutral
43333.0,"Companies That Earlier Made New 52-Wk Highs Include Coty, S&P Global, and Estee Lauder; Those That Made New 52-Wk Lows Include Regeneron Pharma, Vornado Realty, Federal Realty Investment, and Allergan",2018-02-14 12:52:00-05:00,AGN,negative
43334.0,"Stocks That Made New 52-Wk Lows Earlier Include: Patterson Companies, Henry Schein, Allergan, and HCP; New 52-Wk Highs Reached Earlier By CSRA (Being Acquired By General Dynamics For $40.75/Share) and AmerisourceBergen (On Rumored Talks With Walgreens)",2018-02-13 13:20:00-05:00,AGN,positive
43335.0,The Alzheimer's Drug Pipeline: High Failure Rates In Research On An Increasingly Common Disease,2018-02-08 09:41:00-05:00,AGN,negative
43336.0,"Credit Suisse Maintains Outperform on Allergan, Raises price target to $215.00",2018-02-07 13:05:00-05:00,AGN,positive
43337.0,"Leerink Swann Maintains Outperform on Allergan, Raises price target to $242.00",2018-02-07 12:30:00-05:00,AGN,neutral
43338.0,5 Biggest Price Target Changes For Wednesday,2018-02-07 09:39:00-05:00,AGN,neutral
43339.0,"Bank of America Maintains Buy on Allergan, Raises Price Target to $215.00",2018-02-07 08:57:00-05:00,AGN,neutral
43340.0,"Allergan Sees Q1 Adj. EPS $3.20-$3.40 vs $3.71 Est., Sales $3.5-$3.6B vs $3.72B Est.",2018-02-06 07:04:00-05:00,AGN,neutral
43341.0,"Allergan Sees FY18 Sales $15-$15.3B vs $15.9B Est., EPS $15.25-$16.00 vs $14.40 Est.",2018-02-06 07:03:00-05:00,AGN,neutral
43342.0,"Allergan Reports Q4 Adj. EPS $4.86 vs $4.74 Est., Sales $4.326B vs $4.28B Est.",2018-02-06 07:02:00-05:00,AGN,neutral
43343.0,UPDATE: Full PR Of Allergan Announcing Positive Top Line Phase 3 Results for Ubrogepant,2018-02-06 06:47:00-05:00,AGN,positive
43344.0,Allergan ACHIEVE I  Meets Co-Primary Endpoints In First Of Two Phase 3 Studies,2018-02-06 06:46:00-05:00,AGN,neutral
43345.0,"Earnings Scheduled For February 6, 2018",2018-02-06 04:22:00-05:00,AGN,neutral
43346.0,The Week Ahead: IPOs Ramp Up Just As Earnings Season Fades,2018-02-05 13:22:00-05:00,AGN,neutral
43347.0,"Allergan Announces FDA Approves AVYCAZ, First Gram-Negative Antibiotic Approved in the U.S. to Treat HABP/VABP in Over 15 Years",2018-02-01 16:31:00-05:00,AGN,positive
43348.0,Vetr Crowd Upgrades Allergan,2018-02-01 15:12:00-05:00,AGN,neutral
43349.0,"Allergan CEO Brent Saunders Tweets: Well done!  @itswarrenbuffet @JeffBezos @jpmorgan We need more innovation to improve the delivery of care and costs.  #boldforlife @amazon  Amazon, Berkshire Hathaway, and JPMorgan Chase to partner on US employee health",2018-01-30 07:19:00-05:00,AGN,positive
43350.0,"Barclays Injects Allergan With An Upgrade, Says Valuation Model Has Improved",2018-01-29 10:39:00-05:00,AGN,positive
43351.0,"Benzinga's Top Upgrades, Downgrades For January 29, 2018",2018-01-29 09:19:00-05:00,AGN,positive
43352.0,"The Market In 5 Minutes: Steve Wynn, Sanofi-Ablynx, Trump's Infrastructure Plan",2018-01-29 09:10:00-05:00,AGN,neutral
43353.0,Barclays Upgrades Allergan to Overweight,2018-01-29 06:35:00-05:00,AGN,negative
43354.0,Hearing Unconfirmed Chatter That Allergan is Considering Acquiring Kandy,2018-01-25 07:45:00-05:00,AGN,negative
43355.0,Teva's Asthma Therapy Reslizumab Fails In Late-Stage Studies,2018-01-23 10:59:00-05:00,AGN,negative
43356.0,"UPDATE: BofA Raises Price Objective On Allergan From $201 To $208, Maintains Buy Rating",2018-01-23 07:59:00-05:00,AGN,neutral
43357.0,"BofA Adds Allergan, Vertex Pharma To 'US 1' List",2018-01-23 07:58:00-05:00,AGN,neutral
43358.0,Mike Khouw Sees Unusual Options Activity In Allergan,2018-01-23 07:20:00-05:00,AGN,neutral
43359.0,"Amgen Reports EC Approval Of Co., Allergan's MVASI For Treatment Of Certain Types Of Cancer",2018-01-18 16:00:00-05:00,AGN,negative
43360.0,13D/A Filing Shows Allergan Reporting 6.8% Stake in Teva Pharmaceuticals,2018-01-12 12:18:00-05:00,AGN,neutral
43361.0,"Ohio Attorney General Says State Is Hoping To Begin Opioid Settlement Talks With Endo, Allergan",2018-01-11 13:51:00-05:00,AGN,positive
43362.0,"Cantor Out With Note On Endo, Says Oxymorphone Subpoena May Not Hurt That Much And Is Isolated To Endo For Now, But More Co.'s Could Be The Target To Investigations Over Time Including Teva, Mylan, Impax, Mallinckrodt, Allergan",2018-01-11 11:18:00-05:00,AGN,positive
43363.0,"Allergan Reports Prelim. FY18 Adj. EPS Greater Than Or Equal To $15.25 vs $15.80 Est., Sales $15B-$15.3B vs $15.61B Est.",2018-01-08 16:31:00-05:00,AGN,positive
43364.0,"8-K From Allergan Reports Workforce Reductions Of Over 1K Employees In Commercial and Other Functions, Will Eliminate 400 Currently Open Positions, Expects To Incur ~$125M Restructuring Charge Majority Of Which To Be Recorded In Q4",2018-01-03 11:25:00-05:00,AGN,neutral
43365.0,Partek Pharma Earns a $5M Milestone Payment From Allergan,2018-01-03 07:10:00-05:00,AGN,neutral
43366.0,Allergan 8-K Shows Forest Labs Merged With And Into Allergan Sales,2018-01-02 16:28:00-05:00,AGN,neutral
43367.0,"Several Biotechs Higher Tuesday Amid Jefferies Mention Of Price Increases In Effect; Insys +13.21%, Synergy Pharmaceuticals +6.72%, Allergan +3.22%, Horizon Pharma +0.99%, Supernus Pharma +0.25%, Teva Pharma +0.53%; Collegium An Outlier, Down 0.64%",2018-01-02 12:26:00-05:00,AGN,neutral
43368.0,"Pershing Square Announces Settlement Agreements Related to Allergan, Pershing Square to Pay $193.75M and Valeant to Pay $96.25M; Pershing Square Had Previously Set Aside $75M For the Case",2017-12-29 12:43:00-05:00,AGN,positive
43369.0,Allergan Reports Acknowledgement Of Appeals Court Decision For COMBIGAN,2017-12-22 14:46:00-05:00,AGN,neutral
43370.0,A Peek Into The Markets: U.S. Stock Futures Up Ahead Of Economic Data,2017-12-21 06:50:00-05:00,AGN,neutral
43371.0,"10 Stocks To Watch For December 21, 2017",2017-12-21 05:32:00-05:00,AGN,neutral
43372.0,5 Stocks Moving In Wednesday's After-Hours Session,2017-12-20 17:07:00-05:00,AGN,neutral
43373.0,Allergan Reports FDA Accepted NDA For Seysara For Treatment Of Moderate To Severe Acne,2017-12-20 16:30:00-05:00,AGN,negative
43374.0,Allergan and Richter Announce Phase 3 Study Of cariprazine Met Primary Endpoint In Study For1.5 mg and 3 mg Dose Groups vs Placebo; Co. Plans To Submit Supplemental New Drug Application To FDA In 2nd Half of 2018,2017-12-18 08:05:00-05:00,AGN,neutral
43375.0,"STAT News' Adam Feuerstein Responds To Tweet Highlighting '$PFE $AGN rumor - no source': 'The other day I heard $PFE for $BMY,' 'Also $ABBV for $BMY'",2017-12-14 10:05:00-05:00,AGN,negative
43376.0,Allergan Shares Spiking Higher As Traders Circulate Chatroom Takeover Chatter,2017-12-14 10:01:00-05:00,AGN,positive
43377.0,"Wall Street's M&A Chatter From December 12: Fox-Disney, Repros Therapeutics-Allergan, Agrium-Macrofertil",2017-12-13 07:33:00-05:00,AGN,neutral
43378.0,Repros Therapeutics Acquired by Allergan for $0.67/Share Cash,2017-12-12 06:31:00-05:00,AGN,neutral
43379.0,Hearing Bill Ackman Likely To Face Trial For Allergan Insider-Trading Claims,2017-12-08 15:30:00-05:00,AGN,neutral
43380.0,"Lightning Round: Jim Cramer Shares His Thoughts On Allergan, ETP, Cisco And More",2017-12-08 07:41:00-05:00,AGN,positive
43381.0,Botox Competition Spurs Argus To Downgrade Allergan,2017-12-07 12:18:00-05:00,AGN,neutral
43382.0,"Benzinga's Top Upgrades, Downgrades For December 7, 2017",2017-12-07 09:21:00-05:00,AGN,positive
43383.0,Argus Downgrades Allergan to Hold,2017-12-07 08:10:00-05:00,AGN,neutral
43384.0,"Allergan CEO Brent Saunders Buys 4,600 @ Avg Price: $164.74 -Form 4",2017-12-06 12:33:00-05:00,AGN,neutral
43385.0,"Benzinga's Top Upgrades, Downgrades For November 29, 2017",2017-11-29 09:11:00-05:00,AGN,positive
43386.0,"The Market In 5 Minutes: Chipotle CEO Search, Matt Lauer Fired, GDP Grows 3.3%",2017-11-29 08:53:00-05:00,AGN,negative
43387.0,"Analyst Says Negative Allergan Headlines Are Priced In, Upgrades Stock",2017-11-29 08:48:00-05:00,AGN,negative
43388.0,Morgan Stanley Upgrades Allergan to Overweight,2017-11-29 06:55:00-05:00,AGN,negative
43389.0,"Leerink Swann Reinstates Outperform on Allergan PLC, Announces $237.00",2017-11-27 08:16:00-05:00,AGN,neutral
43390.0,Allergan 13G Filing From GIC Private Shows New 5.11% Stake,2017-11-16 16:38:00-05:00,AGN,neutral
43391.0,"Q3 13F Roundup: How Buffett, Einhorn, Paulson, And Others Adjusted Their Portfolio",2017-11-15 12:14:00-05:00,AGN,neutral
43392.0,13F Filing Shows Paulson & Co. Reduced Stake In Allergan,2017-11-14 16:59:00-05:00,AGN,neutral
43393.0,"Omega Advisors Takes Stake In Aetna, Dissolves Stake In Allergan; Cuts Stake In AIG",2017-11-14 10:30:00-05:00,AGN,negative
43394.0,Allergan Receives FDA Approval For Use of VRAYLAR in the Maintenance Treatment of Schizophrenia,2017-11-13 07:36:00-05:00,AGN,positive
43395.0,Amgen And Allergan Receive a Positive CHMP Opinion For ABP 215 For The Treatment Of Certain Types Of Cancer,2017-11-10 07:28:00-05:00,AGN,positive
43396.0,"The Companies That Manipulated The Tax System, According To The Paradise Papers",2017-11-06 17:03:00-05:00,AGN,positive
43397.0,Allergan Shares Not Reacting Strongly As Traders Circulate 'Desk Chatter' Suggesting Co. Considering Break Up,2017-11-03 10:24:00-04:00,AGN,positive
43398.0,"Allergan Shares Down 5.52%; Earlier Morgan Stanley Cut Co. Price Target 12% From $228 to $200, Citing Lower Restasis Earnings and Competitive Threats To Botox",2017-11-02 14:10:00-04:00,AGN,negative
43399.0,5 Biggest Price Target Changes For Thursday,2017-11-02 09:54:00-04:00,AGN,neutral
43400.0,11 Technical Levels Discussed On Wednesday's PreMarket Prep,2017-11-01 09:37:00-04:00,AGN,neutral
43401.0,A Peek Into The Markets: U.S. Stock Futures Climb; Facebook Earnings In Focus,2017-11-01 07:15:00-04:00,AGN,neutral
43402.0,"Allergan Narrows FY17 Adj. EPS Outlook From $16.05-$16.45 To $16.15-$16.45 vs $16.21 Est., Sales From $15.85B-$16.05B To $15.875B-$16.025B vs $16.21B Est.",2017-11-01 07:07:00-04:00,AGN,neutral
43403.0,"Allergan Reports Q3 Adj. EPS $4.15 vs $4.06 Est., Sales $4.034B vs $4.03B Est.",2017-11-01 07:06:00-04:00,AGN,neutral
43404.0,"Earnings Scheduled For November 1, 2017",2017-11-01 04:33:00-04:00,AGN,neutral
43405.0,Allergan Presented New Phase 3 Data of Ulipristal Acetate in Women with Uterine Fibroids at the American Society for Reproductive Medicine Annual Congress,2017-10-31 16:01:00-04:00,AGN,neutral
43406.0,Allergan Receives Approval for Ozurdex in China for the Treatment of Retinal Vein Occlusion,2017-10-30 08:04:00-04:00,AGN,positive
43407.0,Allergan Increases Qtr. Dividend From $0.70 to $0.72/Share,2017-10-27 08:06:00-04:00,AGN,neutral
43408.0,Allergan Raises Qtr. Dividend From $0.70 To $0.72/Share,2017-10-27 08:01:00-04:00,AGN,neutral
43409.0,"Jim Cramer Shares His Thoughts On Caterpillar, Coca-Cola And More",2017-10-23 09:20:00-04:00,AGN,positive
43410.0,38 Biggest Movers From Yesterday,2017-10-20 06:21:00-04:00,AGN,neutral
43411.0,Mid-Afternoon Market Update: Crude Oil Down 1.25%; Alcobra Shares Spike Higher,2017-10-19 14:30:00-04:00,AGN,negative
43412.0,32 Stocks Moving In Thursday's Mid-Day Session,2017-10-19 12:59:00-04:00,AGN,neutral
43413.0,Mid-Day Market Update: Heritage-Crystal Clean Drops On Weak Q3 Results; Imprimis Pharmaceuticals Shares Surge,2017-10-19 12:37:00-04:00,AGN,positive
43414.0,Mid-Morning Market Update: Markets Open Lower; Verizon Sales Beat Estimates,2017-10-19 10:05:00-04:00,AGN,negative
43415.0,5 Biggest Price Target Changes For Thursday,2017-10-19 09:41:00-04:00,AGN,neutral
43416.0,"The Market In 5 Minutes: Chaos In Catalonia, Black Monday's 30th Anniversary",2017-10-19 09:31:00-04:00,AGN,negative
43417.0,"Benzinga's Top Upgrades, Downgrades For October 19, 2017",2017-10-19 09:08:00-04:00,AGN,positive
43418.0,Imprimis Launches 99-Cent Generic Drug To Compete With Allergan's Restasis,2017-10-19 07:50:00-04:00,AGN,neutral
43419.0,Mizuho Downgrades Allergan plc Ordinary Shares to Neutral,2017-10-19 06:43:00-04:00,AGN,positive
43420.0,Allergan Lower After Edward Jones Downgrade,2017-10-18 13:13:00-04:00,AGN,negative
43421.0,Edward Jones Downgrades Allergan plc Ordinary Shares to Hold,2017-10-18 09:45:00-04:00,AGN,positive
43422.0,"Syndax Expands Pipeline with Exclusive Worldwide License to Allergan's Portfolio of Menin-MLL Inhibitors, Terms Not Disclosed",2017-10-17 07:19:00-04:00,AGN,neutral
43423.0,UPDATE: Allergan Says None Of The Proposed Generic Versions Of RESTASIS Have Received Approval And None Of These Products Would Be Able To Launch In Market,2017-10-16 13:47:00-04:00,AGN,positive
43424.0,"U.S. District Court for the Eastern District of Texas Issues Adverse Trial Decision Concerning RESTASIS, Says They Will Appeal U.S. District Court Ruling",2017-10-16 13:45:00-04:00,AGN,negative
43425.0,Hearing Allergan Patents For Restasis Are Invalidated By Federal Judge,2017-10-16 12:56:00-04:00,AGN,neutral
43426.0,"Pharma Stock Roundup: Pfizer Mulls Options For Consumer Healthcare, Eli Lilly's Pipeline Setback",2017-10-13 12:19:00-04:00,AGN,neutral
43427.0,"Allergan Reaches Settlement On RESTASIS Patent Litigation With InnoPharma; Litigation Will Be Dismissed, Allergan Will Grant InnoPharma Licenses To Market Generic RESTASIS",2017-10-12 16:16:00-04:00,AGN,neutral
43428.0,Watch These 8 Huge Put Purchases In Thursday Trade,2017-10-12 04:04:00-04:00,AGN,positive
43429.0,Benzinga's Option Alert Recap From October 11,2017-10-11 16:15:00-04:00,AGN,positive
43430.0,Allergan Option Alert: Oct 27 $207.5 Puts Sweep (10) at the Bid: 1000 @ $4.25 vs 132 OI; Ref=$208.17,2017-10-11 09:48:00-04:00,AGN,positive
43431.0,"Dermira Shares Spike Higher Following Discussion From Evercore ISI Analyst On CNBC, Dermira, Allergan Are Analyst's Top Picks",2017-10-10 15:23:00-04:00,AGN,positive
43432.0,"Allergan Reports FDA Has Accepted NDA For Ulipristal Acetate For Uterine Fibroids, Sees PDUFA Action Date Occurring In 1H'18",2017-10-10 08:03:00-04:00,AGN,positive
43433.0,Health Care Sector Back In Focus In Congress Ahead Of Q3 Earnings Result,2017-10-09 15:56:00-04:00,AGN,positive
43434.0,Life (Science) Lessons: The Hows And Whos To Play Biotech,2017-10-06 11:09:00-04:00,AGN,positive
43435.0,Teva Shares Plummet After Mylan's Copaxone Generic Gets FDA Approval,2017-10-05 12:08:00-04:00,AGN,positive
43436.0,"Jim Cramer Advises His Viewers On Teva, AT&T And More",2017-10-05 07:51:00-04:00,AGN,neutral
43437.0,Allergan Shares Tick Slightly Lower As Hearing House Oversight Committee Has Opened Investigation Into Co.'s Patent Deal With Tribe,2017-10-03 13:36:00-04:00,AGN,positive
43438.0,FDA Approves Allergan's BOTOX Cosmetic for the Temporary Improvement in the Appearance of Moderate to Severe Forehead Lines Associated with Frontalis Muscle Activity In Adults,2017-10-03 07:34:00-04:00,AGN,positive
43439.0,Allergan Issues Release Highlighting FDA Approval For BOTOX Cosmetic For Temporary Improvement In The Appearance Of Moderate To Severe Forehead Lines Associated With Frontalis Muscle Activity In Adults,2017-10-03 07:33:00-04:00,AGN,positive
43440.0,Meg Tirrell Tweets: Missed this Fri: federal court ruled Obama admn acted unlawfully in rules that resulted in $PFE abandoning $AGN deal uk.reuters.com/article/uk-usa…,2017-10-02 13:47:00-04:00,AGN,negative
43441.0,"Meg Tirell Tweets: $SHPG sues $AGN, alleging it schemed to block drs from prescribing Restasis competitor uk.reuters.com/article/us-all…",2017-10-02 12:29:00-04:00,AGN,negative
43442.0,UPDATE: Allergan Avycaz Application Seeks Label Extension To Include Indication And Phase 3 Data For Treatment Of Hospital Patients,2017-10-02 08:02:00-04:00,AGN,neutral
43443.0,FDA Accepts Supplemental New Drug Application (sNDA) filing for AVYCAZ,2017-10-02 08:01:00-04:00,AGN,positive
43444.0,"Attention Biotech Investors, Here's Your PDUFA Primer For October",2017-09-28 10:51:00-04:00,AGN,neutral
43445.0,The Market In 5 Minutes: The Market Wakes Up To The Trump Tax Plan,2017-09-28 08:25:00-04:00,AGN,neutral
43446.0,"In a Letter, U.S. Senators Ask Senate Judiciary Committee To Investigate Allergan Transfer Deal And Impact On Drug Prices",2017-09-27 15:54:00-04:00,AGN,neutral
43447.0,Allergan CFO to Retire,2017-09-25 07:36:00-04:00,AGN,neutral
43448.0,Allergan 'Affirms Commitment to Increasing Cash Dividend',2017-09-25 07:33:00-04:00,AGN,positive
43449.0,Allergan Announces $2B Buyback,2017-09-25 07:32:00-04:00,AGN,neutral
43450.0,Allergan Reports Co. Received Refusal To File Letter From FDA Related To Vraylar sNDA For Treatment Of Negative Symptoms In Schizophrenia,2017-09-22 16:51:00-04:00,AGN,negative
43451.0,"Allergan Reports Top-Line Results From New Data For CENTAUR Phase 2b Study Support Anti-Fibrotic Efficacy, Safety Of Cenicriviroc For Treatment Of Liver Fibrosis In Adults With NASH",2017-09-22 08:01:00-04:00,AGN,positive
43452.0,2 Allergan Option Alerts In The Past Minute: Oct 20 $210 Calls at the Ask: 1000 at $3.25 vs 690 OI; Ref=$203.22; and Oct 20 $202.5 Calls Sweep (37) at the Ask: 592 at $6.551 vs 0 OI; Ref=$203.42,2017-09-21 13:06:00-04:00,AGN,neutral
43453.0,"Benzinga's Top Upgrades, Downgrades For September 20, 2017",2017-09-20 09:12:00-04:00,AGN,positive
43454.0,The Market In 5 Minutes,2017-09-20 07:50:00-04:00,AGN,neutral
43455.0,Morgan Stanley Downgrades Allergan plc Ordinary Shares to Equal-Weight,2017-09-20 06:07:00-04:00,AGN,positive
43456.0,Morgan Stanley Downgrades Allergan to Equal-Weight from Overweight from ; Lowers PT to $228 from $284,2017-09-20 04:54:00-04:00,AGN,negative
43457.0,"UPDATE: NY AG Schneiderman Served Subpoenas To Endo Int'l, J&J's Janssen Pharma, Teva, Allergan",2017-09-19 12:35:00-04:00,AGN,neutral
43458.0,"Statement From Senator Sherrod Brown Shows He's Looking For A Meeting With Allergan, Shows Concern With Co.'s Patent Deal With Native American Tribe",2017-09-15 11:32:00-04:00,AGN,neutral
43459.0,"Apple, JPMorgan Among Top Picks On New List From UBS",2017-09-14 15:28:00-04:00,AGN,positive
43460.0,FDA Approves Amgen and Allergan's Bevacizumab,2017-09-14 12:04:00-04:00,AGN,positive
43461.0,REMINDER: Today Is BsUFA Date For Amgen & Allergan's Bevacizumab,2017-09-14 09:10:00-04:00,AGN,neutral
43462.0,"Allergan, Equifax, Target, Thermo Fisher: Fast Money Picks For September 14",2017-09-14 07:13:00-04:00,AGN,neutral
43463.0,"Jim Cramer Gives His Opinion On Allergan, USG And Arena Pharmaceuticals",2017-09-12 08:01:00-04:00,AGN,neutral
43464.0,"Amgen, Allergan Present Phase 3 Data On Biosimilar Trastuzumab Candidate ABP 980 at ESMO 2017",2017-09-09 15:52:00-04:00,AGN,neutral
43465.0,Allergan Shares Make Delayed Reaction Higher Following Resumption: Stock Now Up 3% For Session,2017-09-08 12:55:00-04:00,AGN,positive
43466.0,"Allergan Shares Resume Trade, Spiked To Session High At $230.30, Quickly Pare Gains, Stock Now Largely Unaffected, Up 0.7% For Session",2017-09-08 12:47:00-04:00,AGN,positive
43467.0,UPDATE: Allergan Shares Indicated $230-$235,2017-09-08 12:44:00-04:00,AGN,positive
43468.0,Allergan Shares Showing Price Indication Suggesting Resume Time Nearing,2017-09-08 12:44:00-04:00,AGN,positive
43469.0,"UPDATE: Allergan Says Saint Regis Mohawk Tribe Now Owns All Orange Book-Listed Patents For RESTASIS 0.05%, Allergan Granted Exclusive Licenses Related To Product",2017-09-08 12:40:00-04:00,AGN,positive
43470.0,UPDATE: Allergan Says Deal With Saint Regis Mohawk Tribe Has No Impact On Pending ANDA Patent Litigations Related To RESTASIS Patent Family Which Completed 5-Day Trial In Federal Court In Texas,2017-09-08 12:39:00-04:00,AGN,negative
43471.0,"UPDATE: Allergan Says Under Terms Of Deal With Saint Regis Mohawk Tribe Will Receive $13.75M Upon Execution Of Deal, Eligible To Receive $15M In Annual Royalties",2017-09-08 12:38:00-04:00,AGN,neutral
43472.0,UPDATE: Allergan Says 'The Tribe Is Filing Motion to Dismiss IPR of RESTASIS Patents Based on its Sovereign Immunity',2017-09-08 12:37:00-04:00,AGN,neutral
43473.0,Allergan Reports Deals With Saint Regis Mohawk Related To RESTASIS Patents,2017-09-08 12:36:00-04:00,AGN,neutral
43474.0,Allergan Shares Halted News Pending,2017-09-08 12:33:00-04:00,AGN,positive
43475.0,"New Mexico Said To Be Suing Johnson & Johnson, Endo, Teva, Allergan & Others Over Their Role In Opioid Drug Epidemic",2017-09-07 15:05:00-04:00,AGN,negative
43476.0,Attention Biotech Investors: September Ushers In Another Slew Of PDUFA Catalysts,2017-09-01 14:03:00-04:00,AGN,neutral
43477.0,Allergan Shares Up ~$2.50 Over Last Few Mins.; Traders Attributing Move Higher To Circulation Of Rumor,2017-08-31 10:19:00-04:00,AGN,positive
43478.0,"Jim Cramer Advises His Viewers On Domino's Pizza, Allergan And More",2017-08-31 09:00:00-04:00,AGN,neutral
43479.0,Allergan Announces Settlement of RESTASIS 0.05% Patent Litigation with Famy Care,2017-08-28 16:15:00-04:00,AGN,positive
43480.0,"Playing The US Pharma Space: Buy Portola, Hold Corvus, Sell Teva",2017-08-24 13:46:00-04:00,AGN,positive
43481.0,"Paratek Pharma's 30% Surge, Explained",2017-08-23 12:38:00-04:00,AGN,neutral
43482.0,"Jim Cramer Weighs In On Teva, International Paper And Inogen",2017-08-16 06:51:00-04:00,AGN,neutral
43483.0,"Every Generation Has Its Drug: How People Are Dealing With Opioids, The New (Old) Thing",2017-08-07 11:55:00-04:00,AGN,neutral
43484.0,Allergan Reports FDA Approved Medicines360 sNDA For LILETTA 52 mg To Prevent Pregnancy For Up To 4 Years,2017-08-07 08:02:00-04:00,AGN,positive
43485.0,Analysts Still Like Allergan,2017-08-04 14:12:00-04:00,AGN,positive
43486.0,"UPDATE: Allergan Raises Outlook: Adj. EPS From $15.85-$16.35 To $16.05-$16.45 vs $16.08 Est., Sales From $15.8B-$16B To $15.85B-$16.05B vs $15.8B Est.",2017-08-03 07:54:00-04:00,AGN,neutral
43487.0,Allergan Raises Outlook,2017-08-03 07:53:00-04:00,AGN,neutral
43488.0,"Allergan Reports Q2 Adj. EPS $4.02 vs $3.92 Est., Sales $4B vs $3.94B Est.",2017-08-03 07:53:00-04:00,AGN,neutral
43489.0,"Earnings Scheduled For August 3, 2017",2017-08-03 04:10:00-04:00,AGN,neutral
43490.0,Watch These 5 Huge Call Purchases In Thursday Trade,2017-08-03 04:02:00-04:00,AGN,positive
43491.0,Benzinga's Option Alert Recap From August 2,2017-08-02 16:03:00-04:00,AGN,positive
43492.0,Allergan Option Alert: Sep 15 $270 Calls Sweep (31) at the Bid: 578 @ $1.248 vs 220 OI; Ref=$250.8099,2017-08-02 14:44:00-04:00,AGN,positive
43493.0,"Lightning Round: Jim Cramer Advises His Viewers On Hertz, Macy's And More",2017-07-26 07:13:00-04:00,AGN,neutral
43494.0,"Amgen, Allergan To Discuss Data Supporting Biologics License Application For ABP 215, Biosimilar Candidate To bevacizumab",2017-07-13 08:03:00-04:00,AGN,positive
43495.0,Allergan Reports Viberzi 'proven safe and effective in patients who reported inadequate response to prior loperamide use1',2017-07-10 10:30:00-04:00,AGN,positive
43496.0,Allergan Shares Volatile Around $244 Level As Traders Circulating ClinicalTrials.gov Site Suggesting Co. Terminated 2 Trials Of AGN-195263 For Treatment Of Dry Eye Syndromes,2017-06-29 13:10:00-04:00,AGN,positive
43498.0,"Benzinga's Top Upgrades, Downgrades For June 16, 2017",2017-06-16 09:35:00-04:00,AGN,positive
43499.0,"Cantor Fitzgerald Initiates Coverage On Allergan plc Ordinary Shares with Neutral Rating, Announces $231.00 Price Target",2017-06-16 06:22:00-04:00,AGN,positive
43501.0,"Wall Street's M&A Chatter From June 7: Banco Santander, Staples, Allergan-Keller Medical",2017-06-08 06:51:00-04:00,AGN,neutral
43503.0,"Amgen, Allergan Report FDA Advisory Committee Meeting To Review ABP 215, A Biosimilar Candidate To Bevacizumab",2017-06-07 09:01:00-04:00,AGN,neutral
43504.0,"Allergan to Acquire Keller Medical, Inc., Terms Not Disclosed",2017-06-07 08:33:00-04:00,AGN,neutral
43505.0,Exclusive: RedHill Biopharma CEO Talks Steering His Company Through A Year Heavy With Potential Catalysts,2017-06-05 15:54:00-04:00,AGN,positive
43506.0,States Are Firing Back At Opioid Drug Producers,2017-06-01 10:48:00-04:00,AGN,negative
43507.0,The 19 Stocks On Leon Cooperman's Radar,2017-05-31 16:44:00-04:00,AGN,neutral
43508.0,"Shares Of Johnons & Johnson, Teva Pharma, Endo Int'l, And Allergan All Higher Today Despite News State Of Ohio Has Sued These Companies For Alleged Role In Opioid Epidemic",2017-05-31 12:59:00-04:00,AGN,positive
43509.0,"Q1 Seasonality In The Pharma/Biotech Space: What It Is, Why It Happens And Who Is Affected",2017-05-24 11:02:00-04:00,AGN,negative
43510.0,"Bank Of America Health Care Conference Continues Today; Presenters Include Celgene, Ionis, Neurocrine Biosciences, Cigna, GW Pharma, Allergan, Ironwood Pharma, Tenet Healthcare, Civitas Solutions, & Amgen",2017-05-17 09:03:00-04:00,AGN,positive
43511.0,Citi Prefers These 4 Stocks Over Pfizer On Bottom-Line Concerns,2017-05-16 11:15:00-04:00,AGN,neutral
43512.0,13F from Carl Icahn Shows Liquidated Position in Allergan,2017-05-15 16:34:00-04:00,AGN,neutral
43513.0,Tepper's Appaloosa Lowers Allergan Stake,2017-05-12 16:03:00-04:00,AGN,negative
43514.0,"Top Picks For The Rest Of 2017, Courtesy Of UBS",2017-05-12 15:25:00-04:00,AGN,positive
43515.0,"Benzinga's Top Upgrades, Downgrades For May 10, 2017",2017-05-10 09:29:00-04:00,AGN,positive
43516.0,The Market In 5 Minutes,2017-05-10 09:04:00-04:00,AGN,neutral
43517.0,Goldman Sachs Downgrades Allergan plc Ordinary Shares to Neutral,2017-05-10 06:05:00-04:00,AGN,positive
43518.0,A Peek Into The Markets: U.S. Stock Futures Up Ahead Of Fed Speakers,2017-05-09 07:35:00-04:00,AGN,neutral
43519.0,Allergan Raises FY17 Outlook,2017-05-09 07:03:00-04:00,AGN,neutral
43520.0,"Allergan Reports Q1 Adj. EPS $3.35 vs $3.30 Est., Sales $3.573B vs $3.54B Est.",2017-05-09 07:03:00-04:00,AGN,neutral
43521.0,"Earnings Scheduled For May 9, 2017",2017-05-09 04:32:00-04:00,AGN,neutral
43522.0,Will TherapeuticsMD's Yuvvexy Pass The FDA Muster?,2017-05-07 14:29:00-04:00,AGN,neutral
43523.0,"Wall Street's M&A Chatter From May 4: General Mills, Brookdale Senior Living, Allergan-Paratek",2017-05-05 07:23:00-04:00,AGN,neutral
43524.0,"Companies Holding Shareholder Meetings Today Include; Capitala Finance, Gildan Activewear, UPS, Alaska Air, Allergan, Boston Scientific, & Verizon",2017-05-04 08:31:00-04:00,AGN,neutral
43525.0,"Alimera's Commercial Steroid Implant For Diabetic Macular Edema, Explored",2017-04-30 12:59:00-04:00,AGN,neutral
43526.0,Seeing Notable Block Trade in Allergan: 550K Shares at $238.03/Share,2017-04-25 13:30:00-04:00,AGN,negative
43527.0,Allergan Announces Granted FDA Marketing Authorization for TrueTear,2017-04-25 07:33:00-04:00,AGN,positive
43528.0,"Allergan, Novartis Enter Phase 2b Clinical Trial to Evaluate Use of Allergan's Cenicriviroc, Novartis Lead FXR Agonist to Treat NASH",2017-04-18 04:03:00-04:00,AGN,positive
43529.0,20 Stocks Moving In Tuesday's Pre-Market Session,2017-04-11 09:27:00-04:00,AGN,neutral
43530.0,"Allergan, ZELTIQ Report Expiration of Hart-Scott-Rodino Waiting Period for Pending Transaction",2017-04-06 08:01:00-04:00,AGN,neutral
43531.0,UPDATE: Allergan BOTOX 30U Dose Demonstrated It Was Numerically Superior Efficacy In MADRS Total Score vs. Placebo,2017-04-05 16:35:00-04:00,AGN,positive
43532.0,UPDATE: Allergan Says 50 Units Of Botox Didn't Show Superior Efficacy Over Placebo In Phase 2 Study,2017-04-05 16:33:00-04:00,AGN,negative
43533.0,Allergan Reports Topline Phase II Data Supporting Advancement of BOTOX For Treatment Of MDD,2017-04-05 16:30:00-04:00,AGN,positive
43534.0,"H.C. Wainwright Holding NASH Investor Conference Today; Attendees Include Allergan, Enanta Pharma, Madrigal Pharma, Vascular Biogenics, Albireo Pharma, CymaBay, Gemphire Therapeutics, And Galectin Therapeutics",2017-04-03 08:28:00-04:00,AGN,neutral
43535.0,Guy Adami And Pete Najarian Share Their Thoughts On Nvidia And Allergan,2017-03-30 06:56:00-04:00,AGN,positive
43536.0,"Allergan and Paratek Announce Phase 3 Trials For Treatment Of Moderate To Severe Acne Meet Primary Endpoints, Program on Track for FDA Submission in the Second Half of 2017",2017-03-27 07:32:00-04:00,AGN,negative
43537.0,Buyback ETF Steady As Repurchases Decline,2017-03-23 09:20:00-04:00,AGN,neutral
43538.0,Teva's Stock Inches Higher Amid Cost-Cutting Plan,2017-03-23 08:19:00-04:00,AGN,neutral
43539.0,Allergan Continues Educational Strategy Amid FDA's Report Linking Breast Implants To Rare Cancer,2017-03-22 10:19:00-04:00,AGN,negative
43540.0,"Allergan Responds To Reports Of Breast Implants Causing Cancer; Highlights To Benzinga Co. Working Closely With FDA On Product Labeling, Has Worked To Advance Knowledge Of Association Of Lymphoma With Textured Implants Since 2014",2017-03-22 09:49:00-04:00,AGN,negative
43541.0,"Allergan Reports Availability of RESTASIS MULTIDOSE, First FDA-Approved Preservative Free Prescription Eye Drop Available in a Multidose Bottle",2017-03-22 07:31:00-04:00,AGN,positive
43542.0,FDA Links Breast Implants To A Rare Form Of Cancer,2017-03-21 17:26:00-04:00,AGN,negative
43543.0,"Watch For Weakness In Sientra, Johnson & Johnson, and Allergan NBC News  Reports That FDA Says Breast Implants Can Cause A Rare Form Of Cancer That May Have Killed At Least 9 People",2017-03-21 16:49:00-04:00,AGN,negative
43544.0,Editas Get A Vetr Upgrade To Strong Buy,2017-03-20 16:51:00-04:00,AGN,positive
43545.0,Allergan Reports FDA Approval Of JUVÉDERM VOLLURE XC For Correction Of Moderate To Severe Wrinkles And Folds,2017-03-20 07:32:00-04:00,AGN,positive
43546.0,"Allergan and Editas Medicine Enter Strategic R&D Partnership To Develop CRISPR Genome Editing Diseases, Editas To Receive Upfront Payment Of $90M For Development Of 5 Candidate Programs",2017-03-14 08:01:00-04:00,AGN,neutral
43547.0,Benzinga's Option Alert Recap From March 13,2017-03-14 06:50:00-04:00,AGN,positive
43548.0,Watch These 7 Huge Put Purchases In Tuesday Trade,2017-03-14 04:31:00-04:00,AGN,positive
43549.0,Option Alert: AGN Mar 240 Puts Sweep: 738 @  ASK  $2.54: 1082 traded vs 2021 OI:  Earnings 5/10 Before Open (est)  $240.98 Ref,2017-03-13 11:45:00-04:00,AGN,positive
43550.0,"Raymond James Institutional Investors Conference Concludes Today; Presenters Include Zayo Group, Habit Restaurants, Allergan, Walmart, And Carrols Restaurant Group",2017-03-08 08:21:00-05:00,AGN,neutral
43551.0,Allergan Announces FDA Accepts sNDA For VRAYLAR,2017-03-08 08:00:00-05:00,AGN,positive
43552.0,Appaloosa's David Tepper On CNBC Says He Still Owns Quite A Bit Of Allergan,2017-03-08 07:52:00-05:00,AGN,neutral
43553.0,"Cowen Annual Healthcare Conference Continues Today; Presenters Include Regulus, Eli Lilly, Oculus, DexCom, Illumina, Allergan, Kite Pharma, Pfizer, and bluebird bio",2017-03-07 08:59:00-05:00,AGN,neutral
43554.0,Icahn's (Potential) Move Into Biotech,2017-03-04 19:25:00-05:00,AGN,neutral
43555.0,FDA Approves Allergan Trademark NOCTIVA Nasal Spray For Adults Who Awaken 2 Times Per Night To Urinate For Condition Known As Nocturnal Polyuria,2017-03-03 14:59:00-05:00,AGN,positive
43556.0,Valeant Shares Recently Made Very Near-Term Parabolic Move Following Intereconomia Unconfirmed Chatter Report; Shares Now Largely Unaffected,2017-03-03 13:40:00-05:00,AGN,positive
43557.0,Carl Icahn's Track Record In Big Pharma,2017-02-24 09:40:00-05:00,AGN,neutral
43558.0,"After Merck Stops Study, What Remains Of The Alzheimer's Drug Pipeline?",2017-02-16 16:13:00-05:00,AGN,negative
43559.0,"Leerink Partners Global Healthcare Conference Began Today; Presenters Include Mannkind, Universal Health Services, Celgene, Inogen, Endologix, Biogen, GW Pharma, Regulus, Fate Therapeutics, Puma Biotech, Allergan, Bristol Myers And Synergy Pharma",2017-02-15 10:29:00-05:00,AGN,neutral
43560.0,6 Biggest Foreign Acquisitions Of American Companies In History,2017-02-14 10:20:00-05:00,AGN,neutral
43561.0,Wall Street's M&A Chatter From February 13,2017-02-14 07:01:00-05:00,AGN,neutral
43562.0,"Meg Tirrell Tweets: $VRX & Pershing agree if they settle $AGN case that $VRX will pay 60%, Pershing to pay 40%; say case w/o merit",2017-02-13 16:48:00-05:00,AGN,positive
43563.0,Key Presenters At Leerink's Healthcare Conference,2017-02-13 15:52:00-05:00,AGN,neutral
43564.0,"Allergan's Chief R&D Officer Talks Avycaz, Assembly Biosciences And 6 'Potential Blockbusters' In The Pipeline",2017-02-13 15:13:00-05:00,AGN,neutral
43565.0,Mid-Afternoon Market Update: Dow Rises 150 Points; Zeltiq Aesthetics Shares Surge Following Acquisition News,2017-02-13 14:58:00-05:00,AGN,positive
43566.0,18 Biggest Mid-Day Gainers For Monday,2017-02-13 12:30:00-05:00,AGN,neutral
43567.0,Zeltiq Aesthetics Saw Aggressive Buying Ahead Of Allergan Takeover,2017-02-13 10:53:00-05:00,AGN,negative
43568.0,18 Stocks Moving In Monday's Pre-Market Session,2017-02-13 08:44:00-05:00,AGN,neutral
43569.0,A Peek Into The Markets: U.S. Stock Futures Signal Higher Start On Wall Street,2017-02-13 08:12:00-05:00,AGN,neutral
43570.0,Allergan to Acquire ZELTIQ For $2.47B Or $56.50/Share,2017-02-13 08:03:00-05:00,AGN,neutral
43571.0,How To Invest Like Seth Klarman,2017-02-09 08:43:00-05:00,AGN,positive
43572.0,Oil Weakness A Possible Drag On Market As Earnings Season Keeps Rolling,2017-02-08 10:57:00-05:00,AGN,negative
43573.0,Q4 2016 Real-Time Call Brief,2017-02-08 10:20:00-05:00,AGN,neutral
43574.0,Allergan CEO Brent Saunders On Conf. Call Says he Believes Stock Is Still Undervalued,2017-02-08 09:19:00-05:00,AGN,neutral
43575.0,"The Market In 5 Minutes: Disney, Gilead Investors Not Too Pleased",2017-02-08 09:03:00-05:00,AGN,negative
43576.0,Allergan CEO Brent Saunders To Appear On Mad Money Tonight,2017-02-08 07:53:00-05:00,AGN,negative
43577.0,A Peek Into The Markets: U.S. Stock Futures Edge Higher Ahead Of Earnings,2017-02-08 07:31:00-05:00,AGN,neutral
43578.0,"Allergan Sees Q1 Rev. ~$3.5B vs. Est. $3.59B; FY17 Rev. $15.5-$15.8B vs. Est. $15.37B, EPS $15.80-$16.30 vs. Est. $16.01",2017-02-08 07:03:00-05:00,AGN,neutral
43579.0,"Allergan Reports Q4 EPS $3.90 vs. Est. $3.76, Rev. $3.86B vs. Est. $3.77B",2017-02-08 07:02:00-05:00,AGN,neutral
43580.0,"Earnings Scheduled For February 8, 2017",2017-02-08 04:40:00-05:00,AGN,neutral
43581.0,Seth Klarman's Thoughts On Investing Risk In The Trump Era,2017-02-07 12:07:00-05:00,AGN,negative
43582.0,Allergan Reports FDA Approved Co.'s sNDA for AVYCAZ to Include New Phase III Data in Patients with cUTI,2017-01-30 07:59:00-05:00,AGN,positive
43583.0,Allergan and Ironwood Pharmaceuticals Reports U.S. Food and Drug Administration Approves 72 mcg Dose of LINZESS,2017-01-26 07:05:00-05:00,AGN,positive
43584.0,"FTC Keeps Pressure On Wall Street, Refiles Suit Against Allergan, Others",2017-01-23 15:18:00-05:00,AGN,negative
43585.0,"FTC Refiles Suits Against Allergan For Blocking Lower-Cost Generic Version Of Painkiller Lidoderm, FTC Issues Administrative Complaint Against Impax Lab For Similar Scheme With Regard To Opana ER",2017-01-23 14:07:00-05:00,AGN,negative
43586.0,Shares Of Allergan & Endo International Move Lower; Hearing FTC Has Sued Both Companies In Federal Court,2017-01-23 13:30:00-05:00,AGN,neutral
43587.0,"The Market In 5 Minutes: McDonald's, Halliburton Ramp Up Q4 Earnings Season",2017-01-23 09:00:00-05:00,AGN,neutral
43588.0,Wall Street's M&A Chatter From January 20-22,2017-01-23 07:07:00-05:00,AGN,neutral
43589.0,"Cynosure in Talks to Consider Strategic Options, Including Potential Sale -Bloomberg",2017-01-22 17:46:00-05:00,AGN,neutral
43590.0,"Allergan Announces FDA Approval Of RHOFADE Cream, 1% For The Topical Treatment Of Persistent Facial Erythema Associated With Rosacea In Adults",2017-01-19 07:59:00-05:00,AGN,positive
43591.0,"Hearing SEC Found Allergan Failed to Disclose Negotiations with Other Potential Merger Partners Following Offer from Valeant, Co-Bidders in Jun. 2014",2017-01-17 16:25:00-05:00,AGN,negative
43592.0,"SEC Says Allergan To Pay $15M For Disclosure Failures During Merger Talks, Co. Admits To Wrongdoing",2017-01-17 16:24:00-05:00,AGN,negative
43593.0,"Allergan, Gedeon Richter Announce Positive Phase III Results for Ulipristal Acetate 5 and 10 mg in Treatment of Uterine Fibroids",2017-01-17 04:06:00-05:00,AGN,positive
43594.0,"Allergan CEO Brent Saunders Says, 'Allergan Is Aligned With The Priorities Of The Incoming Trump Administration'",2017-01-11 14:21:00-05:00,AGN,neutral
43595.0,5 Manufacturing Stocks With 25% Upside Potential,2017-01-10 16:06:00-05:00,AGN,neutral
43596.0,"Allergan Enters Parkinson's Disease Through Option Arrangement To Acquire Lysosomal Therapeutics Inc., Terms Not Disclosed",2017-01-09 08:31:00-05:00,AGN,neutral
43597.0,"Allergan Enters Into Licensing Agreement with Assembly Biosciences to Obtain Worldwide Rights to Microbiome Gastrointestinal Development Programs, Will Pay $50M For Rights",2017-01-09 08:01:00-05:00,AGN,positive
43598.0,The Year's Biggest Healthcare Conference Commences This Week; Here's What You Need To Know,2017-01-09 06:33:00-05:00,AGN,neutral
43599.0,Here Are Some Of Leon Cooperman's Top Stock Picks For 2017,2017-01-05 15:46:00-05:00,AGN,positive
43600.0,"Leon Cooperman On CNBC Says Shire Pharmaceuticals, Allergan, Walgreen's Are His Healthcare Picks For 2017",2017-01-05 12:54:00-05:00,AGN,neutral
43601.0,"Allergan Chair, CEO, Pres Saunders at Goldman Healthcare Unscripted Conference Says 'Proper Guidance' Will Be Issued in Several Weeks",2017-01-05 10:33:00-05:00,AGN,neutral
43602.0,FDA Accepts For Filing Supplemental New Drug Application (sNDA) For LILETTA,2017-01-04 07:44:00-05:00,AGN,positive
43603.0,"Martin Shkreli Tweets: More math for confused journalists. A 10% price increase on 5 blockbusters is ""worse"" than two 5000% increases on a small drug @Allergan",2017-01-03 11:38:00-05:00,AGN,negative
43604.0,Allergan Reports FDA Approval of NATRELLE INSPIRASoftTouch Breast Implants,2017-01-03 07:40:00-05:00,AGN,positive
43605.0,Allergan Poised To End 2016 With A 5-Day Rally,2016-12-30 11:39:00-05:00,AGN,positive
43606.0,Which Wall Street Firm Made The Best Stock Picks Of 2016?,2016-12-30 10:09:00-05:00,AGN,positive
43607.0,Option Alert: AGN Feb 220 Calls Sweep: 666 @  ASK  $5.20: 799 traded vs 1388 OI:  Earnings 2/22 Before Open (est)  $207.93 Ref,2016-12-29 14:33:00-05:00,AGN,positive
43608.0,Technical Alert: Allergan High For Fourth Day In A Row,2016-12-29 13:55:00-05:00,AGN,positive
43609.0,Option Alert: AGN Feb 210 Calls Sweep: 600 @  ASK  $8.00: 922 traded vs 2419 OI:  Earnings 2/22 Before Open (est)  $206.34 Ref,2016-12-29 13:07:00-05:00,AGN,positive
43610.0,Expensive Breakups In 2016 Surpass GDPs Of Dozens Of Developing Nations,2016-12-28 15:00:00-05:00,AGN,neutral
43611.0,"Allergan Issues Statement On 'Social Contract' With Patients, Says It Is Its Responsibility To Price Treatments In An Affordable Manner While Providing Return To Shareholders",2016-12-22 15:03:00-05:00,AGN,neutral
43612.0,Ironwood and Allergan Report Topline Phase IIb Data Supporting Advancement of Linaclotide Colonic Release-1 in IBS-C,2016-12-22 07:02:00-05:00,AGN,positive
43613.0,"Watch Carl Icahn-Related Stocks in After-Hours Amid Report Trump Has Named Icahn a Special Advisor: CVR Energy, CVR Refining, Allergan, AIG, American Railcar Industries, Cheniere, Federal-Mogul, Freeport, Herbalife, Hertz, Navistar, Nuance, PayPal, Voltar",2016-12-21 16:15:00-05:00,AGN,positive
43614.0,7 Companies That Could Be Acquired In 2017,2016-12-20 10:00:00-05:00,AGN,neutral
43615.0,"UPDATE: Allergan Sees Transaction Immediately Accretive Acquisition Expected To Generate ~$450M In Rev, ~75% Gross Margin and ~40% Operating Margin in 2016",2016-12-20 09:27:00-05:00,AGN,negative
43616.0,Allergan to Acquire Acelity L.P. Inc.'s LifeCell Corporation for $2.9 Billion Cash,2016-12-20 09:26:00-05:00,AGN,neutral
43617.0,"Allergan Announces Civil Resolution Concluding Federal Investigation into Forest Sales & Marketing Practices, Forest To Pay $38M To Federal Govt.",2016-12-15 14:19:00-05:00,AGN,negative
43618.0,CNBC's List Of 20 Beaten-Up Stocks,2016-12-15 12:36:00-05:00,AGN,neutral
43619.0,Goldman Takes Allergan Off Conviction Buy List,2016-12-15 11:14:00-05:00,AGN,neutral
43620.0,A Primer On NASH,2016-12-15 09:47:00-05:00,AGN,neutral
43621.0,Technical Alert: Allergan plc Lower But Still Range Bound,2016-12-14 13:02:00-05:00,AGN,neutral
43622.0,"Cramer Gives His Opinion On Reynolds American, AstraZeneca And Sony",2016-12-14 06:58:00-05:00,AGN,neutral
43623.0,"European Crohn's, Colitis Organisation Issues New Statement Support a Switch to Biosimilar from Reference Product in Inflammatory Bowel Disease",2016-12-09 10:18:00-05:00,AGN,positive
43624.0,Allergan Weakness Being Attributed to Report Several of Mylan's IPR Petitions Against Restasis Have Been Instituted,2016-12-08 15:41:00-05:00,AGN,negative
43625.0,Teva Pharmaceuticals Has Had An Eventful 24 Hours,2016-12-06 16:25:00-05:00,AGN,neutral
43626.0,Key Exec Announcing His Retirement From Teva 'Creates More Uncertainties',2016-12-06 08:45:00-05:00,AGN,negative
43627.0,Allergan's Strength Lies In Its New Products And Robust Pipeline,2016-12-05 12:04:00-05:00,AGN,positive
43628.0,"Amgen, Allergan Submit Biosimilar Marketing Authorization Application To European Medicines Agency For ABP 215",2016-12-02 09:00:00-05:00,AGN,neutral
43629.0,"Allergan Announces Settlement of a DELZICOL Patent Litigation, Zydus And Cadila May Be Able To Market Generic In U.S. In 2020",2016-12-02 07:02:00-05:00,AGN,negative
43630.0,"Allergan Reports Settlement of a DELZICOL Patent Litigation, No Terms Disclosed",2016-12-02 07:00:00-05:00,AGN,negative
43631.0,UPDATE: Allergan CEO Brent Saunders Says Trump May Be More 'Vicious' Than Clinton On Drug Price,2016-12-01 08:49:00-05:00,AGN,neutral
43632.0,"Forbes Healthcare Summit Concludes Today; Presenters Include Express Scripts, Allergan, IBM, Bristol-Myers Squibb, Merck, Anthem, Eli Lilly, And Regeneron",2016-12-01 08:21:00-05:00,AGN,neutral
43633.0,Allergan CEO Brent Saunders Tweets: My new piece on drug pricing under Trump Administration & $AGN enhanced Patient Assistance Programs: bit.ly/2gbkPVY #SocialContract,2016-12-01 08:04:00-05:00,AGN,neutral
43634.0,"Appaloosa's David Tepper, at Robin Hood Conference, Says He Likes Allergan as a Long",2016-11-29 09:42:00-05:00,AGN,positive
43635.0,Eli Lilly's Solanezumab Failure: Alzheimer's Treatment Space Feels Aftershock,2016-11-23 13:22:00-05:00,AGN,negative
43636.0,Allergan CEO Brent Saunders Tweets: As a leader in #Alzheimer disease $AGN is committed to investing in R&D for treatments and hopefully one day cures...,2016-11-23 09:41:00-05:00,AGN,positive
43637.0,Allergan CEO Brent Saunders Tweets: #Alzheimer patients are counting on industry to solve this disease.  Hard science and big investment required.  How about a moonshot?,2016-11-23 09:39:00-05:00,AGN,positive
43638.0,Allergan CEO Brent Saunders Tweets: Disappointed of failure of a amyloid-targeted antibody drug for #Alzheimer disease need to invest for disease modification & symptom relief,2016-11-23 09:38:00-05:00,AGN,negative
43639.0,Allergan Acquires Chase Pharmaceuticals For $125M,2016-11-22 16:15:00-05:00,AGN,neutral
43640.0,Allergan Gets FDA Clearance for ZEN Gel Stent,2016-11-22 07:35:00-05:00,AGN,neutral
43641.0,Allergan CEO Brent Saunders Buys 5250 Shares @ Prices Ranging From $188.43-$189.81,2016-11-21 16:26:00-05:00,AGN,positive
43642.0,Allergan Announces Additional Approval From Health Canada For FIBRISTAL,2016-11-21 08:04:00-05:00,AGN,positive
43643.0,Wall Street's M&A Chatter From November 18-20,2016-11-21 06:59:00-05:00,AGN,neutral
43644.0,Is Allergan Going After Valeant's Eye Surgery Assets?,2016-11-18 11:47:00-05:00,AGN,positive
43645.0,Allergan Tells Benzinga In Response To Report It Is Considering Bidding For Valeant's Eye-Surgery Assets 'Allergan Does Not Comment On Market Rumor or Speculation',2016-11-18 10:35:00-05:00,AGN,positive
43646.0,Allergan and TPG in Talks to Buy Valeant's Eye-Surgery Assets,2016-11-18 10:28:00-05:00,AGN,positive
43647.0,Allergan Shares Trading Up 3% Heading Into The Market Close,2016-11-17 15:20:00-05:00,AGN,positive
43648.0,"Repros Therapeutics Shares Rally Following Ladenburg Upgrade To Buy, Positive Data",2016-11-16 10:43:00-05:00,AGN,positive
43649.0,"Amgen, Allergan Submit Biosimilar Biologics License Application For ABP 215 To U.S. Food And Drug Administration",2016-11-15 16:00:00-05:00,AGN,neutral
43650.0,Some Of The Most Notable Changes This 13F Season,2016-11-15 15:06:00-05:00,AGN,neutral
43651.0,Allergan Shares Up 3.5% from Session Lows; Hearing Cowen Recently Issuing Defense; Stock Still Down 3.4%,2016-11-15 10:33:00-05:00,AGN,positive
43652.0,Allergan to Present New Data on BYSTOLIC at AHA Meeting in New Orleans,2016-11-12 08:09:00-05:00,AGN,neutral
43653.0,Allergan Announces Launch of TAYTULLA™ (Norethindrone Acetate and Ethinyl Estradiol Capsules and Ferrous Fumarate Capsules) 1 mg/20 mcg,2016-11-10 07:32:00-05:00,AGN,neutral
43654.0,Can Trump Make Your Portfolio Great Again?,2016-11-09 11:27:00-05:00,AGN,positive
43655.0,"Pharma Stocks Up Post Election: Ariad 16%, Infinity Up 13%, Allergan, Progenics, Endo 10%, Pfizer, Regeneron 8%, AbbVie 7%, Mylan, Medicines Co. 6%, Perrigo, Merck 5%, Bristol-Myers, Eli Lilly, Sanofi, Novartis 3.5%",2016-11-09 09:41:00-05:00,AGN,neutral
43656.0,Allergan Shares Spike ~$2 Over Last Few Mins as Hearing Unconfirmed Chatter Related to Pfizer Deal,2016-11-08 11:17:00-05:00,AGN,positive
43657.0,"The Market In 5 Minutes: Jobs Numbers, Big Earnings Close The Week",2016-11-04 09:00:00-04:00,AGN,neutral
43658.0,Technical Alert: Allergan Lower For Tenth Day In A Row,2016-11-03 14:09:00-04:00,AGN,neutral
43659.0,Technical Alert: Allergan Lower After Q3 Miss And Lowered Guidance,2016-11-02 13:52:00-04:00,AGN,negative
43660.0,JP Morgan Says Allergan's Valuation Still Very Attractive And Remains Buyers Of Allergan Shares At These Levels Despite Underperformance Of Non-Promoted and Established barnd,2016-11-02 12:52:00-04:00,AGN,positive
43661.0,Valeant's Potential Salix Sale Appears To Be A Positive,2016-11-02 09:26:00-04:00,AGN,positive
43662.0,"The Market In 5 Minutes: Alibaba, Brocade And A Game 6",2016-11-02 09:05:00-04:00,AGN,neutral
43663.0,"A Peek Into The Markets: U.S. Stock Futures Mostly Lower Ahead of ADP Report, Fed Decision",2016-11-02 08:00:00-04:00,AGN,negative
43664.0,"Investors Cheer Allergan's Share Buyback Program, Dividend Initiation Despite Q3 Miss",2016-11-02 07:23:00-04:00,AGN,positive
43665.0,"UPDATE: Allergan Cuts FY16 Adj. EPS Outlook from $13.75-$14.20 to $13.30-$13.50 vs $13.94 Est., Sales from $14.65B-$14.9B to $14.45B-$14.65B vs $14.72B Est.",2016-11-02 06:42:00-04:00,AGN,negative
43666.0,Allergan Cuts FY16 Adj. Outlook,2016-11-02 06:40:00-04:00,AGN,negative
43667.0,"Allergan Reports Q3 Adj. EPS $3.32 vs $3.58 Est., Sales $3.622B vs $3.69B Est.",2016-11-02 06:39:00-04:00,AGN,neutral
43668.0,"Allergan Adds $5B to Buyback Plan, $10B of Which Will Be Under Accelerated Buyback Plan; Initiates $0.70/Share Qtr. Dividend Beginning in Q1'17",2016-11-02 06:32:00-04:00,AGN,neutral
43669.0,"Earnings Scheduled For November 2, 2016",2016-11-02 04:27:00-04:00,AGN,neutral
43670.0,ContraVir CEO Talks Hep. B Treatment's Future,2016-11-01 12:11:00-04:00,AGN,neutral
43671.0,October 2016 Sets Record For M&A At $251 Billion,2016-10-31 15:21:00-04:00,AGN,neutral
43672.0,Technical Alert: Allergan Lower For Fourth Day In A Row,2016-10-31 11:50:00-04:00,AGN,neutral
43673.0,"Barclays Assumes Allergan plc Ordinary Shares at Equal-Weight, Announces $250.00",2016-10-31 05:46:00-04:00,AGN,positive
43674.0,"Allergan to Acquire GI Disease Subsidiary of Rhythm Holding Company, LLC For $200M",2016-10-27 07:30:00-04:00,AGN,neutral
43675.0,"Allergan Names Brenton Saunders Chair, Christopher Coughlin as Lead Independent Director",2016-10-26 16:32:00-04:00,AGN,neutral
43676.0,"Cramer Shares His Opinion On 8Point3 Energy, PPG Industries And Allergan",2016-10-24 06:20:00-04:00,AGN,positive
43677.0,"Barron's Picks And Pans: Super Chip Stocks, Time Warner And More",2016-10-22 18:31:00-04:00,AGN,positive
43678.0,Allergan Reports FDA Advisory Committee Recommends Approval of SER120,2016-10-20 14:37:00-04:00,AGN,positive
43679.0,FDA Panel Has Voted Allergan's Treatment for Frequent Night-Time Urination Should Win Approval,2016-10-19 15:55:00-04:00,AGN,positive
43680.0,Allergan Expects An FDA Advisory Committee Meeting on SER-120 To Take Place Today,2016-10-19 08:28:00-04:00,AGN,neutral
43681.0,Kevin Kelly's Allergan Trade,2016-10-18 16:40:00-04:00,AGN,neutral
43682.0,"Exclusive: SunTrust Top Analysts Explain Fatty Liver Diseases, Galmed's Potential In The Space",2016-10-18 13:32:00-04:00,AGN,positive
43683.0,Allergan JUVÉDERM VOLBELLA XC Now Available To Doctors And Patients In The U.S.,2016-10-18 09:01:00-04:00,AGN,neutral
43684.0,Allergan Earlier Announced A Late Breaking Abstract For Ulipristal Phase 3 Study To Be Presented At The American Society Of Reproductive Medicine Expo Wednesday 2pm EST,2016-10-17 11:41:00-04:00,AGN,neutral
43685.0,Allergan Expects FDA To Release Briefing Docs Ahead Of Oct. 19th Advisory Panel On SER-120,2016-10-17 08:26:00-04:00,AGN,neutral
43686.0,"Allergan, Vitae Pharma Report Expiration of HSR Waiting Period for Deal",2016-10-17 08:03:00-04:00,AGN,neutral
43687.0,UroGen Pharma Announces Agreement to License RTGel for Use with Neurotoxins to Allergan,2016-10-14 07:00:00-04:00,AGN,positive
43688.0,Allergan Partners with SonarMD to Develop Innovative IBS-D Patient Engagement Platform for Better Identification and Care of IBS-D Patients,2016-10-13 09:02:00-04:00,AGN,positive
43689.0,Allergan's BELKYRA Receives Marketing Authorization In Sweden For The Treatment Of Moderate To Severe Fullness Under The Chin,2016-10-13 07:02:00-04:00,AGN,negative
43690.0,Allergan Reports FDA Acceptance of sNDA for AVYCAZ,2016-10-11 08:08:00-04:00,AGN,positive
43691.0,Allergan's New Products And Robust R&D Pipeline Support A Positive Long-Term View,2016-10-03 10:31:00-04:00,AGN,positive
43692.0,Allergan Announces Licensing Agreement with AstraZeneca to Obtain Worldwide Rights to MEDI2070 Inflammatory Disorder Development Program,2016-10-03 04:07:00-04:00,AGN,positive
43693.0,The Market In 5 Minutes: OPEC's Deal And Gary Johnson's Moment,2016-09-29 09:00:00-04:00,AGN,neutral
43694.0,"Benzinga's M&A Chatter for Wednesday September 28, 2016",2016-09-28 21:22:00-04:00,AGN,neutral
43695.0,Acadia Shares Popping on Volume ; Hearing DealReporter Says Allergan Could Bid for Co,2016-09-28 13:05:00-04:00,AGN,positive
43696.0,The Drug Price Increase Debate: Separating The Winners From The Losers,2016-09-27 11:23:00-04:00,AGN,positive
43697.0,Allergan Announces FDA Approval of NATRELLE INSPIRA Cohesive Breast Implants,2016-09-23 16:30:00-04:00,AGN,positive
43698.0,Will Allergan Buy Gilead? Don't Count On 'The Mother Of All Blockbusters',2016-09-22 14:43:00-04:00,AGN,neutral
43699.0,Jim Cramer: The Pharmaceutical 'Good Guys' Need To Stand Up,2016-09-22 11:07:00-04:00,AGN,positive
43700.0,The Market In 5 Minutes: No Interest Rate Hike...Yet,2016-09-22 09:04:00-04:00,AGN,positive
43701.0,"Allergan, Adamas Report U.S. Availability of New Dosage Strengths for NAMZARIC XR",2016-09-22 08:02:00-04:00,AGN,positive
43702.0,Can You Guess This Chart?,2016-09-22 07:31:00-04:00,AGN,neutral
43703.0,The Street's Adam Feuerstein Tweets: $AGN ($94B) is not buying $GILD ($107B)  Please shut up.,2016-09-21 10:30:00-04:00,AGN,positive
43704.0,Allergan Going After Gilead? Gabelli Says CEO 'Playing Chess While The Market Is Playing Checkers',2016-09-21 10:30:00-04:00,AGN,positive
43705.0,Cantor Fitzgerald Never Gave Up On Tobira Therapeutics,2016-09-21 10:10:00-04:00,AGN,neutral
43706.0,More Pharma Deals In The Pipeline?,2016-09-21 09:56:00-04:00,AGN,neutral
43707.0,Traders Highlighting Barron's Article On Gabelli Note Speculating Allergan Possibly Preparing Bid For Gilead,2016-09-21 09:46:00-04:00,AGN,neutral
43708.0,"The Market In 5 Minutes: We're Waiting For You, Mrs. Yellen",2016-09-21 08:59:00-04:00,AGN,neutral
43709.0,Allergan's Tobira Acquisition Represents The Highest Premium Ever Paid In Biopharma,2016-09-21 07:21:00-04:00,AGN,neutral
43710.0,Allergan Acquires Akarna Therapeutics Global Rights To AKN-083For Up-Front Payment Of $50M,2016-09-20 16:16:00-04:00,AGN,neutral
43711.0,Cowen Defends Allergan,2016-09-20 16:02:00-04:00,AGN,neutral
43712.0,New 5-Year Contraceptive Coming To U.S. Adds To Long-Acting Reversible Contraceptives List,2016-09-20 15:18:00-04:00,AGN,neutral
43713.0,NASH Sympathy Plays On Tobira Therapeutics Deal,2016-09-20 14:43:00-04:00,AGN,positive
43714.0,Mid-Afternoon Market Update: Ascena Retail Drops On Earnings Miss; DTS Shares Spike Higher,2016-09-20 14:37:00-04:00,AGN,positive
43715.0,"UPDATE: Cowen Says Allergan Premium Paid Appears Manageable, Speculates Co. Has Substantially More Info On Specifics Of Phase II Data",2016-09-20 12:54:00-04:00,AGN,neutral
43716.0,Cowen & Co. Defending Allergan,2016-09-20 12:52:00-04:00,AGN,neutral
43717.0,18 Biggest Mid-Day Gainers For Tuesday,2016-09-20 12:43:00-04:00,AGN,neutral
43718.0,Mid-Day Market Update: Tobira Therapeutics Jumps Following Allergan Buyout; HNI Shares Slide,2016-09-20 12:16:00-04:00,AGN,positive
43719.0,Benzinga's Volume Movers,2016-09-20 10:49:00-04:00,AGN,neutral
43720.0,"Tobira Therapeutics Up 760% Following Allergan Buyout, Liver Drug A Key Focus",2016-09-20 10:29:00-04:00,AGN,neutral
43721.0,Mid-Morning Market Update: Markets Open Higher; Lennar Tops Q3 Expectations,2016-09-20 10:15:00-04:00,AGN,positive
43722.0,"Allergan Reports Will Purchase Tobira Therapeutics for Upfront Payment of $28.35/Share in Cash, U p to $49.84/share in CVRs",2016-09-20 08:02:00-04:00,AGN,neutral
43723.0,Barclays Sees 44-48% Upside In Perrigo Shares; Co. Remains Vulnerable To Activist Investors,2016-09-19 14:03:00-04:00,AGN,positive
43724.0,"Benzinga's M&A Chatter for Wednesday September 14, 2016",2016-09-14 22:38:00-04:00,AGN,neutral
43725.0,Mid-Afternoon Market Update: Dow Turns Lower; Radiant Logistics Shares Drop Following Q4 Results,2016-09-14 14:38:00-04:00,AGN,positive
43726.0,12 Biggest Mid-Day Gainers For Wednesday,2016-09-14 12:51:00-04:00,AGN,neutral
43727.0,Mid-Day Market Update: Crude Oil Down Over 2%; Vitae Pharmaceuticals Shares Surge Following Allergan Buyout,2016-09-14 12:08:00-04:00,AGN,negative
43728.0,Benzinga's Volume Movers,2016-09-14 10:51:00-04:00,AGN,neutral
43729.0,Stocks Hitting 52-Week Highs,2016-09-14 10:10:00-04:00,AGN,neutral
43730.0,Mid-Morning Market Update: Markets Edge Higher; Bayer To Buy Monsanto For $66B,2016-09-14 09:53:00-04:00,AGN,neutral
43731.0,"The Market In 5 Minutes: Huge FDA News, Major Mid-Week M&A",2016-09-14 09:17:00-04:00,AGN,positive
43732.0,Vitae Pharma Spikes 158% Following Allergan Buyout,2016-09-14 08:38:00-04:00,AGN,neutral
43733.0,"Allergan, Medicines360 Announce Launch of New LILETTA 52 mg Single-Handed Inserter",2016-09-14 08:03:00-04:00,AGN,neutral
43734.0,"Allergan Reports Purchase of Vitae Pharma for $21/Share in Cash, Total Value of ~$639M",2016-09-14 08:02:00-04:00,AGN,positive
43735.0,Emerging Markets And Financials: Fast Money Picks For September 14,2016-09-14 06:47:00-04:00,AGN,neutral
43736.0,"2100: Goldman Sachs Is A Short-Term Bear, But A Long-Term Bull",2016-09-12 10:13:00-04:00,AGN,neutral
43737.0,Allergan CEO Brent Saunders To Appear On CNBC Shortly,2016-09-08 15:23:00-04:00,AGN,neutral
43738.0,Bayer Exploring Sale of Dermatology Business; Allergan Potential Buyer -Bloomberg,2016-09-08 13:01:00-04:00,AGN,neutral
43739.0,"Allergan CEO Says Emergency Imports Of Drugs To Ease Drug Shortages, Prices Could Subject U.S. Public To Lower Safety Standards",2016-09-06 11:05:00-04:00,AGN,neutral
43740.0,This Pharmaceutical CEO Just Laid Out The 4 Principles Of Its 'Social Contract' With Shareholders,2016-09-06 10:17:00-04:00,AGN,neutral
43741.0,Allergan Acquires RetroSense Therapeutics for $60M,2016-09-06 08:03:00-04:00,AGN,neutral
43742.0,4 Reasons Leon Cooperman Sells A Stock,2016-08-31 16:07:00-04:00,AGN,neutral
43743.0,"Allergan, Adamas Announce Settlement with Amneal Related to NAMZARIC Patent Litigation; Forest & Adamas To Grant Amneal A License To Market Generic Namzaric Beginning Jan. 1, 2025",2016-08-31 08:02:00-04:00,AGN,positive
43744.0,Here Are All The Big Biotech Mergers In 2016,2016-08-27 18:36:00-04:00,AGN,neutral
43745.0,Pfizer's $1.5 Billion Antibiotics Buy: Strategic Long-Term Planning Or Pre-Split Prep?,2016-08-24 14:42:00-04:00,AGN,neutral
43746.0,Pfizer Has Had A Busy M&A Year...Or Has It?,2016-08-23 08:58:00-04:00,AGN,neutral
43747.0,The Market In 5 Minutes: Up And Down Week Comes To A Close,2016-08-19 08:56:00-04:00,AGN,neutral
43748.0,Benzinga's Top Upgrades,2016-08-19 08:45:00-04:00,AGN,positive
43749.0,Mizuho Securities Upgrades Allergan to Buy,2016-08-19 06:27:00-04:00,AGN,positive
43750.0,11 Biopharma CEOs To Follow On Twitter,2016-08-18 10:52:00-04:00,AGN,neutral
43751.0,The Least Popular Stocks This 13F Season,2016-08-16 12:08:00-04:00,AGN,negative
43752.0,The Most Popular Stocks This 13F Season,2016-08-16 12:07:00-04:00,AGN,positive
43753.0,Credit Suisse Presents Bull And Bear Cases For Allergan,2016-08-16 10:01:00-04:00,AGN,positive
43754.0,13F from Carl Icahn Shows New Stake In Allergan,2016-08-15 16:06:00-04:00,AGN,neutral
43755.0,"13F from Cooperman's Omega Shows Increased Stakes in Allergan, Altisource, Delta, EA, United Continental",2016-08-15 09:54:00-04:00,AGN,positive
43756.0,Jana Partners Dissolves Stake In Allergan,2016-08-15 09:53:00-04:00,AGN,neutral
43757.0,Biogen Cancels Out Of Citigroup Conference Following Weeks Of Rumors,2016-08-11 15:02:00-04:00,AGN,negative
43758.0,Allergan to Acquire Eye Care Company ForSight VISION5 For $95M Upftont Payment And A Launch Milestone Payment,2016-08-11 08:01:00-04:00,AGN,positive
43759.0,"UPDATE: Cowen Analyst Publishes on Allergan: 'This Stock Should Be Up, Not Down – We Would Be Adding Aggressively'; Reiterates Outperform Rating, $400 Target",2016-08-08 13:50:00-04:00,AGN,neutral
43760.0,"Allergan Shares at Session Lows; Hearing Cowen Issued Mid-Day Comment Reiterating Buy Rating, $400 Target",2016-08-08 13:48:00-04:00,AGN,positive
43761.0,From Conf. Call Allergan CEO Says Doesn't Need To Do Big M&A,2016-08-08 09:20:00-04:00,AGN,neutral
43762.0,"Allergan Posts Mixed Q2 Results, Guidance Disappoints",2016-08-08 08:58:00-04:00,AGN,negative
43763.0,A Peek Into The Markets: U.S. Stock Futures Signal Higher Start On Wall Street,2016-08-08 07:49:00-04:00,AGN,neutral
43764.0,"Allergan Sees FY16 Rev. $14.65-$14.9B vs. Est. $16.6B, EPS $13.75-$14.20 vs. Est. $14.21",2016-08-08 07:06:00-04:00,AGN,neutral
43765.0,"Allergan Reports Q2 EPS $3.35 vs. Est. $3.34, Rev. $3.684B vs. Est. $4.1B",2016-08-08 07:05:00-04:00,AGN,neutral
43766.0,10 Stocks You Should Be Watching Today,2016-08-08 04:52:00-04:00,AGN,neutral
43767.0,"Earnings Scheduled For August 8, 2016",2016-08-08 04:12:00-04:00,AGN,neutral
43768.0,"Walt Disney, Alibaba On Deck For Earnings Announcements",2016-08-07 09:56:00-04:00,AGN,neutral
43769.0,"Allergan, Richter Provide Update on Cariprazine Program",2016-08-05 04:07:00-04:00,AGN,neutral
43770.0,"Benzinga's M&A Chatter for Wednesday August 3, 2016",2016-08-03 20:26:00-04:00,AGN,neutral
43771.0,Generics Keeping The Pressure On Big Pharma,2016-08-03 17:13:00-04:00,AGN,negative
43772.0,"Biogen Shares Down $3 Over Last Min Following Reuters Report Co. Not Soliciting Offers; Allergan, Merck Shares Relatively Quiet, Not Impacted",2016-08-03 14:16:00-04:00,AGN,positive
43773.0,A Timeline Of Teva's M&A Over The Past Year,2016-08-03 10:29:00-04:00,AGN,neutral
43774.0,The Market In 5 Minutes: Downtrend Continues,2016-08-03 08:59:00-04:00,AGN,neutral
43775.0,Why Is Biogen Attractive? Credit Suisse Sees 12-24% Upside Takeout Potential,2016-08-03 07:42:00-04:00,AGN,positive
43776.0,Teva Announces Acquisition of Anda Inc. For $500M,2016-08-03 07:00:00-04:00,AGN,neutral
43777.0,"Benzinga's M&A Chatter for Tuesday August 2, 2016",2016-08-02 19:35:00-04:00,AGN,neutral
43778.0,CNBC's Meg Tirrell Reports Allergan Unlikely to Pursue Biogen Deal,2016-08-02 17:26:00-04:00,AGN,neutral
43779.0,6 Stocks Moving In Tuesday's After-Hours Session,2016-08-02 17:03:00-04:00,AGN,neutral
43780.0,Allergan Sells off to Low $250.07,2016-08-02 14:52:00-04:00,AGN,negative
43781.0,"Wall Street Journal Reports Biogen Drawing Interest From Merck, Allergan On Possibility Of Huge Deal",2016-08-02 14:46:00-04:00,AGN,positive
43782.0,Allergan said it has received $33.4B in cash and 100.3M shares of Teva stock valued at $5.4B,2016-08-02 12:46:00-04:00,AGN,positive
43783.0,The Lowdown On Activist Investing,2016-07-29 17:52:00-04:00,AGN,negative
43784.0,Option Alert: AGN Sep16 245 Puts Sweep: 960 @  ASK  $5.60: 960 traded vs 157 OI:  Earnings 8/8 Before Open  $258.91 Re,2016-07-28 09:40:00-04:00,AGN,positive
43785.0,"Benzinga's M&A Chatter for Wednesday July 27, 2016",2016-07-27 20:55:00-04:00,AGN,neutral
43786.0,PR Confirms Teva Receives Clearance from the U.S. Federal Trade Commission for Actavis Generics Acquisition,2016-07-27 14:36:00-04:00,AGN,neutral
43787.0,"Watch Potential Buyers of Generic Assets Following Report FTC Will Require Teva to Divest Generic Drugs: Valeant, Mylan, Akorn, Novartis",2016-07-27 14:35:00-04:00,AGN,positive
43788.0,Hearing FTC Will Require Teva to Divest 75+ Generic Drugs to Settlement Competition Concerns Related to Allergan Deal,2016-07-27 14:29:00-04:00,AGN,neutral
43789.0,Hearing FTC Could Give Approval for Teva/Allergan Deal 'in Days',2016-07-27 11:30:00-04:00,AGN,positive
43790.0,"Third Point Investor Letter from Dan Loeb Shows Liquidated Stake in Amgen, Continued Stakes in Allergan, Baxter",2016-07-26 17:29:00-04:00,AGN,neutral
43791.0,Allergan Gets Positive Opinion For Its Truberzi For Irritable Bowel Syndrome With Diarrhoea Treatment In Adults,2016-07-25 13:13:00-04:00,AGN,positive
43792.0,Allergan Receives Positive Opinion For Truberzi For Treatment Of Irritable Bowel Syndrome With Diarrhoea In Adults,2016-07-25 11:30:00-04:00,AGN,positive
43793.0,Benzinga's Top Initiations,2016-07-25 09:30:00-04:00,AGN,positive
43794.0,Allergan's Pipeline Is 'Underappreciated',2016-07-25 08:58:00-04:00,AGN,neutral
43795.0,"Credit Suisse Initiates Coverage on Allergan at Outperform, Announces $327.00 PT",2016-07-25 05:33:00-04:00,AGN,positive
43796.0,UPDATE: Adamis Says Decision by Allergan's Watson Follows Receipt of FDA CRL in June,2016-07-21 09:06:00-04:00,AGN,neutral
43797.0,"UPDATE: Adamis Pharma Says Received Notice from Allergan Subsidiary, Watson Labs, of Termination of License Deal to Commercialize Co.'s Epinephrine PFS Candidate",2016-07-21 09:05:00-04:00,AGN,neutral
43798.0,Adamis Pharma Offers Update on License Deal with Allergan,2016-07-21 09:04:00-04:00,AGN,neutral
43799.0,"UPDATE: Amgen, Allergan Report ABP 980 Results 'ruled out inferiority compared to trastuzumab but could not rule out superiority based on its primary efficacy endpoint'",2016-07-21 09:02:00-04:00,AGN,negative
43800.0,"Amgen, Allergan Report Results from Phase 3 Study of ABP 980 vs Trastuzumab in Patients with Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer",2016-07-21 09:02:00-04:00,AGN,negative
43801.0,Allergan and Adamas Announce New Expanded Indication for NAMZARIC Extended Release for the Treatment of Moderate to Severe Alzheimer's Disease,2016-07-19 07:59:00-04:00,AGN,negative
43802.0,Allergan Files De Novo Application For Approval Of Oculeve Intranasal Tear Neurostimulator,2016-07-18 13:57:00-04:00,AGN,positive
43803.0,Option Alert: AGN Fri 7/22 235 Puts (Wkly) Sweep: 500 @  ASK  $0.95: 1565 traded vs 667 OI:  Earnings 8/8 Before Open  $243.13 Ref,2016-07-18 13:28:00-04:00,AGN,positive
43804.0,Allergan Files Application to FDA for Approval of Oculeve Intranasal Tear Neurostimulator,2016-07-18 08:06:00-04:00,AGN,positive
43805.0,5 Stocks That Had A Lot Of Social Chatter This Week With Low Investor Confidence,2016-07-15 17:00:00-04:00,AGN,positive
43806.0,Goldman Sachs Sees 'Limited Upside' In Teva Regardless Of Acquisition Results,2016-07-15 08:30:00-04:00,AGN,negative
43807.0,Option Alert: AGN Aug16 215 Puts Sweep: 2790 @  ASK  $2.35: 4325 traded vs 2558 OI:  Earnings 8/8 Before Open  $243.13 Ref,2016-07-14 14:04:00-04:00,AGN,positive
43808.0,Allergan Spokesman Say Antitrust Clearance Is Imminent; Agrees With Teva that Deal Could Close at Any Time -Reuters,2016-07-13 10:23:00-04:00,AGN,positive
43809.0,"CNBC Now Tweets 'Allergan, Teva deal approval expected in next 2 weeks - sources • $TEVA $AGN'",2016-07-13 09:34:00-04:00,AGN,positive
43810.0,"CNBC Now @CNBCnow Tweet; Allergan, Teva deal approval expected in next 2 weeks - sources • $TEVA $AGN",2016-07-13 09:34:00-04:00,AGN,positive
43811.0,"Allergan, Teva Pharmaceutical Industries Entered into Amendment, Dated July 11, 2016 to Master Purchase Agreement; Amendment Reduced Cash Consideration to Be Paid By $221M;  Actonel; Carafate Added to List of Excluded Products -8K",2016-07-13 06:57:00-04:00,AGN,positive
43812.0,10 Stocks Cramer's Watching To See If The Market Rebound Is Sustainable,2016-07-12 15:03:00-04:00,AGN,neutral
43813.0,Watch These 7 Huge Call Purchases In Monday Trade,2016-07-11 03:06:00-04:00,AGN,positive
43814.0,Option Alert: AGN Nov16 260 Calls: 700 @  ASK  $10.00: 3367 traded vs 331 OI:  Earnings 8/4  $240.94 Ref,2016-07-08 15:26:00-04:00,AGN,positive
43815.0,Allergan Reports Received Positive Opinion Through European Decentralised Procedure for BELKYRA,2016-07-01 07:30:00-04:00,AGN,positive
43816.0,Allergan Shares Rally Nearly 5%; BofA Added To US-1 List,2016-06-28 17:38:00-04:00,AGN,positive
43817.0,A Peek Into The Markets: U.S. Stock Futures Surge Ahead Of GDP Report,2016-06-28 07:52:00-04:00,AGN,neutral
43818.0,Allergan Says New Research Indicates New Attitude To Beauty As Women Seek To Score Over Youth On Confidence,2016-06-28 07:49:00-04:00,AGN,positive
43819.0,Allergan Gets FDA Approval Of sNDA To Update Label For AVYCAZ,2016-06-23 11:29:00-04:00,AGN,positive
43820.0,Allergan Reports FDA approval of sNDA for AVYCAZ,2016-06-23 08:02:00-04:00,AGN,positive
43821.0,"Benzinga's M&A Chatter for Tuesday June 21, 2016",2016-06-21 20:06:00-04:00,AGN,neutral
43822.0,8 Biggest Mid-Day Losers For Tuesday,2016-06-21 12:56:00-04:00,AGN,negative
43823.0,The Market In 5 Minutes: #TrumpSoPoor And More,2016-06-21 08:47:00-04:00,AGN,neutral
43824.0,Impax Agrees To Buy Genetic Products For $586 Million,2016-06-21 07:51:00-04:00,AGN,positive
43825.0,"UPDATE: Impax To Add These Generics Upon Closing Of The Deal, See Body",2016-06-21 07:02:00-04:00,AGN,neutral
43826.0,UPDATE: Impax Deal Signifies Return Of Impax To Its Generic Equivalent To Concerta For $586M,2016-06-21 07:01:00-04:00,AGN,neutral
43827.0,"Impax Reports Deal to Buy Generic Products from Teva, Affiliates of Allergan for $586M",2016-06-21 07:01:00-04:00,AGN,neutral
43828.0,Cadila Healthcare says Zydus Acquires Two ANDAs from Teva; Financial Details Not Disclosed,2016-06-20 03:49:00-04:00,AGN,neutral
43829.0,Allergan Gets FDA Acceptance Of Premarket Notification Filing For XEN Glaucoma Treatment System,2016-06-15 08:00:00-04:00,AGN,positive
43830.0,Allergan Reports FDA Acceptance of 510(k) Premarket Notification Filing for XEN Glaucoma Treatment System,2016-06-15 07:31:00-04:00,AGN,positive
43831.0,Benzinga's Weekend M&A Chatter,2016-06-12 22:07:00-04:00,AGN,neutral
43832.0,Barron's: The Midyear Roundtable,2016-06-12 15:08:00-04:00,AGN,neutral
43833.0,Dr. Reddy's to Acquire Portfolio of Eight ANDA's from TEVA for US Market for $350M in Cash,2016-06-11 08:49:00-04:00,AGN,neutral
43834.0,Allergan's New Data Suggests Misperceptions May Lead Chronic Migraine To Be Undertreated In Men,2016-06-10 11:08:00-04:00,AGN,neutral
43835.0,Bernstein Lists Active Buyers Of Ophthalmology Companies,2016-06-09 14:12:00-04:00,AGN,positive
43836.0,Takeover Talk A Help To Wide-Moat ETFs,2016-06-09 09:21:00-04:00,AGN,positive
43837.0,"Icahn on CNBC Says, ""Allergan Has Great Pipeline, Undervalued With At Very Good CEO""",2016-06-09 08:49:00-04:00,AGN,positive
43838.0,"Ironwood Pharma, Allergan Report sNDA for 72 mcg Linaclotide in Chronic Idiopathic Constipation Accepted for FDA Review",2016-06-09 08:02:00-04:00,AGN,positive
43839.0,"Valeant Shares Spiking, Traders Passing Around A Link With Comments Of A Possible Allergan Bid For Valeant",2016-06-08 15:25:00-04:00,AGN,positive
43840.0,Watson Files for Dismissal to End Patent Litigation Against Amarin Regarding Vascepa Capsules,2016-06-08 06:37:00-04:00,AGN,negative
43841.0,"Citron's Andrew Left Calls Brent Saunders A Total Superstar, Says Mallinckrodt Cannot Rebound",2016-06-06 16:48:00-04:00,AGN,neutral
43842.0,Acadia Pharmaceuticals May Be Subject Of A Bidding War,2016-06-06 12:21:00-04:00,AGN,negative
43843.0,5 Takeaways From Vanity Fair's New Valeant Expose,2016-06-06 12:18:00-04:00,AGN,negative
43844.0,"CNBC Now @CNBCnow Tweet: Allergan CEO to CNBC: Will begin to buyback shares immediately upon close of Teva deal, which is expected at end of this month.",2016-06-06 10:53:00-04:00,AGN,positive
43845.0,"Allergan CEO Brent Saunders To CNBC, ""Don't Know Exactly"" How Large Icahn's Position Is",2016-06-06 10:51:00-04:00,AGN,neutral
43846.0,Allergan Gets FDA Approval For BYVALSON,2016-06-06 08:48:00-04:00,AGN,positive
43847.0,Allergan Reports FDA Approval of BYVALSON,2016-06-06 07:32:00-04:00,AGN,positive
43848.0,Benzinga's Weekend M&A Chatter,2016-06-05 20:21:00-04:00,AGN,neutral
43849.0,"AstraZeneca, Teva, Biogen, Allergan Said to be Potential Bidders for Acadia -Daily Mail",2016-06-03 18:38:00-04:00,AGN,neutral
43850.0,"Cantor Fitzgerald Assumes Coverage Of Glaukos Corp With Buy, $35TP",2016-06-03 09:47:00-04:00,AGN,neutral
43851.0,Allergan Gets FDA Approval For JUVÉDERM VOLBELLA For Use In Lips And Perioral Rhytids,2016-06-01 09:54:00-04:00,AGN,positive
43852.0,JUVÉDERM VOLBELLA XC Approved By U.S. FDA For Use In Lips And Perioral Rhytids,2016-06-01 07:32:00-04:00,AGN,positive
43853.0,Option Alert: AGN Jul16 195 Puts: 900 @  ASK  $1.25: 928 traded vs 13 OI: $236.23 Ref,2016-05-31 14:00:00-04:00,AGN,positive
43854.0,Carl Icahn's New Stake In Allergan,2016-05-31 10:16:00-04:00,AGN,neutral
43855.0,Allergan Says It 'Has No Reason to Believe' Icahn Investment Was Made for Purposes of Influencing Management or Control of Company,2016-05-31 09:49:00-04:00,AGN,negative
43856.0,Carl Icahn Statement Regarding Allergan From His Website,2016-05-31 09:48:00-04:00,AGN,neutral
43857.0,Carl Icahn @Carl_C_Icahn We have recently acquired a large position in Allergan $ACT & are very supportive of CEO Brent Saunders. Read more: carlicahn.com/statement-rega…,2016-05-31 09:19:00-04:00,AGN,positive
43858.0,Allergan Receives FDA Approval For Teflaro For Pediatric Patients 2 Months Of Age To Less Than 18 Years Of Age,2016-05-31 07:33:00-04:00,AGN,positive
43859.0,JPMorgan: Monsanto Shares Could Hit $180 Over The Next 5 Years,2016-05-24 15:32:00-04:00,AGN,positive
43860.0,Allergan Says FDA Accepts Its NDA Filing Of Oxymetazoline HCI Cream 1.0%,2016-05-24 08:26:00-04:00,AGN,positive
43861.0,Allergan Announces FDA Acceptance Of NDA Filing For Oxymetazoline HCI Cream,2016-05-24 07:32:00-04:00,AGN,positive
43862.0,"Salesforce, Allergan, Intrexon: Fast Money Picks For May 24",2016-05-24 06:00:00-04:00,AGN,neutral
43863.0,Allergan Announces BOTOX Vista Has Received National Marketing Authorisation in Japan for Treatment of Crow's Feet,2016-05-23 16:34:00-04:00,AGN,neutral
43864.0,UPDATE: Allergan CEO Saunders Says Company Weeks Away from Closing Asset Sale to Teva; Says Company Is Free To Do Multibillion Dollar Deals Following Closing of Teva Deal,2016-05-23 11:49:00-04:00,AGN,positive
43865.0,"Allergan Pres, CEO, Brent Saunders, Currently Speaking at UBS Global Healthcare Conference: Sales Could 'Easily' Grow 10% YoY In Next Few Years If Experimental Drugs Succeed",2016-05-23 11:37:00-04:00,AGN,positive
43866.0,Allergan Launches 'IBS-D on Tract',2016-05-22 09:12:00-04:00,AGN,neutral
43867.0,A Look At All Of Pfizer's Acquisitions Over The Past 2 Years,2016-05-17 11:22:00-04:00,AGN,neutral
43868.0,Bull And Bear Takeaways From Pfizer's $5.2 Billion Deal,2016-05-17 07:26:00-04:00,AGN,neutral
43869.0,13F Season: David Einhorn's New Positions,2016-05-17 06:34:00-04:00,AGN,neutral
43870.0,Allergan Spikes to High of $228.53,2016-05-16 14:46:00-04:00,AGN,neutral
43871.0,Allergan's Pivotal Trials Of Oculeve Intranasal Tear Neurostimulator Meet Primary And Secondary Efficacy Endpoints,2016-05-16 09:47:00-04:00,AGN,neutral
43872.0,"Allergan Reports OCUN-009 and OCUN-010 Each Met Primary, Secondary Efficacy Endpoints",2016-05-16 07:16:00-04:00,AGN,neutral
43873.0,"Dan Loeb's Q1 Moves: Allergan, Alphabet, Baxalta And More",2016-05-13 17:16:00-04:00,AGN,neutral
43874.0,"Third Point Increase Stake In Time Warner Cable, Sealed Air, Amgen, Allegan",2016-05-13 16:29:00-04:00,AGN,positive
43875.0,13F Season: Some Early Trends For Q1 2016,2016-05-13 10:54:00-04:00,AGN,neutral
43876.0,The Market In 5 Minutes: Friday The 13th,2016-05-13 09:42:00-04:00,AGN,neutral
43877.0,Goldman Removes Mylan From Its Conviction List,2016-05-13 09:17:00-04:00,AGN,neutral
43878.0,"Allergan Is Primed For Growth, Goldman Sees 27% Upside Potential",2016-05-13 08:00:00-04:00,AGN,positive
43879.0,What To Expect This 13F Season (And Which Hedge Funds To Watch),2016-05-13 06:50:00-04:00,AGN,neutral
43880.0,"Goldman Sachs Removes Mylan From Conviction Buy List & Maintains Buy Rating With $60 PT, Adds Allergan To Conviction Buy List & Maintains Buy Ratings With $275 PT",2016-05-13 06:32:00-04:00,AGN,neutral
43881.0,"Berenberg Unimpressed With Pfizer, Initiates Coverage At Hold",2016-05-12 17:59:00-04:00,AGN,negative
43882.0,Is This The Right Time To Do A Huge M&A Deal?,2016-05-12 13:46:00-04:00,AGN,positive
43883.0,Moody's Says Allergan's Share Repurchase Announcement Is Credit Negative,2016-05-11 14:36:00-04:00,AGN,neutral
43884.0,Irish Law May Force Allergan To 'Gradually' Buy Back Shares,2016-05-11 10:41:00-04:00,AGN,positive
43885.0,JPMorgan On Allergan: Solid Core Product Performance,2016-05-11 09:14:00-04:00,AGN,positive
43886.0,Citi Maintains Its Constructive Stance On Allergan,2016-05-11 09:01:00-04:00,AGN,neutral
43887.0,Mid-Afternoon Market Update: Dow Jumps Over 200 Points; SolarCity Shares Tumble,2016-05-10 15:45:00-04:00,AGN,positive
43888.0,Allergan Q1'16 Earnings Conference Call: Full Transcript,2016-05-10 15:39:00-04:00,AGN,neutral
43889.0,Mid-Day Market Update: Sodastream Gains Following Earnings Beat; NewLink Genetics Shares Decline,2016-05-10 12:14:00-04:00,AGN,positive
43890.0,Mid-Morning Market Update: Markets Open Higher; Allergan Earnings Top Views,2016-05-10 10:10:00-04:00,AGN,positive
43891.0,TD Ameritrade's IMX Sentiment For April Shows Clients Were Net Sellers Of Some Popular Names,2016-05-10 09:14:00-04:00,AGN,positive
43892.0,"Allergan Q1 Adjusted Earnings Beat Predictions, Revenue Miss",2016-05-10 09:05:00-04:00,AGN,negative
43893.0,Allergan Board Authorizes Fresh $10 Billion Share Repurchase Program,2016-05-10 08:04:00-04:00,AGN,positive
43894.0,UPDATE: Allergan Affirms FY16 Sales ~$17B vs $16.86B Est.,2016-05-10 07:31:00-04:00,AGN,neutral
43895.0,Allergan Reaffirms FY16 Outlook,2016-05-10 07:30:00-04:00,AGN,neutral
43896.0,"Allergan Reports Q1 Adj. EPS $3.04 vs $3.01 Est., Sales $3.8B vs $3.95B Est.",2016-05-10 07:30:00-04:00,AGN,neutral
43897.0,Allergan Reports $10B Buyback Plan,2016-05-10 07:18:00-04:00,AGN,neutral
43898.0,"UPDATE: Watson to Obtain Commercial Rights for U.S. in Exchange for Upfront Fee, Potential Regulatory and Performance Based Milestone Payments Totaling up to $32.5M",2016-05-10 06:49:00-04:00,AGN,neutral
43899.0,Mike Khouw Sees Unusual Options Activity In Allergan,2016-05-10 06:17:00-04:00,AGN,neutral
43900.0,"Keep an Eye on These 10 Stocks for May 10, 2016",2016-05-10 05:15:00-04:00,AGN,neutral
43901.0,"Earnings Scheduled For May 10, 2016",2016-05-10 04:29:00-04:00,AGN,neutral
43902.0,Dealogic: 2016 Has Already Seen Failed U.S. Deals Worth $378 Billion,2016-05-09 15:51:00-04:00,AGN,negative
43903.0,Allergan Rallies Ahead Of Q1 Report,2016-05-09 15:50:00-04:00,AGN,neutral
43904.0,Allergan Shares Have Flirted with $215 Level Over Last Half Hour Since Pulling Back from Session High Right at $217; Stock Up ~6.6% for Session,2016-05-09 11:35:00-04:00,AGN,positive
43905.0,"Allergan, Richter Announce Phase III Study of Ulipristal Acetate 5 and 10 mg in the Treatment of Uterine Fibroids Met all Co-primary and Secondary Endpoints",2016-05-09 04:11:00-04:00,AGN,neutral
43906.0,Why This Analyst Upgraded Shares Of Cardiome To 'Speculative Buy'; Stock Skyrockets In Pre-Market,2016-05-06 09:13:00-04:00,AGN,positive
43907.0,"Cardiome, Allergan Reports XYDALBA Licensing Agreement in International Markets",2016-05-05 16:53:00-04:00,AGN,positive
43908.0,"Cardiome, Allergan Report XYDALBA Licensing Deal in Int'l Markets",2016-05-05 16:45:00-04:00,AGN,neutral
43909.0,Teva Selling Assets to Clear Way for Purchase of Allergan Generic Drug Portfolio -Reuters,2016-05-05 16:34:00-04:00,AGN,positive
43910.0,"Synergy Pharma Seen 'Weighing' Options, Sell-Side Forecasts Upside Regardless Of M&A Rumors",2016-05-05 12:29:00-04:00,AGN,neutral
43911.0,Pfizer Rallies Off Q1 Report,2016-05-03 15:07:00-04:00,AGN,neutral
43912.0,"Perrigo, Allergan Report First-To-Market Launch Of Store Brand OTC Equivalent To Mucinex",2016-05-03 08:54:00-04:00,AGN,neutral
43913.0,Allergan Lowers Cost To Help U.S. Military Servicewomen Access LILETTA 52 mg At Military Treatment Facilities,2016-05-02 07:59:00-04:00,AGN,positive
43914.0,Allergan Receives FDA Approval and Launches First Generic Version of CRESTOR,2016-05-02 07:33:00-04:00,AGN,positive
43915.0,$45 Billion Thursday For M&A Shows There Are Still Plenty Of Buyers Out There,2016-04-29 16:14:00-04:00,AGN,neutral
43916.0,Allergan Gets Positive Opinion From EU's CHMP For Its ENZEPI,2016-04-29 12:49:00-04:00,AGN,positive
43917.0,EMA Recommends Approval of Allergan's Zavicefta to Treat Severe Infection,2016-04-29 07:26:00-04:00,AGN,positive
43918.0,Another New Social Sentiment ETF,2016-04-27 16:26:00-04:00,AGN,neutral
43919.0,Allergan Again A Core Holding At UBS,2016-04-27 10:41:00-04:00,AGN,neutral
43920.0,"Allergan Reports Ground Breaking on $200M Waco Facility Expansion, Will Create 100 Full Time Jobs",2016-04-25 16:09:00-04:00,AGN,positive
43921.0,Pharma Names Under Pressure Amid Perrigo Warning,2016-04-25 13:53:00-04:00,AGN,negative
43922.0,The Largest M&A Spreads On The Market,2016-04-25 13:11:00-04:00,AGN,neutral
43923.0,The Market In 5 Minutes: Sometimes It Snows In April,2016-04-22 10:07:00-04:00,AGN,neutral
43924.0,"Allergan Announces Acquisition Of Topokine Therapeutics, Highlights Fat Reduction Development Program",2016-04-22 09:56:00-04:00,AGN,neutral
43925.0,"Benzinga's M&A Chatter for Thursday April 21, 2016",2016-04-21 20:49:00-04:00,AGN,neutral
43926.0,"Allergan Reports Purchase of Topkine Therapeutics for Upfront Payment of $85M Plus Success-Based Development, Sales Milestones for XAF5",2016-04-21 16:31:00-04:00,AGN,neutral
43927.0,Cramer Gives His Opinion On Starwood And Time Warner Cable,2016-04-19 06:27:00-04:00,AGN,neutral
43928.0,"Piper Jaffray Downgrades Allergan, Slashes Target To $238",2016-04-18 10:45:00-04:00,AGN,negative
43929.0,Benzinga's Top Initiations,2016-04-18 09:47:00-04:00,AGN,positive
43930.0,"The Market In 5 Minutes: Brazil, Doha, And Earnings Season",2016-04-18 09:44:00-04:00,AGN,neutral
43931.0,Benzinga's Top Downgrades,2016-04-18 09:29:00-04:00,AGN,positive
43932.0,Goldman Reinstates Coverage On Pfizer And Allergan Following Failed Merger,2016-04-18 08:06:00-04:00,AGN,negative
43933.0,"Goldman Sachs Reinstates Buy on Allergan, Announces $275.00 PT",2016-04-18 07:05:00-04:00,AGN,neutral
43934.0,Guggenheim Securities Initiates Coverage on Allergan at Neutral,2016-04-18 06:59:00-04:00,AGN,positive
43935.0,AstraZeneca has Held Internal Talks Regarding  a Bid for Medivation; Allergan has Yet to Make Formal Offer -Sunday Times,2016-04-17 19:07:00-04:00,AGN,neutral
43936.0,"Barron's Picks And Pans: Ford, Intel, Sealed Air And More",2016-04-17 18:47:00-04:00,AGN,neutral
43937.0,Adam Feuerstein @adamfeuerstein Tweet: But why would $AGN buy $SGYP if they already have a marketing partnership with $IRWD? Someone's playing Friday fun.,2016-04-15 15:22:00-04:00,AGN,positive
43938.0,Favus Gives 10 Reasons To Sell Allergan,2016-04-13 11:06:00-04:00,AGN,neutral
43939.0,Option Alert: AGN May16 235 Puts: 1989 @  ASK  $19.70: 1989 traded vs 3721 OI:  Earnings 5/9  $220.63 Ref,2016-04-13 10:42:00-04:00,AGN,positive
43940.0,Stocks Hitting 52-Week Lows,2016-04-13 10:33:00-04:00,AGN,negative
43941.0,"Hearing Favus Out With Negative Note On Allergan, Gives 10 Reasons To Sell",2016-04-13 10:07:00-04:00,AGN,negative
43942.0,Cautious Comments from Favus Research on Allergan,2016-04-13 09:48:00-04:00,AGN,negative
43943.0,"Benzinga's M&A Chatter for Monday April 11, 2016",2016-04-11 20:38:00-04:00,AGN,neutral
43944.0,"CORRECTION: ENDP Shares Spike, DealReporter Says AGN Could Be Looking To Buy ENDP",2016-04-11 12:04:00-04:00,AGN,positive
43945.0,"ENDP Shares Spike, DealReporter Says AGN Could Be Looking To Buy ENDP",2016-04-11 12:03:00-04:00,AGN,positive
43946.0,The 10 Least Likely M&A Deals To Go Through,2016-04-11 10:06:00-04:00,AGN,neutral
43947.0,"Street Struggles for Direction, Looking for Catalyst As Earnings Approach",2016-04-07 14:04:00-04:00,AGN,negative
43948.0,White House Says Treasury Department Working on More Steps to Counter Tax Avoidance -Reuters,2016-04-07 13:25:00-04:00,AGN,negative
43949.0,"The Market In 5 Minutes: Thursday, April 7, 2016",2016-04-07 10:36:00-04:00,AGN,neutral
43950.0,"Pfizer's Valuation Is Attractive, And JPMorgan Wouldn't Be Surprised To See A Breakup",2016-04-07 09:52:00-04:00,AGN,positive
43951.0,Benzinga's Top Downgrades,2016-04-07 09:13:00-04:00,AGN,positive
43952.0,"Morgan Stanley Assumes Allergan at Overweight, Announces $300.00 PT",2016-04-07 08:26:00-04:00,AGN,negative
43953.0,"JP Morgan Assumes Allergan at Overweight, Announces $325.00 PT",2016-04-07 07:27:00-04:00,AGN,neutral
43954.0,"Susquehanna Downgrades Allergan to Neutral, Lowers PT to $275.00",2016-04-07 07:20:00-04:00,AGN,negative
43955.0,"Pfizer, Allergan: Fast Money Picks For April 7",2016-04-07 06:40:00-04:00,AGN,neutral
43956.0,"Sosei Subsidiary Heptares, Allergan Enter into Global R&D and Commercialization Partnership for Novel Treatments in Alzheimer's and Other Neurological Disorders",2016-04-07 04:21:00-04:00,AGN,positive
43957.0,"Benzinga's M&A Chatter for Wednesday April 6, 2016",2016-04-06 20:22:00-04:00,AGN,neutral
43958.0,6 Investment Banks Lost More Than $200 Million From Pfizer-Allergan Deal Collapse,2016-04-06 15:51:00-04:00,AGN,negative
43959.0,New Tax Inversions Rules: Threats To Healthcare ETFs?,2016-04-06 15:33:00-04:00,AGN,negative
43960.0,"PPH May Be Home To Hedge Fund Hotels, But This ETF Can Endure",2016-04-06 14:26:00-04:00,AGN,neutral
43961.0,Mylan Is 'Comfortable Moving Forward' With Acquisition Of Sweden-Based Meda,2016-04-06 13:23:00-04:00,AGN,positive
43962.0,Barron's: Allergan And Pfizer Still Buys Even After Deal Fell Through,2016-04-06 13:18:00-04:00,AGN,neutral
43963.0,Investors Applaud Ending Of Pfizer-Allergan Deal,2016-04-06 12:25:00-04:00,AGN,positive
43964.0,Is Allergan Worth Over $300 Without Pfizer?,2016-04-06 11:57:00-04:00,AGN,positive
43965.0,What Will Fed Minutes Mean To Markets?,2016-04-06 11:39:00-04:00,AGN,neutral
43966.0,"The Market In 5 Minutes: Wednesday, April 6, 2016",2016-04-06 10:33:00-04:00,AGN,neutral
43967.0,Benzinga's Volume Movers,2016-04-06 10:16:00-04:00,AGN,neutral
43968.0,Benzinga's Top Downgrades,2016-04-06 08:57:00-04:00,AGN,positive
43969.0,10 Stocks Moving In Wednesday's Pre-Market Session,2016-04-06 08:19:00-04:00,AGN,neutral
43970.0,Pfizer Announces Merger Termination With Allergan; Will Pay $150 Million Breakup Fee,2016-04-06 07:09:00-04:00,AGN,negative
43971.0,Allergan Release Says Company Still Has Strong Future Following Pfizer Merger Termination,2016-04-06 06:50:00-04:00,AGN,positive
43972.0,Pfizer to Pay Allergan $150M Breakup Fee,2016-04-06 06:46:00-04:00,AGN,negative
43973.0,Pfizer Announces Termination of Merger with Allergan,2016-04-06 06:45:00-04:00,AGN,neutral
43974.0,Mizuho Securities Downgrades Allergan to Neutral,2016-04-06 04:32:00-04:00,AGN,positive
43975.0,"Stocks To Watch For April 6, 2016",2016-04-06 04:29:00-04:00,AGN,neutral
43976.0,"Benzinga's M&A Chatter for Tuesday April 5, 2016",2016-04-05 20:22:00-04:00,AGN,neutral
43977.0,"If Pfizer Saves Allergan Deal, These Two Things Should Be Changed",2016-04-05 16:13:00-04:00,AGN,neutral
43978.0,Mid-Afternoon Market Update: Dow Falls Over 100 Points; Valeant Pharmaceuticals Shares Spike Higher,2016-04-05 15:52:00-04:00,AGN,positive
43979.0,Report: Pfizer May Abandon Allergan Deal,2016-04-05 15:11:00-04:00,AGN,negative
43980.0,A Veteran Trader Took One Of The Worst Losses Of His Career Monday. Here's What He Learned.,2016-04-05 14:28:00-04:00,AGN,negative
43981.0,Obama: Tax Inversions Are 'Wasteful',2016-04-05 13:50:00-04:00,AGN,neutral
43982.0,"Hearing Pfizer is Leaning Towards Abandoning, Not Altering, Deal with Allergan",2016-04-05 13:39:00-04:00,AGN,negative
43983.0,Pfizer Rallies Off Allergan News,2016-04-05 12:56:00-04:00,AGN,neutral
43984.0,Evidence Pfizer Could Revisit GlaxoSmithKline Or AstraZeneca Deals If Allergan Falls Through,2016-04-05 12:30:00-04:00,AGN,neutral
43985.0,Mid-Day Market Update: Intercept Pharmaceuticals Gains Following Release of FDA Advisory Committee Documents; Godaddy Shares Decline,2016-04-05 12:11:00-04:00,AGN,positive
43986.0,Allergan Now Trades Cheaper Than Its Standalone Value,2016-04-05 11:07:00-04:00,AGN,positive
43987.0,Hearing Pres Obama Will Make Statement on Tax Inversions at 12:15 p.m. EDT,2016-04-05 11:06:00-04:00,AGN,neutral
43988.0,"The Market In 5 Minutes: Tuesday, April 5, 2016",2016-04-05 10:38:00-04:00,AGN,neutral
43989.0,Shire Selling Off After Inversion Announcement,2016-04-05 10:32:00-04:00,AGN,neutral
43990.0,Stocks Hitting 52-Week Lows,2016-04-05 10:17:00-04:00,AGN,negative
43991.0,Mid-Morning Market Update: Markets Open Lower; Walgreens Earnings Top Views,2016-04-05 10:10:00-04:00,AGN,negative
43992.0,"Leerink: Treasury Notice Lowers Pfizer-Allergan Deal Chances, Ownership Test Changes A 'Surprise'",2016-04-05 08:49:00-04:00,AGN,positive
43993.0,Allergan Spikes to Premarket High of $227,2016-04-05 07:41:00-04:00,AGN,neutral
43994.0,"Pfizer, Allergan, Disney, Tesla: Fast Money Picks For April 5",2016-04-05 07:02:00-04:00,AGN,neutral
43995.0,"Pfizer Says Conducting Review of Treasury Action, Won't Speculate on Potential Impact -Reuters",2016-04-04 19:01:00-04:00,AGN,positive
43996.0,Betting On The Pfizer-Allergan Merger? You Now Have A 35% Arbitrage Opportunity After New Treasury Fears,2016-04-04 18:38:00-04:00,AGN,positive
43997.0,David Faber @davidfaber Tweet: 3 year look back provision on new inversion regs from Treasury is aimed at killing $PFE $AGN deal and may well succeed in doing just that.,2016-04-04 18:08:00-04:00,AGN,positive
43998.0,"Allergan Shares Down From $277 To Low Of $228 After Hours On Tax Inversion Limitations By US Treasury, Now Trading At $235/Share",2016-04-04 17:25:00-04:00,AGN,positive
43999.0,Cramer Gives His Opinion On Fitbit And Allergan,2016-04-03 16:48:00-04:00,AGN,neutral
44000.0,UPDATE: FTC Complaint Also Names Allergan,2016-03-31 09:35:00-04:00,AGN,negative
44001.0,"Pfizer, Allergan Announce Received Added Info from FTC Related to Deal, Continue to Expect Deal to Close in 2H'16",2016-03-30 12:42:00-04:00,AGN,neutral
44002.0,UPDATE: Court Rules Shire Entitled to Requested Injuctive Relief,2016-03-28 10:42:00-04:00,AGN,positive
44003.0,UPDATE: U.S. Court Says Watson Pharma Infringed Two Claims of '720 Patent,2016-03-28 10:41:00-04:00,AGN,neutral
44004.0,"U.S. Court Rules Watson ANDA Product Meets Additional Requirements for Claim Constructions of Inner Lipophilic Matrix, Outer Hydrophilic Matrix -Reuters",2016-03-28 10:39:00-04:00,AGN,neutral
44005.0,"Perrigo, Allergan Report First-To-Market Launch Of Store Brand OTC Equivalent To Mucinex 1200mg ER Tablets",2016-03-23 08:32:00-04:00,AGN,neutral
44006.0,Why Valeant's New CEO Could Be An Allergan Exec,2016-03-21 15:41:00-04:00,AGN,neutral
44007.0,Why Is The Allergan-Pfizer Spread Near All-Time Highs?,2016-03-21 10:25:00-04:00,AGN,neutral
44008.0,"BTIG: Buy Teva On Weakness, U.S. Lawmakers Have Little Appetite For Direct Government Negotiation Of Drug Prices",2016-03-21 08:56:00-04:00,AGN,negative
44009.0,Specialty Pharma Worries Could Be Bigger Than Valeant,2016-03-18 11:17:00-04:00,AGN,negative
44010.0,"Gabelli & Co Cuts Allergan FY 2016 EPS Est From $16.15 To $14.68, Cuts FY 2017 EPS Est From $19.95 To $18.30 To Reflect Delayed Debt Repayment Schedule",2016-03-17 09:17:00-04:00,AGN,negative
44011.0,Allergan Confirms Patent Challenge on Generic Abraxane,2016-03-17 07:30:00-04:00,AGN,positive
44012.0,Allergan Announces U.S. Availability of VRAYLAR for Treatment of Bipolar Mania and Schizophrenia in Adults,2016-03-16 08:04:00-04:00,AGN,neutral
44013.0,Teva Pharma Reports Received EC Approval for Allergan Generics Acquisition,2016-03-10 09:06:00-05:00,AGN,positive
44014.0,Allergan Reports Received FDA CRL for Prior Approval Supplement for RESTASIS 0.05% Multi-Dose Preservative-Free bottle,2016-03-10 08:12:00-05:00,AGN,positive
44015.0,UPDATE: EU Regulators Set to Approve Teva Bid for Allergan Generics Unit,2016-03-09 14:25:00-05:00,AGN,neutral
44016.0,UPDATE: Shares of Teva Spike Higher Amid EU Antitrust Regulators Ready to Clear Co.'s Bid for Allergan Generic Unit,2016-03-09 14:25:00-05:00,AGN,positive
44017.0,Teva Agrees To Divest Some On-Market Drugs And Others In The Pipeline To Address EU Antitrust Concerns -Reuters,2016-03-09 14:25:00-05:00,AGN,positive
44018.0,"UBS Maintains Buy On Pfizer & PT $36, Says Allergan Deal Makes Strategic Sense And Believes Consensus Fails To Give Sufficient Credit To Allergan Pipeline",2016-03-08 06:51:00-05:00,AGN,negative
44019.0,ICYMI: Everything Barron's Covered This Weekend,2016-03-07 15:57:00-05:00,AGN,neutral
44020.0,BTIG Recommends 'Beaten Down' Drug Manufacturers Like Teva,2016-03-07 10:31:00-05:00,AGN,positive
44021.0,"BTIG Research Says TEVA Shares Inexpensive, Sees Catalyst To Shares Coming From Closure of AGN Generics Deal",2016-03-07 09:13:00-05:00,AGN,positive
44022.0,Allergan Files Form S-4 for Offering of Securities Related to Merger With Pfizer,2016-03-07 06:25:00-05:00,AGN,positive
44023.0,Allergan Reports Launch of Bold Access to LILETTA,2016-03-03 07:31:00-05:00,AGN,positive
44024.0,3 Mega Biotechs Leerink Loves,2016-02-29 13:25:00-05:00,AGN,positive
44025.0,Allergan Reports FDA Acceptable for Filing Letter for Generic XIFAXAN ANDA,2016-02-29 07:35:00-05:00,AGN,positive
44027.0,"Valeant Says CEO Pearson Returns, Will Remove Prior Guidance, Expects To Release Q4 2015 & 2016 Guidance 'in the near term', Confirms Salix Pharma Received Letter From Actavis Labs",2016-02-28 19:52:00-05:00,AGN,neutral
44028.0,UPDATE: Valeant Says FDA Has Received Actavis' NDA for Approval to Market Generic Version of Salix's Xifaxan,2016-02-28 19:48:00-05:00,AGN,positive
44029.0,Allergan Announces FDA Approval of ACZONE for Treatment of Acne Vulgaris,2016-02-25 16:43:00-05:00,AGN,positive
44030.0,Bernie Sanders  ‏@SenSanders Tweet: Enough is enough. Pfizer and other pharmaceutical companies can no longer be allowed to rip off American patients.,2016-02-25 14:12:00-05:00,AGN,negative
44031.0,Hearing Evercore ISI Group Out With Negative Comments On AGN,2016-02-25 11:26:00-05:00,AGN,negative
44032.0,"Enernoc Announces Allergan Purchased Enernoc's EIS to Centralize its Energy Management and Sustainability Reporting Across its Portfolio of Manufacturing, R&D, and Office Sites",2016-02-24 08:36:00-05:00,AGN,positive
44033.0,"FDA Accepts and Grants Priority Review for AVYCAZ Supplemental New Drug Application, Application Seeks To Expand AVYCAZ Label For Treatment Of cIAI",2016-02-24 07:32:00-05:00,AGN,positive
44034.0,"Nomura Says Allergan Remains A Top Pick, Says Co Is Fundamentally Undervalued, Maintains Buy And $350 PT",2016-02-23 07:06:00-05:00,AGN,positive
44035.0,Fast Money Picks For February 23,2016-02-23 06:35:00-05:00,AGN,neutral
44036.0,Earnings Recap For February 22,2016-02-22 16:39:00-05:00,AGN,neutral
44037.0,"Allergan Gains 1.50% Following Q4 Beat, Company Updates On M&A Activity",2016-02-22 08:51:00-05:00,AGN,positive
44038.0,Slump Could Be Healthcare ETF Buying Opportunity,2016-02-22 07:44:00-05:00,AGN,positive
44039.0,Allergan Sees FY16 Rev. $17B vs. Est. $17.66B,2016-02-22 07:33:00-05:00,AGN,neutral
44040.0,"Allergan Reports Q4 EPS $3.41 vs. Est. $3.34, Rev. $4.2B vs. Est. $4.19B",2016-02-22 07:33:00-05:00,AGN,neutral
44041.0,7 Stocks You Should Be Watching Today,2016-02-22 04:35:00-05:00,AGN,neutral
44042.0,"Earnings Scheduled For February 22, 2016",2016-02-22 04:09:00-05:00,AGN,neutral
44043.0,Valeant Had A 58% Chance Of Bankruptcy Last Year,2016-02-19 10:15:00-05:00,AGN,positive
44044.0,Wells Fargo Initiates Coverage on Allergan at Outperform,2016-02-19 08:40:00-05:00,AGN,positive
44045.0,"Wells Fargo Initiates AGN, TEVA, MNK, PRGO at Outperform; Starts VRX At Underperform; Starts MYL At Market Perform",2016-02-19 08:00:00-05:00,AGN,positive
44046.0,"ICYMI: Paulson Was Trading Valeant, Etsy And Allergan Last Quarter",2016-02-18 15:36:00-05:00,AGN,neutral
44047.0,Argus: Teva Worth $75,2016-02-18 10:34:00-05:00,AGN,positive
44048.0,Report: Teva Looking To Win Early EU Approval For Its Acquisition Of Allergan's Generics Unit,2016-02-17 14:49:00-05:00,AGN,positive
44049.0,Teva Said to Seek Fast EU Approval for Allergan Generics Unit Bid; Will Make Concessions to Regulators -Bloomberg,2016-02-17 08:22:00-05:00,AGN,positive
44050.0,13F from Lone Pine Capital Shows Liquidated Position in Allergan,2016-02-16 17:27:00-05:00,AGN,negative
44051.0,13F from Einhorn's Greenlight Shows New Stake in Allergan,2016-02-16 17:03:00-05:00,AGN,neutral
44052.0,Everything You Might Have Missed This 13F Season: Part 1,2016-02-16 16:21:00-05:00,AGN,negative
44053.0,10 M&A Deals The Market Thinks Might Not Happen,2016-02-16 14:53:00-05:00,AGN,neutral
44054.0,"Allergan Reports FDA Accepts sNDA For TEFLARO, Seeks To Expand Label",2016-02-16 07:36:00-05:00,AGN,positive
44055.0,BoA Adds Pfizer To US 1 List; It 'Won't Keep You Up At Night',2016-02-09 09:52:00-05:00,AGN,neutral
44056.0,How To Invest In An Aging World With The 'Live Long & Prosper' ETF,2016-02-08 10:53:00-05:00,AGN,neutral
44057.0,RBC Analyst Says 'Buy The Spread' On Allergan-Pfizer Deal,2016-02-08 09:12:00-05:00,AGN,neutral
44058.0,"RBC Capital Positive On AGN, Would Use Co To Be Long On PFE/AGN Spread, Expects Deal To Close In H2 2016, Maintains Outperform And $354 PT",2016-02-08 07:57:00-05:00,AGN,positive
44059.0,Supernus Pharmaceuticals  Prevails In Patent Litigation vs Allergan In New Jersey Federal Court -Reuters,2016-02-05 15:03:00-05:00,AGN,negative
44060.0,From Conf Call: Pfizer CEO Feels Planned Tax-Inversion Merger With Allergan Is Fully Within U.S. Law,2016-02-02 10:47:00-05:00,AGN,neutral
44061.0,"Allergan's Rapastinel Receives FDA Breakthrough Therapy Designation for Adjunctive Treatment of Major Depressive Disorder, Plans To Begin Phase 3 Studies In 2016",2016-01-29 07:37:00-05:00,AGN,negative
44062.0,"Alleran, AstraZeneca Partner To Commercialize ATM-AVI For Gram-Negative Antibiotic Resistant Infections",2016-01-29 07:07:00-05:00,AGN,neutral
44063.0,Allergan FDA Approves BOTOX For Lower Limb Spasticity In Adults,2016-01-22 08:07:00-05:00,AGN,positive
44064.0,Allergan Reports FDA Approval Of Updated Label For DALVANCE Dosing Regimen,2016-01-21 07:36:00-05:00,AGN,positive
44065.0,"Allergan's VIBERZI Phase 3 Results Published In New England Journal of Medicine, Demonstrates Effective Ab Pain and Diarrhea Relief",2016-01-21 07:06:00-05:00,AGN,positive
44066.0,"Allergan Reports New Data On Rapstinel, Shown To Improve Ketamine Or PCP-Induced Cognitive Impairment in Mice",2016-01-19 08:11:00-05:00,AGN,positive
44067.0,New ETF Is A Refined Pharmaceuticals Play,2016-01-14 10:00:00-05:00,AGN,positive
44068.0,"Pfizer at J.P. Morgan Healthcare Conference, Says Experimental Off-The-Shelf Car T Cell Therapies for Cancer May Have Advantages Over Personalized Car T Cells",2016-01-12 14:05:00-05:00,AGN,negative
44069.0,"Empire Analyst: Sell Sucampo Pharma, It Has 50% Downside",2016-01-12 10:45:00-05:00,AGN,negative
44070.0,CNBC's Meg Tirrell Interviewing Pfizer CEO Ian Read: 'We're confident' Deal with Allergan Will Close This Year,2016-01-11 12:13:00-05:00,AGN,positive
44071.0,"Allergan Acquires Medical Dermatology For $90M, Adds To Neurotoxin Development Pipeline",2016-01-07 08:04:00-05:00,AGN,neutral
44072.0,"Allergan, Perrigo Report First-To-Market Launch Of Store Brand Equivalent To Mucinex D 600mg ER Tablets",2016-01-04 08:24:00-05:00,AGN,neutral
44073.0,$4.6 Trillion In Global M&A Broke Records This Year,2015-12-21 15:59:00-05:00,AGN,negative
44074.0,3 Biotechs Atlantic Equities Loves And 1 It's Avoiding,2015-12-18 14:10:00-05:00,AGN,positive
44075.0,Piper Jaffray Makes 15 'Provocative' Predictions For Biopharma Sector In 2016,2015-12-18 10:52:00-05:00,AGN,neutral
44076.0,The Top 20 Wall Street Analysts Of 2015,2015-12-17 10:44:00-05:00,AGN,positive
44077.0,Allergan Announces U.S. Availability of VIBERZI for Treatment of Irritable Bowel Syndrome with Diarrhea in Adults,2015-12-14 08:01:00-05:00,AGN,negative
44078.0,Allergan and Gedeon Richter Plc. to Present Data on VRAYLAR (cariprazine) at the American College of Neuropsychopharmacology (ACNP) Annual Meeting,2015-12-04 07:01:00-05:00,AGN,neutral
44079.0,Teva Divesting ~$1B in Assets to Alleviate Ant-Trust Concerns Over Proposed Allergan Acquisition -Reuters,2015-12-03 11:36:00-05:00,AGN,positive
44080.0,Merger Landscape Still Inviting To Inversions,2015-12-02 20:18:00-05:00,AGN,positive
44081.0,"Hearing Pfizer Has Said Proforma Allergan Deal, Expecting FY15 Sales $63.5B",2015-12-01 17:40:00-05:00,AGN,neutral
44082.0,Pfizer Is At A 'Strategic Crossroads',2015-12-01 08:09:00-05:00,AGN,neutral
44083.0,"UPDATE: Ironwood, Allergan to Make Decision Related to Advancement of OIC Program Following Review of Results from Linaclotide Colonic Release Phase IIB Trial",2015-11-30 08:03:00-05:00,AGN,neutral
44084.0,Allergan Reports Settlement with NY AG in Memantine Immediate Release Litigation,2015-11-25 11:22:00-05:00,AGN,negative
44085.0,New York AG Resolves Antitrust Lawsuit vs Allergan Over Alzheimers Drug Pricing -Reuters,2015-11-25 11:11:00-05:00,AGN,negative
44086.0,"Will The New Pfizer Be A Winner? SunTrust Analyst Thinks So, Upgrades Stock",2015-11-25 10:51:00-05:00,AGN,positive
44087.0,"EXCLUSIVE: FBB's Mike Bailey On Pfizer-Allergan Deal, Taxes, Rate Hike And Biotech Picks",2015-11-25 09:53:00-05:00,AGN,positive
44088.0,"Allergan, Rugen Therapeutics Reports Collaboration to Discover, Develop Groundbreaking Medicines to Treat Autism, Obsessive-Compulsive Disorders",2015-11-25 08:05:00-05:00,AGN,positive
44089.0,"FBB Capital's Bailey Believes Pfizer's Interest In Allergan Lies In Eye-Care Pipeline, Big Cash Cow For Allergan That Is Being Followed Up By Next-Generation Drug Developments",2015-11-24 13:44:00-05:00,AGN,positive
44090.0,"FBB Capital Partners Mike Bailey On Pfizer, Allergan Deal: ""Allergan good choice for [Pfizer], less risk of cultural clash compared to British company like GlaxoSmithKline""",2015-11-24 13:38:00-05:00,AGN,positive
44091.0,Pfizer Delaying Decision to Split -NY Times Deal Book,2015-11-24 12:23:00-05:00,AGN,neutral
44092.0,"Attn. Investors: Watch Healthcare Stocks, Yuan Devaluation Speculation This Week",2015-11-24 08:29:00-05:00,AGN,neutral
44093.0,"Benzinga's M&A Chatter for Monday November 23, 2015",2015-11-23 20:21:00-05:00,AGN,neutral
44094.0,"Clinton, Sanders And Trump Not Big Fans Of The Pfizer-Allergan Deal",2015-11-23 15:36:00-05:00,AGN,neutral
44095.0,Mid-Afternoon Market Update: US Stocks Down; GameStop Shares Dip On Weak Results,2015-11-23 15:04:00-05:00,AGN,negative
44096.0,Mid-Day Market Update: TeleCommunication Systems Surges On Acquisition News; ProQR Therapeutics Shares Slide,2015-11-23 12:28:00-05:00,AGN,positive
44097.0,Bernie Sanders Condemns Pfizer Buyout of Allergan; Says Disaster for Consumers -Reuters,2015-11-23 11:53:00-05:00,AGN,negative
44098.0,Mid-Morning Market Update: Markets Mostly Flat; Pfizer To Buy Allergan,2015-11-23 10:16:00-05:00,AGN,neutral
44099.0,Morning Market Losers,2015-11-23 09:57:00-05:00,AGN,negative
44100.0,Pfizer Buys Allergan In Largest Healthcare Deal Ever,2015-11-23 09:26:00-05:00,AGN,neutral
44101.0,Benzinga's Top #PreMarket Losers,2015-11-23 08:18:00-05:00,AGN,negative
44102.0,"UPDATE: Pfizer, Allergan to be Combined Under Allergan plc, Which Will Be Renamed 'Pfizer plc' and Trade on NYSE Under Symbol 'PFE'",2015-11-23 07:10:00-05:00,AGN,neutral
44103.0,"UPDATE: Allergan Holders Will Receive 11.3 Shares of Combined Co., Pfizer Holders Will Receive One Share",2015-11-23 07:07:00-05:00,AGN,positive
44104.0,"UPDATE: Pfizer, Allergan Deal Expected to be Neutral to Pfizer's FY17 Adj. EPS, Will Become Accretive Starting CY18, 10%+ Accretive in '19, High-Teens Percentage Accretion in 2020",2015-11-23 07:06:00-05:00,AGN,neutral
44105.0,"UPDATE: Pfizer, Allergan Combine to Form Growth Pharma in Deal Valued at $363.63/AGN Share",2015-11-23 07:05:00-05:00,AGN,positive
44106.0,"UPDATE: Pfizer, Allergan Deal Will Be ~$160B Deal on Total Enterprise Value Basis",2015-11-23 07:04:00-05:00,AGN,positive
44107.0,"Pfizer, Allergan Issue Release 'to Combine'",2015-11-23 07:03:00-05:00,AGN,neutral
44108.0,"Must Watch Stocks for November 23, 2015",2015-11-23 04:37:00-05:00,AGN,neutral
44109.0,Benzinga's Weekend M&A Chatter,2015-11-22 21:15:00-05:00,AGN,neutral
44110.0,"Pfizer, Allergan Agree on Merger Deal -Wall Street Journal",2015-11-22 20:10:00-05:00,AGN,positive
44111.0,Pfizer Near Deal to Acquire Allergan for 11.3  Pfizer Shares Per Allergan Share; Deal Would Value Allergan @$150B -DJ,2015-11-22 15:12:00-05:00,AGN,positive
44112.0,Hearing Pfizer's Ian Read Will Lead Co. Following Deal with Allergan,2015-11-20 13:30:00-05:00,AGN,neutral
44113.0,Bank Of America: We're Still Buying Allergan,2015-11-20 08:00:00-05:00,AGN,neutral
44114.0,Pfizer Said to Offer $380+/Share for Allergan -FT,2015-11-19 13:29:00-05:00,AGN,neutral
44115.0,"Allergan Should Hit $370 Despite Tax Inversion Drama, Analyst Predicts",2015-11-19 10:28:00-05:00,AGN,neutral
44116.0,"Pfizer, Allergan In 'Final Innings' Of Merger Talks",2015-11-19 09:41:00-05:00,AGN,neutral
44117.0,CNBC's David Faber Says Pfizer-Allergan Will be All-Stock Deal,2015-11-19 09:07:00-05:00,AGN,neutral
44118.0,"Early Global News: Starboard Asks Yahoo Not To Spin Off Alibaba, China's Tinder & KaloBios",2015-11-19 07:30:00-05:00,AGN,neutral
44119.0,Fast Money Picks For November 19,2015-11-19 06:22:00-05:00,AGN,neutral
44120.0,"Benzinga's M&A Chatter for Wednesday November 18, 2015",2015-11-18 21:03:00-05:00,AGN,neutral
44121.0,UPDATE: Pfizer to Pay as Much as $380 Per Share for Allergan,2015-11-18 19:15:00-05:00,AGN,positive
44122.0,Pfizer Near Deal to Acquire Allergan -Bloomberg,2015-11-18 19:11:00-05:00,AGN,neutral
44123.0,Allergan Shares Fall 5% After-Hours as New Tax Inversion Guidance Could Put Merger With Pfizer in Jeopardy,2015-11-18 16:51:00-05:00,AGN,negative
44124.0,Treasury Department Plans Anti-Inversion Tax Rules This Week; Secretary Lew Promises Targeted Guidance But No Details on New Rules -DJ,2015-11-18 16:48:00-05:00,AGN,negative
44125.0,Market Chatter Going Around Saying Dan Loeb Of Third Point May Pitch Allergan As Long Position At Robin Hood,2015-11-17 09:23:00-05:00,AGN,neutral
44126.0,UPDATE: Hill Says hasn't Lost Confidence in Bill Ackman,2015-11-16 14:00:00-05:00,AGN,negative
44127.0,"Moelis, Centerview Partners Said To Advise Pfizer on Merger Talks With Allergan -Reuters",2015-11-16 13:18:00-05:00,AGN,neutral
44128.0,"Allergan Shares Moving Higher as Hearing Moelis, Centerview Working with Pfizer related to Possible Deal for Co.",2015-11-16 13:17:00-05:00,AGN,positive
44129.0,"Allergan Reports Phase I, II Interim Data of Bimatoprost SR Implant for IOP Therpay in Glaucoma",2015-11-16 08:02:00-05:00,AGN,neutral
44130.0,Hayman Capital Adds New Positions,2015-11-16 06:26:00-05:00,AGN,neutral
44131.0,Allergan Offers EARLY BCVA Analysis Data AAO Meeting Related to DME Patients Treated with Anti-VEGF Therapy: Says Suggests Long-Term Response Can Be Assessed After Three Injections,2015-11-13 14:41:00-05:00,AGN,neutral
44132.0,"Benzinga's M&A Chatter for Thursday November 12, 2015",2015-11-12 20:31:00-05:00,AGN,neutral
44133.0,"Treasury Spokesperson Says 'We are Continuing our Review of a Broad Range of Options for Further Action, But there is a Limit to What We Can do Administratively'",2015-11-12 15:34:00-05:00,AGN,positive
44134.0,Allergan Shares Selling Off Sharply on Rumor of Deal With Pfizer Being Blocked by US,2015-11-12 13:48:00-05:00,AGN,neutral
44135.0,Hearing Deal Reporter Says Treasury Preparing to Block Allergan/Pfizer Merger,2015-11-12 13:43:00-05:00,AGN,negative
44136.0,"Pfizer, Allergan Near Deal to Make Brent Saunders CEO if Companies Reach Takeover Agreement- Bloomberg",2015-11-10 16:54:00-05:00,AGN,positive
44137.0,"Allergan Shares Moving Higher Post Market as Hearing Bloomberg Reporting Co., Pfizer Could Be Planning to Make Allergan's Brent Saunders CEO if Takeover Deal Reached",2015-11-10 16:33:00-05:00,AGN,positive
44138.0,10 S&P 500 Companies With Green Operations,2015-11-10 15:10:00-05:00,AGN,neutral
44139.0,Valeant To Be Sold? Ackman Hints At It,2015-11-06 09:30:00-05:00,AGN,neutral
44140.0,"Allergan Says Data on Rapastinel, NRX-1074 (AGN-241660) to be Presented at SfN Annual Meeting",2015-11-04 18:30:00-05:00,AGN,neutral
44141.0,"Allergan Reports Q3 EPS $3.48 vs. Est. $3.18, Rev. $4.1B vs. Est. $4.03B",2015-11-04 07:30:00-05:00,AGN,neutral
44142.0,"Keep an Eye on These 10 Stocks for November 4, 2015",2015-11-04 04:59:00-05:00,AGN,neutral
44143.0,"Earnings Scheduled For November 4, 2015",2015-11-04 04:03:00-05:00,AGN,neutral
44144.0,GSK CEO Says 'No Comment' to Report Pfizer Approached GSK Prior to Allergan Talks -Reuters,2015-11-03 07:26:00-05:00,AGN,negative
44145.0,"Guggenheim Partners, Goldman Sachs Advising Pfizer,, JPMorgan Chase, Morgan Stanley  Advising Allergan in Merger Talks -Reuters",2015-11-02 12:19:00-05:00,AGN,neutral
44146.0,Pfizer's Stock Responds To Positive Barron's Article,2015-11-02 11:17:00-05:00,AGN,positive
44147.0,Hearing Credit Suisse Confirming Allergan-Pfizer Dropping Out Of Conference,2015-11-02 11:02:00-05:00,AGN,positive
44148.0,"Visa, Shire The Latest Adding To Merger Frenzy",2015-11-02 10:15:00-05:00,AGN,negative
44149.0,"Pfizer, Allergan Looking To Come To Terms On Deal By Thanksgiving-BBG",2015-11-02 08:24:00-05:00,AGN,neutral
44150.0,"Ironwood, Allergan Announce Initiation of Phase IIb Trial of Linaclotide Colonic Release",2015-11-02 08:06:00-05:00,AGN,neutral
44151.0,ETF Week Ahead Preview: Hoping For No November Rain,2015-11-02 06:47:00-05:00,AGN,positive
44152.0,11 Stocks Moving In Friday's After-Hours Session,2015-10-30 16:47:00-04:00,AGN,neutral
44153.0,"UBS: The Bull Market Is Ending, Just Not Yet",2015-10-30 13:29:00-04:00,AGN,neutral
44154.0,Hearing DealReporter Says Pfizer Deal to Acquire Allergan to be Announced Next Week,2015-10-30 09:58:00-04:00,AGN,neutral
44155.0,Fast Money Picks For October 30,2015-10-30 06:24:00-04:00,AGN,neutral
44156.0,"Benzinga's M&A Chatter for Thursday October 29, 2015",2015-10-29 20:04:00-04:00,AGN,neutral
44157.0,"Allergan Reports Resolution Closing Federal Probe Into Warner Chilcott Sales, Marketing Practices: Will Pay Total of ~$102M Plus Interest",2015-10-29 16:17:00-04:00,AGN,positive
44158.0,"Carl Icahn: Best U.S. Companies May Leave In 'Exodus,' But Here's How To Stop It",2015-10-29 14:44:00-04:00,AGN,negative
44159.0,"Carl Icahn: Congress Must Act Now, Pfizer Leaving America And Many More To Follow",2015-10-29 14:25:00-04:00,AGN,neutral
44160.0,"Carl Icahn Sends Series of Tweets, Including: 'Today Pfizer confirmed they are planning to move out of the country. The situation is much more dangerous than most people believe.'",2015-10-29 14:02:00-04:00,AGN,negative
44161.0,How Allergan Could Be Pfizer's Rocket Ship,2015-10-29 12:19:00-04:00,AGN,neutral
44162.0,Wild Ride In Pfizer As The Street Digests Potential Deal With Allergan,2015-10-29 10:39:00-04:00,AGN,neutral
44163.0,Pfizer And Allergan Resume Trading,2015-10-29 10:18:00-04:00,AGN,neutral
44164.0,UPDATE: Pfizer Confirms Prelim. Friendly Discussions with Allergan,2015-10-29 10:09:00-04:00,AGN,positive
44165.0,Pfizer Announcement Regarding Allergan plc,2015-10-29 10:09:00-04:00,AGN,neutral
44166.0,"Prizer, Allergan Shares Halted",2015-10-29 09:31:00-04:00,AGN,positive
44167.0,Allergan plc Confirms Discussions Regarding Potential Business Combination Transaction With Pfizer Inc.,2015-10-29 09:30:00-04:00,AGN,neutral
44168.0,Pfizer CEO Ian Read Says Co at Tremendous Disadvantage Due U.S. Corp Tax Code -Wall Street Journal,2015-10-29 08:54:00-04:00,AGN,negative
44169.0,Benzinga's Top #PreMarket Gainers,2015-10-29 08:44:00-04:00,AGN,positive
44170.0,Pfizer CEO Declines Comment on Allergan Acquisition -Reuters,2015-10-29 08:36:00-04:00,AGN,neutral
44171.0,"Deutsche Bank Analyst Says Allergan, Pfizer Deal Makes Sense On Surface; Would Not Be Surprised To See This Come To Fruition",2015-10-29 08:28:00-04:00,AGN,negative
44172.0,These ETFs Should Love The Pfizer-Allergan News,2015-10-29 06:55:00-04:00,AGN,positive
44173.0,Allergan Shares +13% Premarket at $325 Following Wednesday's Wall Street Journal Report on Potential Merger With Pfizer,2015-10-29 04:57:00-04:00,AGN,positive
44174.0,"Pfizer, Allergan Considering Combination -DJ",2015-10-28 20:36:00-04:00,AGN,neutral
44175.0,Lone Pine To Investors: We Had A Tough Third Quarter,2015-10-28 14:14:00-04:00,AGN,negative
44176.0,"Leon Cooperman Loves Google Stock, But His Other Top Four Holdings Will Surprise You",2015-10-28 13:50:00-04:00,AGN,positive
44177.0,US Stock Futures Edge Lower Ahead Of Earnings,2015-10-27 06:37:00-04:00,AGN,negative
44178.0,Fast Money Picks For October 27,2015-10-27 06:19:00-04:00,AGN,neutral
44179.0,Allergan Acquires Rights to Ironwood's CONSTELLA from Almirall 40+ Countries,2015-10-27 04:15:00-04:00,AGN,neutral
44180.0,Martin Shkreli @MartinShkreli Tweet: Exited the $AGN $VRX trade. 3% loss or so. Bad idea. Onward and upward.,2015-10-26 13:56:00-04:00,AGN,negative
44181.0,"Noted Biotech Analyst Doesn't Think Valeant And Horizon Are Frauds, But Did Push A Line",2015-10-22 13:38:00-04:00,AGN,negative
44182.0,Martin Shkreli @MartinShkreli Tweet: I have taken a long position in $VRX and shorted $AGN as a hedge. Both companies have similar prospects and one is at half the price.,2015-10-21 15:48:00-04:00,AGN,positive
44183.0,"Allergan Shares Spike To HOD, Enter Positive Territory",2015-10-21 14:20:00-04:00,AGN,positive
44184.0,UPDATE: Allergan Shares Down 3.8% for Session Upon Resumption,2015-10-21 12:23:00-04:00,AGN,positive
44185.0,"Allergan Resumes Trading, Shares Beginning To Spike Higher",2015-10-21 12:19:00-04:00,AGN,positive
44186.0,"UPDATE: Allergan Says Anda Distribution Unit is Traditional Pharma Wholesaler with No Specialty Pharmacy Capabilities, Licensing",2015-10-21 12:10:00-04:00,AGN,negative
44187.0,UPDATE: Allergan Says ~3% of US-Branded Sales Distributed Through Unaffiliated Specialty Pharmacies,2015-10-21 12:09:00-04:00,AGN,neutral
44188.0,UPDATE: Allergan Calls Speculation 'Potentially Distracting',2015-10-21 12:08:00-04:00,AGN,negative
44189.0,UPDATE: Allergan Confirms Co. Does Not Rely on Specialty Pharmacies for Distribution of Brand Products,2015-10-21 12:08:00-04:00,AGN,neutral
44190.0,Allergan Issues Statement on Specialty Pharmacy Utilization,2015-10-21 12:07:00-04:00,AGN,neutral
44191.0,Allergan Trading Halted News Pending,2015-10-21 12:05:00-04:00,AGN,neutral
44192.0,Evercore ISI Analyst Notes Allergan Does Not Use Specialty Pharmacies,2015-10-21 11:28:00-04:00,AGN,neutral
44193.0,Teva to Raise Up to $7B Through Stock Sale To Fund Acquisition Of Allergan's Generic Drug Business -Bloomberg,2015-10-21 09:09:00-04:00,AGN,neutral
44194.0,Allergan Expands Dry Eye Portfolio With Launch Of REFRESH OPTIVE® Gel Drops,2015-10-21 08:07:00-04:00,AGN,positive
44195.0,Allergan Reports Successful Closing of AqueSys Purchase; Announces Adding XEN45 Minimally Invasisve Implantable Shunt for Glaucoma,2015-10-19 08:06:00-04:00,AGN,positive
44196.0,Allergan Presents Harmony Data at American Society of Dermatologic Surgery Meeting,2015-10-17 18:41:00-04:00,AGN,positive
44197.0,Allergan Presents Men's Maximum Difference Data at American Society of Dermatologic Surgery Meeting,2015-10-17 18:41:00-04:00,AGN,neutral
44198.0,Allergan Reports New Long-Term OnabotulinumtoxinA Treatment Study Results at AUSM,2015-10-15 12:46:00-04:00,AGN,neutral
44199.0,"Notable Biotech Analyst Jason Napodano Comments On Pfizer, Allergan Rumor",2015-10-13 12:37:00-04:00,AGN,neutral
44200.0,"Pfizer, Allergan Shares Pop After Buyout Rumor",2015-10-13 11:59:00-04:00,AGN,positive
44201.0,"Pfizer Spokesperson Declines Comment on Speculation Related to Potential Allergan, Pfizer Talks",2015-10-13 11:48:00-04:00,AGN,neutral
44202.0,"BZ NOTE: Regarding Mizuho Roadshow Rumor That Pfizer May Acquire Allergan, Deal May Be Easier To Finance For Pfizer Once Allergan Sells Off $40.5B Generic Drug Business To Teva Pharmaceuticals. Current Market Cap For Allergan Is $107.62B.",2015-10-13 11:35:00-04:00,AGN,positive
44204.0,Data Presented at IDWeek Reports AVYCAZ Demonstrated In Vitro Antimicrobial Activity Against Common Enterobacteriaceae Pathogens,2015-10-10 10:08:00-04:00,AGN,neutral
44205.0,How To Invest During Biotech's Latest Crisis,2015-10-09 11:25:00-04:00,AGN,negative
44206.0,Benzinga's Top Initiations,2015-10-09 09:34:00-04:00,AGN,positive
44207.0,"Mizuho Securities Initiates Coverage on Allergan at Buy, Announces $337.00 PT",2015-10-09 07:22:00-04:00,AGN,positive
44208.0,UPDATE: Allergan Says Data Demonstrated 1500 Mg Single Dose of Dalvance Achieved Primary Endpoint,2015-10-09 07:03:00-04:00,AGN,neutral
44209.0,FDA Accepts Supplemental New Drug Application (sNDA) for DALVANCE® (dalbavancin),2015-10-09 07:01:00-04:00,AGN,positive
44210.0,"Mizuho Securities Initiates Coverage on Allergan at Buy, Announces $337.00 PT",2015-10-08 19:21:00-04:00,AGN,positive
44211.0,"UPDATE: Shares of Allergan Breakout Over $272 Resistance Level, Now Up ~0.6% for Session",2015-10-07 13:42:00-04:00,AGN,positive
44212.0,Allergan Shares Spiking Higher,2015-10-07 13:40:00-04:00,AGN,positive
44213.0,"Don't Worry Spec. Pharma Investors, Drug Pricing Legislation Probably Won't Affect You",2015-10-05 15:06:00-04:00,AGN,positive
44214.0,"Allergan, Humana Report Research Partnership",2015-10-02 08:32:00-04:00,AGN,neutral
44215.0,US Stock Futures Gain Ahead Of Economic Data,2015-10-01 07:18:00-04:00,AGN,positive
44216.0,Allergan: U.S. FDA Approves JUVEDERM® ULTRA XC for Use in Lips,2015-10-01 07:02:00-04:00,AGN,positive
44217.0,"Wednesday's After-Hours Movers: PBF Energy, BioMarin Pharmaceutical And More",2015-09-30 16:42:00-04:00,AGN,positive
44218.0,5 Specialty Pharma Stocks Nomura Is Picking To Weather The Storm,2015-09-29 15:27:00-04:00,AGN,neutral
44219.0,2 Pharma Stocks To Hide In While Drug Pricing Fears Play Out,2015-09-29 13:37:00-04:00,AGN,negative
44220.0,Why Cowen Thinks Allergan Has Massive Upside To $400,2015-09-29 10:29:00-04:00,AGN,neutral
44221.0,"JP Morgan on Allergan Following 'Inline Guidance,' Sees 'Compelling Buying Opportunity Following Recent Selloff'",2015-09-29 08:08:00-04:00,AGN,positive
44222.0,"Nomura Lists AGN, VRX, PCRX, ENDP, & PDHL As Top Picks, Says M&A Remains Value Driver & More Consolidation",2015-09-29 06:28:00-04:00,AGN,positive
44223.0,Evercore ISI Analyst Calls Allergan's Guidance 'better than expectations',2015-09-28 16:51:00-04:00,AGN,positive
44224.0,"UPDATE: Allergan on Long-Term Growth: 10% Branded Sales Growth, Adj. Gross Margins 77-79%",2015-09-28 16:17:00-04:00,AGN,positive
44225.0,"UPDATE: Allergan Sees 2H'15 Sales Greater Than $8B, Adj. EPS $6.25-$6.65",2015-09-28 16:16:00-04:00,AGN,positive
44226.0,Allergan Issues Update to 2H'15 Forecast,2015-09-28 16:15:00-04:00,AGN,neutral
44227.0,Allergan Reports Launch of Generic Version of INVEGA,2015-09-25 08:01:00-04:00,AGN,neutral
44228.0,"Amgen, Allergan Report Top-Line Results from Phase 3 Study of ABP 215: Primary Endpoint Within Prescpecified Margin",2015-09-23 09:01:00-04:00,AGN,neutral
44229.0,Allergan Confirms Generic Rytary Patent Challenge,2015-09-21 08:05:00-04:00,AGN,positive
44230.0,Allergan Trading At $304.84/Share After Spike Following FD Approval Of VRAYLAR For Treatment Of Bipolar I Disorder & Schizophrenia In Adults,2015-09-17 14:59:00-04:00,AGN,positive
44231.0,UPDATE: Hearing Comment from Allergan CEO Saunders at Morgan Stanley Conference Suggested Uncertainty Related to Previously-Discussed EPS Outlook Figure,2015-09-17 11:34:00-04:00,AGN,negative
44232.0,Shares of Allergan Down ~2% Over Last ~50 Mins; Co. Exec Recently Spoke at Morgan Stanley's Global Healthcare Conference,2015-09-17 11:32:00-04:00,AGN,positive
44233.0,"Allergan, U.S. Women's Health Alliance Partner Increasing Access to LILETTA52 mg",2015-09-16 08:06:00-04:00,AGN,neutral
44234.0,"UPDATE: Evercore ISI's Schoenebaum Believes Premium in AbbVie Has Recently Come Out Amid Allergan, Valeant Bid Rumors Which Have Died Down",2015-09-15 15:51:00-04:00,AGN,negative
44235.0,"Allergan, Perrigo Announce Receiving FDA Approval of Three-ER Products Equal to Mucinex, Mucinex DM",2015-09-10 16:35:00-04:00,AGN,positive
44236.0,Morning Market Gainers,2015-09-10 09:43:00-04:00,AGN,neutral
44237.0,Allergan Expands Access to IUDs for Millions of Underserved Women in the US by Announcing Agreement with Apexus for Nationwide Distribution of LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg,2015-09-10 08:04:00-04:00,AGN,positive
44238.0,Allergan Announces Agreement with Amneal Related to NAMENDA XR® Patent Litigation,2015-09-10 07:01:00-04:00,AGN,positive
44239.0,"Benzinga's M&A Chatter for Thursday September 3, 2015",2015-09-03 19:05:00-04:00,AGN,neutral
44240.0,"Allergan Expecting Final Approval By US FDA In Late 2016, Early 2017 Via 510K Device Pathway",2015-09-03 17:17:00-04:00,AGN,positive
44241.0,Allergan To Acquire Aqueyes For $300M Upfront,2015-09-03 17:16:00-04:00,AGN,neutral
44242.0,How Is Viking Global Beating The Market?,2015-09-03 12:13:00-04:00,AGN,negative
44243.0,Allergan Reports FDA Approval of Updated Label for TEFLARO,2015-09-02 07:16:00-04:00,AGN,positive
44244.0,Positive Phase III Results Show Efficacy Of Antibiotic Medicine AVYCAZ In Complicated Urinary Tract Infections,2015-09-02 07:03:00-04:00,AGN,positive
44245.0,"Daniel Loeb's Third Point Hedge Fund Down 5.2% in August; Up 1.2% YTD, According to Source -Reuters",2015-08-31 19:54:00-04:00,AGN,neutral
44246.0,"6-K from Teva Pharma Shows Co. Will Refrain from Attending, Voting at Mylan Special General Meeting on Aug. 28; Says 'Wishes to Remain Neutral' Given Withdrawal of Mylan Offer",2015-08-25 11:11:00-04:00,AGN,positive
44247.0,Allergan Gedeon Richter Plc. to Present Data from Cariprazine Trials at ECNP Annual Meeting in Amsterdam,2015-08-25 04:26:00-04:00,AGN,neutral
44248.0,Hearing Allergan Has Issued Voluntary Recall in US Related to Specific Lots of Refresh Lacri-Lube,2015-08-24 08:37:00-04:00,AGN,neutral
44249.0,U.S. FDA Accepts BOTOX Resubmission for the Treatment of Lower Limb Spasticity in Adults,2015-08-20 08:13:00-04:00,AGN,neutral
44250.0,13F Recap: The Most Popular (And Unpopular) Stocks Of Q2,2015-08-19 08:48:00-04:00,AGN,positive
44251.0,"Dan Loeb Is Still Bullish On Amgen, Allergan and Dow Chemical",2015-08-18 16:33:00-04:00,AGN,neutral
44252.0,A Look At Bill Ackman's Super-Concentrated Equity Portfolio,2015-08-18 15:51:00-04:00,AGN,neutral
44253.0,John Paulson Betting On Healthcare And Consumer Discretionary Stocks,2015-08-18 15:11:00-04:00,AGN,neutral
44254.0,13F from Loeb's Third Point Shows New 3.3M Share Stake in Allergan,2015-08-14 16:13:00-04:00,AGN,positive
44255.0,"13F from Barry Rosenstein's JANA Partners Shows Dissolved Sole Share Stake in Actavis, Takes Sole Share Stake of 1.6M Shares in Allergan",2015-08-14 07:11:00-04:00,AGN,positive
44256.0,"Howard Marks Still Likes Store Capital, Sold Out Of Tata Motors In New 13F",2015-08-13 16:50:00-04:00,AGN,positive
44257.0,Allergan Confirms Generic Noxafil Patent Challenge,2015-08-11 16:10:00-04:00,AGN,positive
44258.0,FDA Approves 28 Additional Styles Of Allergan's Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants,2015-08-06 16:49:00-04:00,AGN,positive
44260.0,From Conf Call: Allergan Says Not Likely to do Any Major Deals Until After Teva Deal Closes,2015-08-06 09:08:00-04:00,AGN,neutral
44261.0,Allergan Q2 Earnings Beat Estimates,2015-08-06 08:10:00-04:00,AGN,neutral
44262.0,"Allergan Reports Q2 EPS $4.41 vs Est $4.38, Sales $5.76B Vs Est $5.7B",2015-08-06 07:03:00-04:00,AGN,neutral
44263.0,10 Must Watch Stocks for Today,2015-08-06 05:02:00-04:00,AGN,neutral
44264.0,"Earnings Scheduled For August 6, 2015",2015-08-06 04:15:00-04:00,AGN,neutral
44265.0,FDA Approves 28 Additional Styles Of Allergan's Natrelle® 410 Highly Cohesive Anatomically Shaped Silicone-Filled Breast Implants,2015-08-05 16:29:00-04:00,AGN,positive
44266.0,Allergan Earnings Are On Deck: Here's Why They Should Meet Expectations,2015-08-05 11:29:00-04:00,AGN,neutral
44267.0,Ironwood and Allergan Enter Agreement to Co-Promote VIBERZI for Irritable Bowel Syndrome with Diarrhea (IBS-D) in the U.S.,2015-08-05 09:25:00-04:00,AGN,neutral
44268.0,5 Biotechs With Catalysts Coming This Week,2015-08-03 16:59:00-04:00,AGN,neutral
44269.0,Calls Of Note: The Street's Research Moving Stocks This Monday,2015-08-03 10:24:00-04:00,AGN,neutral
44270.0,Dan Loeb's Favorite Stock Picks,2015-08-03 08:39:00-04:00,AGN,positive
44271.0,"JP Morgan Reinstates Overweight on Allergan, Raises PT to $400.00",2015-08-03 07:27:00-04:00,AGN,neutral
44272.0,"Morgan Stanley Resumes Teva At Overweight, Sees Large EPS Growth Coming",2015-07-29 09:37:00-04:00,AGN,neutral
44273.0,5 Stocks With Notable Short-Selling Activity,2015-07-29 09:12:00-04:00,AGN,neutral
44274.0,"RBC Says Stay Away From Mylan, Perrigo; Go Long Teva, Allergan",2015-07-29 08:54:00-04:00,AGN,neutral
44275.0,Is More M&A On The Way For Large-Cap Biotechs?,2015-07-28 13:18:00-04:00,AGN,neutral
44276.0,ETFs For The Next Pharma Takeover Candidates,2015-07-28 13:08:00-04:00,AGN,neutral
44277.0,"Teva Still A 'Must-Own' Stock, Worth $86",2015-07-28 09:15:00-04:00,AGN,positive
44278.0,Juniper Pharmaceuticals Reports Regulatory Approvals for CRINONE Progesterone Gel in Nine New EU Countries,2015-07-28 07:00:00-04:00,AGN,neutral
44279.0,"Benzinga's M&A Chatter for Monday July 27, 2015",2015-07-27 18:39:00-04:00,AGN,neutral
44280.0,Why The $40.5 Billion Acquisition Of Allergan's Generic Business For Teva Is 'Right Deal At The Right Time',2015-07-27 16:49:00-04:00,AGN,neutral
44281.0,Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA,2015-07-27 16:45:00-04:00,AGN,neutral
44282.0,"With The Teva Money, Allergan Could Engage In 'Large M&A' Next: Evercore ISI",2015-07-27 16:25:00-04:00,AGN,positive
44283.0,"Evercore ISI says Allergan may now engage in ""large M&A,"" buyside survey indicates Biogen, AbbVie, BioMarin, or a combination with Pfizer as possible takeout targets.",2015-07-27 15:46:00-04:00,AGN,positive
44284.0,Allergan CEO: Teva Made A 'Compelling Offer' We Couldn't Refuse,2015-07-27 15:19:00-04:00,AGN,positive
44285.0,"Chardan's Take On Axovant, Avalanche & VistaGen",2015-07-27 12:47:00-04:00,AGN,neutral
44286.0,"Market Update: Monday's Mid-Day Movers, China's Stock Market Crash And More",2015-07-27 12:36:00-04:00,AGN,negative
44287.0,"Teva Buys Allergan Unit: How Mylan, Other Biotech Stocks Are Reacting",2015-07-27 12:08:00-04:00,AGN,neutral
44288.0,Benzinga's Volume Movers,2015-07-27 10:23:00-04:00,AGN,neutral
44289.0,Stocks Hitting 52-Week Highs,2015-07-27 10:07:00-04:00,AGN,neutral
44290.0,Morning Market Losers,2015-07-27 09:50:00-04:00,AGN,negative
44291.0,Morning Market Gainers,2015-07-27 09:39:00-04:00,AGN,neutral
44293.0,Teva Says Allergan Deal to have Fewer Antitrust Issues than Mylan Deal Would Have -Reuters,2015-07-27 08:36:00-04:00,AGN,neutral
44294.0,Benzinga's Top #PreMarket Losers,2015-07-27 08:22:00-04:00,AGN,negative
44295.0,Benzinga's Top #PreMarket Gainers,2015-07-27 08:13:00-04:00,AGN,positive
44296.0,US Stock Futures Signal Lower Start On Wall Street,2015-07-27 07:07:00-04:00,AGN,negative
44297.0,UPDATE: Mylan Issues Comment on Teva Deal to Buy Allergan's Generic Drug Unit,2015-07-27 06:43:00-04:00,AGN,neutral
44298.0,Mylan Issues Comment on Teva Deal to Buy Allergan's Generic Drug Unit,2015-07-27 06:43:00-04:00,AGN,neutral
44299.0,"Teva +10% Premarket, Mylan -13%; Perrigo +3%",2015-07-27 05:11:00-04:00,AGN,neutral
44300.0,Teva Preliminary Q2 EPS $1.43 vs $1.31 Est,2015-07-27 04:56:00-04:00,AGN,neutral
44301.0,Teva Sees FY 2015 EPS $5.15-$5.40 vs $5.23 Est,2015-07-27 04:54:00-04:00,AGN,neutral
44303.0,UPDATE: Teva to Review Options With Respect to 4.6% Stake in Mylan,2015-07-27 04:37:00-04:00,AGN,positive
44304.0,"UPDATE: Allergan to Receive $33.75B in Cash, $6.75B in Shares of Teva",2015-07-27 04:34:00-04:00,AGN,positive
44305.0,UPDATE: Teva to Acquire Allergan Generics for $40.5 B,2015-07-27 04:32:00-04:00,AGN,neutral
44306.0,Teva Withdraws Proposal to Acquire Mylan,2015-07-27 04:31:00-04:00,AGN,neutral
44308.0,Tel Aviv Stock Exchange Halts Trading in Teva Pending Announcement -Reuters,2015-07-27 04:29:00-04:00,AGN,neutral
44309.0,"Stocks To Watch For July 27, 2015",2015-07-27 04:18:00-04:00,AGN,neutral
44310.0,Benzinga's Weekend M&A Chatter,2015-07-26 20:26:00-04:00,AGN,neutral
44311.0,Allergan to Acquire Naurex for $560M in Cash,2015-07-26 08:39:00-04:00,AGN,neutral
44312.0,"Teva To Buy Allergan's Generic Drug Unit, Unit Worth ~$45B, Deal May Be Announced Monday",2015-07-25 18:03:00-04:00,AGN,positive
44313.0,Benzinga's Top Downgrades,2015-07-17 09:47:00-04:00,AGN,positive
44314.0,"RBC Capital Downgrades Allergan, But Still Keeps It As 'Core' Holding",2015-07-17 08:10:00-04:00,AGN,neutral
44315.0,RBC Capital Downgrades Allergan to Outperform,2015-07-17 06:03:00-04:00,AGN,neutral
44316.0,Allergan Notes Receipt of Paragraph IV Notification on Restasis,2015-07-15 16:02:00-04:00,AGN,neutral
44317.0,"Barclays Expects M&A In Specialty Pharma To Continue, Likes Valeant And Jazz",2015-07-09 08:56:00-04:00,AGN,positive
44318.0,"Allergan, Merck Enter Licensing Agreement to Obtain Exclusive Worldwide Rights to CGRP Migraine Development Program",2015-07-07 07:00:00-04:00,AGN,positive
44319.0,"Carter Worth Is Bullish Mohawk Industries, Allergan And Morgan Stanley",2015-07-07 06:45:00-04:00,AGN,positive
44320.0,Allergan To Acquire Oculeve In All-Cash Transaction OF $125M Upfront Along With Commercialization Milestone Payments,2015-07-06 07:01:00-04:00,AGN,neutral
44321.0,Top Takeaways From BMO's Specialty Pharma Day,2015-07-01 13:13:00-04:00,AGN,positive
44322.0,"Leerink Downgrades Kythera, Says Allergan Deal Likely To Close At $75 Mark",2015-06-29 07:46:00-04:00,AGN,neutral
44323.0,"Benzinga's M&A Chatter for Thursday June 25, 2015",2015-06-25 18:16:00-04:00,AGN,neutral
44324.0,"Benzinga's M&A Chatter for Thursday June 18, 2015",2015-06-18 20:06:00-04:00,AGN,neutral
44325.0,Hearing The Deal Says Allergan May Bid for Zeltiq,2015-06-18 12:40:00-04:00,AGN,neutral
44326.0,"Benzinga's M&A Chatter for Wednesday June 17, 2015",2015-06-17 18:17:00-04:00,AGN,neutral
44327.0,Mid-Afternoon Market Update: DavidsTea Falls After Q1 Results; Synergy Pharmaceuticals Shares Spike Higher,2015-06-17 14:55:00-04:00,AGN,positive
44328.0,Mid-Day Market Update: Kythera Biopharmaceuticals Jumps On Acquisition News; La-Z-Boy Shares Slide,2015-06-17 13:03:00-04:00,AGN,positive
44329.0,Mid-Morning Market Update: Markets Rise; Allergan To Acquire Kythera Biopharmaceuticals For $2.1B,2015-06-17 10:30:00-04:00,AGN,neutral
44330.0,Benzinga's Volume Movers,2015-06-17 10:20:00-04:00,AGN,neutral
44331.0,Stocks Hitting 52-Week Highs,2015-06-17 10:06:00-04:00,AGN,neutral
44332.0,Morning Market Gainers,2015-06-17 09:42:00-04:00,AGN,neutral
44333.0,Benzinga's Top #PreMarket Gainers,2015-06-17 08:09:00-04:00,AGN,positive
44334.0,"Kythera Biopharma Shares Rise 22% Premarket Following Announcement it Will be Acquired by Allergan for $75/Share in Cash, Stock",2015-06-17 07:54:00-04:00,AGN,positive
44335.0,US Stock Futures Up; All Eyes On Fed Decision,2015-06-17 07:29:00-04:00,AGN,neutral
44336.0,UPDATE: Allergan to Acquire KYTHERA Biopharmaceuticals,2015-06-17 07:02:00-04:00,AGN,neutral
44338.0,"Richter, Allergan Announce FDA Extended Review Period for Cariprazine to September 2015",2015-06-16 04:41:00-04:00,AGN,neutral
44339.0,Actavis plc Becomes Allergan plc,2015-06-15 07:04:00-04:00,AGN,neutral
44340.0,"Viking Global Liked AIG, Google, Actavis, Illumina And Cheniere Energy Last Quarter",2015-05-18 13:38:00-04:00,AGN,positive
44341.0,John Paulson Continues To Bet On Health Care And TV,2015-05-17 10:49:00-04:00,AGN,positive
44342.0,Bill Ackman's Latest Moves In Health Care & Some Other Positions From Q1,2015-05-16 09:54:00-04:00,AGN,positive
44343.0,"The Latest Stock Picks From Cliff Asness, AQR Capital's 13F",2015-05-15 15:46:00-04:00,AGN,neutral
44344.0,"Allergan, Valeant, Pershing Square Settle Lawsuits Over Takeover Attempt, According to Sources -DJ",2015-04-09 11:02:00-04:00,AGN,negative
44345.0,"Icon Bioscience Announces Successful Outcomes of Phase 3 Study of IBI-10090, a Novel Sustained Release Drug Being Developed to Treat Inflammation with Cataract Surgery",2015-04-06 09:06:00-04:00,AGN,positive
44346.0,Morning Market Gainers,2015-03-17 09:46:00-04:00,AGN,neutral
44347.0,"Actavis Completes Allergan Acquisition For Approx $70.5B In Cash, Equity Deal",2015-03-17 08:57:00-04:00,AGN,neutral
44348.0,Benzinga's Top #PreMarket Gainers,2015-03-17 08:13:00-04:00,AGN,positive
44349.0,Standard & Poor's Announces American Air to Replace Allergan in S&P 500,2015-03-16 17:19:00-04:00,AGN,neutral
44350.0,Actavis Announces European Commission Has Cleared Co.'s Pending Purchase of Allergan,2015-03-16 10:23:00-04:00,AGN,positive
44351.0,Bill Ackman's Pershing Square Takes 5% Stake In Valeant Pharmaceuticals,2015-03-09 15:02:00-04:00,AGN,neutral
44352.0,"Books on Acatvis Jumbo Acquisition Bond at $65B+, According to Source -Reuters",2015-03-02 12:40:00-05:00,AGN,neutral
44353.0,FDA Approves Allergan's NATRELLE INSPIRA,2015-02-27 08:30:00-05:00,AGN,positive
44354.0,"Actavis To Begin 3-day Roadshow for Allergan Acquisition Bond On Wednesday, According to Source -Reuters",2015-02-24 14:32:00-05:00,AGN,neutral
44355.0,A Look At Dan Loeb's Diversified 13F,2015-02-18 18:04:00-05:00,AGN,neutral
44356.0,Paulson & Company's Q4 Moves: Healthcare And Beyond,2015-02-18 16:12:00-05:00,AGN,neutral
44357.0,"Ackman's Pershing Square Scaled Back Allergan, Added To Platform Specialty Products In Q4",2015-02-17 18:17:00-05:00,AGN,neutral
44358.0,Paulson & Co Increase Stake in Allergan,2015-02-17 17:17:00-05:00,AGN,positive
44359.0,"Simons-Founded Renaissance Technologies Buys Apple, Closes Facebook, Trims McDonald's In Q4",2015-02-13 14:19:00-05:00,AGN,neutral
44360.0,Sterne Agee Dives Deep Into 3 Biotechs,2015-02-13 10:49:00-05:00,AGN,neutral
44361.0,Allergan's CEO Explains Why Fighting Bill Ackman Was 'All Consuming',2015-02-10 14:27:00-05:00,AGN,negative
44362.0,What's GlaxoSmithKline Doing In The E.U.?,2015-02-09 21:13:00-05:00,AGN,neutral
44363.0,"After A Blockbuster 2014, What Will 2015 Hold For Pharmaceutical M&A?",2015-02-06 15:28:00-05:00,AGN,positive
44364.0,"Allergan Reports Q4 Adj. EPS $2.17 vs $1.83 Est., Product Sales $1.89B vs $1.9B Est.",2015-02-04 16:30:00-05:00,AGN,neutral
44365.0,Pfizer Just Won With This Breast Cancer Drug,2015-02-04 14:37:00-05:00,AGN,negative
44366.0,"Earnings Scheduled For February 4, 2015",2015-02-04 05:08:00-05:00,AGN,neutral
44367.0,Actavis Registration Statement for Pending Acquisition of Allergan Declared Effective by the SEC,2015-01-26 17:36:00-05:00,AGN,positive
44368.0,"Actavis Seeks Allergan CEO Pyott as Board Member Once Allergan Takeover Deal Closes, According to Sources -Reuters",2015-01-15 15:45:00-05:00,AGN,neutral
44369.0,Valeant CEO On Allegations Against The Company And Future M&A Deals,2015-01-14 08:38:00-05:00,AGN,neutral
44370.0,"Actavis, Allergan Announce Early Termination of Hart-Scott-Rodino Waiting Period",2015-01-12 08:06:00-05:00,AGN,neutral
44371.0,What Investors Are Expecting Ahead Of Multiple Nektar Therapeutics Catalysts,2015-01-09 12:53:00-05:00,AGN,neutral
44372.0,Bill Ackman Says Can Trade on Inside Information if You Receive it from Someone Who is Not Breaching a Duty -CNBC,2015-01-07 07:09:00-05:00,AGN,neutral
44373.0,"Ackman: Allergan Is A Good Merger Arbitrage Play, Potential 28% Upside",2014-12-18 16:15:00-05:00,AGN,positive
44374.0,Bill Ackman Interview on Bloomberg TV Concludes,2014-12-17 10:58:00-05:00,AGN,neutral
44375.0,"Ackman Says 'Still Own Every Share of Allergan,' Except for Piece Valeant Purchased",2014-12-17 10:48:00-05:00,AGN,positive
44376.0,Benzinga's Top Downgrades,2014-12-15 09:20:00-05:00,AGN,positive
44377.0,Stifel Nicolaus Downgrades Allergan To Hold,2014-12-15 08:59:00-05:00,AGN,neutral
44378.0,"Stifel Nicolaus Downgrades Allergan, Inc. to Hold, Removes $200.00 PT",2014-12-15 06:27:00-05:00,AGN,neutral
44379.0,"Stifel Nicolaus Downgrades Allergan, Inc. to Hold, Removes $200.00 PT",2014-12-15 05:16:00-05:00,AGN,neutral
44380.0,"Goldman Sachs Downgrades Allergan, Inc. to Hold, Announces $(aN) undefined",2014-12-15 05:16:00-05:00,AGN,neutral
44381.0,Zoetis Inc. Spikes Briefly On Remarks From Sanofi CEO,2014-12-09 15:02:00-05:00,AGN,neutral
44382.0,Where Could ValueAct Capital's New $1.5 Billion Go?,2014-12-09 13:38:00-05:00,AGN,neutral
44383.0,"#PreMarket Primer: Wednesday, December 3: Investors Weigh The Possibility Of More Easing In The Eurozone",2014-12-03 08:15:00-05:00,AGN,positive
44384.0,"#PreMarket Primer: Friday, November 21: Immigration Reform Could Have Lasting Impact In More Ways Than One",2014-11-21 08:09:00-05:00,AGN,neutral
44385.0,"Dow, S&P 500 Add To Gains Following Encouraging International News",2014-11-18 17:02:00-05:00,AGN,positive
44386.0,"FBR Analyst Discussed Valeant Following ACT-AGN Deal: Believes Likely Co. Will Do 'Sizeable Deal' Before Mid '15, Another Smaller Deal Later in Year",2014-11-18 14:34:00-05:00,AGN,neutral
44387.0,Bill Ackman Says He Supports The Allergan-Actavis Deal And CEO Brent Saunders,2014-11-18 14:17:00-05:00,AGN,positive
44388.0,Ackman Pledges Support For Actavis Bid On Allergan,2014-11-18 13:10:00-05:00,AGN,positive
44389.0,"Nikkei Reports Mizuho Bank Joining JPMorgan Chase, Wells Fargo in Financing Actavis' Purchase of Allergan; Banks to Provide $45B Bridge Loan for $66B Deal",2014-11-18 12:28:00-05:00,AGN,positive
44390.0,Ackman to Withdraw Special Meeting Over Allergan; Says he Supports Actavis Deal -CNBC,2014-11-18 10:58:00-05:00,AGN,positive
44391.0,Is Bill Ackman Back?,2014-11-18 10:56:00-05:00,AGN,neutral
44392.0,Benzinga's Top Downgrades,2014-11-18 08:53:00-05:00,AGN,positive
44393.0,Citi Raises Price Target On Actavis,2014-11-18 08:44:00-05:00,AGN,neutral
44394.0,William Blair Downgrades Allergan To Market Perform,2014-11-18 07:29:00-05:00,AGN,neutral
44395.0,"#PreMarket Primer: Tuesday, November 18: Abe To Delay Sales Tax Increase In Japan",2014-11-18 07:23:00-05:00,AGN,neutral
44396.0,US Stock Futures Mostly Flat Ahead Of Housing Data,2014-11-18 07:11:00-05:00,AGN,neutral
44397.0,"William Blair Downgrades Allergan, Inc. to Market Perform, Announces $219.00 PT",2014-11-18 06:12:00-05:00,AGN,neutral
44398.0,"Benzinga's M&A Chatter for Monday November 17, 2014",2014-11-17 18:11:00-05:00,AGN,neutral
44399.0,3 Stocks (And 4 Trades) Blowing Up On Twitter,2014-11-17 17:39:00-05:00,AGN,neutral
44400.0,U.S. Markets Recover From Early-Day Losses As Japan's Economy Contracts,2014-11-17 16:46:00-05:00,AGN,negative
44401.0,Mid-Day Market Update: Allergan Jumps On Actavis Bid; Denbury Resources Shares Slip,2014-11-17 13:23:00-05:00,AGN,positive
44402.0,"Midday Gainers From November 17: Celldex Therapeutics, Amicus Therapeutics, Baker Hughes, Allergan",2014-11-17 12:34:00-05:00,AGN,neutral
44403.0,"Top Performing Industries For November 17, 2014",2014-11-17 10:46:00-05:00,AGN,positive
44404.0,Mid-Morning Market Update: Markets Edge Lower; Halliburton To Acquire Baker Hughes For $34.6 Billion,2014-11-17 10:42:00-05:00,AGN,negative
44405.0,Benzinga's Volume Movers,2014-11-17 10:29:00-05:00,AGN,neutral
44406.0,Stocks Hitting 52-Week Highs,2014-11-17 10:18:00-05:00,AGN,neutral
44407.0,Actavis plc Buying Allergan In $66 Billion Deal,2014-11-17 10:06:00-05:00,AGN,neutral
44408.0,Morning Market Movers,2014-11-17 09:51:00-05:00,AGN,neutral
44409.0,Valeant Offers Comment on Allergan Deal: Says Can Not Justify Holders Paying $219+ for Allergan,2014-11-17 09:31:00-05:00,AGN,neutral
44410.0,Actavis to Acquire Allergan To Create Top 10 Global Growth Pharmaceutical Company with $23B In Revenue,2014-11-17 09:17:00-05:00,AGN,positive
44411.0,UPDATE: David Faber Tweets: 'Actavis to buy Allergan for $129 in cash and .3683 ACT share. Deal worth $219 at open of trading.',2014-11-17 09:14:00-05:00,AGN,positive
44412.0,CNBC Reports Actavis to Acquire Allergan for $219/Share,2014-11-17 09:13:00-05:00,AGN,neutral
44413.0,CNBC's David Faber Reporting Actavis to Buy Allergan for $129/Share Plus 0.3683 ACT Share,2014-11-17 09:13:00-05:00,AGN,positive
44414.0,Allergan Spikes Higher,2014-11-17 09:11:00-05:00,AGN,neutral
44415.0,"#PreMarket Primer: Monday, November 17: Japan's Economy Unexpectedly Slips",2014-11-17 08:33:00-05:00,AGN,neutral
44416.0,Must Watch Stocks for Today,2014-11-17 04:59:00-05:00,AGN,neutral
44417.0,Benzinga's Weekend M&A Chatter,2014-11-16 20:30:00-05:00,AGN,neutral
44418.0,"Actavis, Allergan Could Announce Merger Deal Monday",2014-11-16 15:08:00-05:00,AGN,neutral
44419.0,"WSJ Reports Allergan, Actavis Close to Merger Deal, Could be Announced Monday, According to Source",2014-11-16 14:54:00-05:00,AGN,neutral
44420.0,"13F from Eric Mindich's Eton Park Recently Out: Shows New 1.2M Share Alibaba Stake; Shows Raised Stakes in Riverbed, Lorillard, Allergan, Reduced Stakes in SanDisk, CBS, Liquidated Stakes in Comcast, eBay",2014-11-14 13:33:00-05:00,AGN,positive
44421.0,"UPDATE: 13F from Sandell Shows New ~129K Share Stake in Allergan, ~157.6K Share Stake in Concur, ~638K Share Stake in Family Dollar",2014-11-14 11:51:00-05:00,AGN,positive
44422.0,Allergan Announces FDA Has Approved New Styles of NATRELLE 410 Highly Cohesive Anatomically Shaped-Silicone-Filled Breast Implants,2014-11-12 16:51:00-05:00,AGN,positive
44423.0,"All Quiet On The Market Front: Dow, S&P 500, Nasdaq Virtually Flat",2014-11-12 16:38:00-05:00,AGN,neutral
44424.0,Analyst: Bill Ackman's Zoetis Move Casts Doubt On Allergan Bid,2014-11-12 16:04:00-05:00,AGN,negative
44425.0,Allergan Spikes Higher On Acquisition Report,2014-11-12 10:45:00-05:00,AGN,neutral
44426.0,"Actavis Rumored to Be in Talks to Buy Allergan for $60B, ~$200/Share",2014-11-12 10:01:00-05:00,AGN,neutral
44427.0,"Allergan, Valeant Spike Higher",2014-11-12 10:00:00-05:00,AGN,neutral
44428.0,UPDATE: Allergan Says Confident it Can Create More Value Than Valeant Pharmaceuticals' Offer,2014-11-12 07:08:00-05:00,AGN,positive
44429.0,Allergan BOD Announces Approval of Amendments to Company's Bylaws,2014-11-12 07:03:00-05:00,AGN,positive
44430.0,Allergan Board of Directors Announces Approval Of Amendments To Company's Bylaws,2014-11-12 07:01:00-05:00,AGN,positive
44431.0,"Allergan Reiterates Valeant's Offers Have Undervalued The Company, Would Consider Increased Offer If Made By Valeant",2014-11-07 14:54:00-05:00,AGN,positive
44432.0,Jefferies Sees Acquisition Of Salix Pharmaceuticals As Being Even More Likely Now,2014-11-07 10:39:00-05:00,AGN,neutral
44433.0,6 Takeaways From Ackman's Letter To Allergan's Board of Directors,2014-11-07 10:39:00-05:00,AGN,neutral
44434.0,"Ackman Tells Allergan Board ""Valeant Can Pay Substantially More For Allergan By Virtue Of The Strategic Overlap""",2014-11-07 10:23:00-05:00,AGN,positive
44435.0,Pershing Square's Bill Ackman Says Allergan Should Run An Auction,2014-11-07 10:16:00-05:00,AGN,neutral
44436.0,Ackman Sends Another Letter To Allergan Board,2014-11-07 09:00:00-05:00,AGN,neutral
44437.0,Actavis Shares Tick Lower Ahead of Bloomberg Headline Suggesting Co. is Gauging Investor Response to Allergan Bid,2014-11-06 11:48:00-05:00,AGN,neutral
44438.0,Reports: Allergan In Talks With Actavis,2014-11-06 11:44:00-05:00,AGN,neutral
44439.0,"Filing from Allergan Shows Discussions with a Third Party Related to Possible Merger Have Continued, Could Lead to Negotitations",2014-11-06 08:57:00-05:00,AGN,positive
44440.0,"Benzinga's M&A Chatter for Tuesday November 4, 2014",2014-11-04 20:38:00-05:00,AGN,neutral
44441.0,"Markets Mostly Lower As Americans Head To Vote, Oil Continues To Tumble",2014-11-04 16:30:00-05:00,AGN,negative
44442.0,Judge: Allergan Can't Block Proxy Battle,2014-11-04 14:27:00-05:00,AGN,positive
44443.0,"Allergan Offers Comment Related to California Federal Court Ruling in Insider Trading Suit Against Valeant, Pershing Square",2014-11-04 13:58:00-05:00,AGN,neutral
44444.0,"UPDATE: Release from Valeant Shows Co., Ackman's Pershing Can Vote at Special Meeting",2014-11-04 13:29:00-05:00,AGN,positive
44445.0,"Valeant, Pershing Square May Vote at Special Meeting",2014-11-04 13:28:00-05:00,AGN,positive
44446.0,"Judge Has Ordered Valeant, Pershing to Make Corrective Disclosures in Proxy Solicitation Related to Allergan Deal",2014-11-04 12:39:00-05:00,AGN,neutral
44447.0,Judge Has Blocked Ackman's Pershing Square from Voting Allergan Shares Until More Disclosures Made,2014-11-04 12:36:00-05:00,AGN,neutral
44448.0,DAVID FABER ‏@davidfaber  33s33 seconds ago Allergan loses battle to prevent Ackman from voting shares at special meeting- court documents. $AGN $VRX,2014-11-04 12:23:00-05:00,AGN,neutral
44449.0,"Allergan, Valeant Spike Higher",2014-11-04 12:16:00-05:00,AGN,neutral
44450.0,"Benzinga's M&A Chatter for Monday November 3, 2014",2014-11-03 19:26:00-05:00,AGN,neutral
44451.0,"Bill Ackman, Valeant Can Amend Counterclaims Against Allergan",2014-11-03 16:48:00-05:00,AGN,neutral
44452.0,Markets Mixed As Oil Continues To Drop,2014-11-03 16:37:00-05:00,AGN,negative
44453.0,WSJ Reporting Allergan's M&A Head David Lawrence Has Left Co.,2014-11-03 12:50:00-05:00,AGN,neutral
44454.0,Report: Allergan Approached By Actavis,2014-11-03 12:22:00-05:00,AGN,neutral
44455.0,WSJ's Liz Hoffman Tweets: 'Allergan confirms prior M&A approach from mystery co (source says Actavis). Sounds like door still open http://1.usa.gov/1wrPmTy  $AGN',2014-11-03 10:53:00-05:00,AGN,positive
44456.0,WSJ Reporting Allergan Confirmed Prior M&A Approach from Actavis,2014-11-03 10:51:00-05:00,AGN,neutral
44457.0,"Option Alert: Valeant Dec $130 Call; 1,743 Contract Trade at Ask @$9.40; Currently $130.86",2014-10-29 11:28:00-04:00,AGN,positive
44458.0,"Benzinga's M&A Chatter for Monday October 27, 2014",2014-10-27 21:44:00-04:00,AGN,neutral
44459.0,"Markets Virtually Flat, Oil Continues To Decline Following Bearish Outlook",2014-10-27 16:58:00-04:00,AGN,neutral
44460.0,Valeant Raises Allergan Takeover Bid,2014-10-27 11:15:00-04:00,AGN,neutral
44461.0,"From Allergan Earnings Conference Call: Expecting Sales Growth in Double-Digit Range, EPS CAGR ~20% for 2014-2019 Period",2014-10-27 10:09:00-04:00,AGN,positive
44462.0,Allergan Issues Comment on Valeant Letter,2014-10-27 09:12:00-04:00,AGN,neutral
44463.0,"UPDATE: Allergan Posts Upbeat Q3 Earnings, Lifts Forecast",2014-10-27 08:11:00-04:00,AGN,neutral
44464.0,"Allergan, Inc. Sees Q4 Product Sales $1.85B-1.92B vs $1.87B Est; FY2014 Product Sales $7.08B-7.16B vs $7.15B Est",2014-10-27 07:11:00-04:00,AGN,neutral
44465.0,Amgen Sees Botox Sales In 2014 Between $2.20 B To $2.24B ,2014-10-27 07:07:00-04:00,AGN,neutral
44466.0,"Allergan, Inc. Reports Q3 GAAP EPS of $1.03 vs $1.68 Est; Revenue of $1.79B vs $1.78B Est.  Non-GAAP EPS Was $1.78/Shr",2014-10-27 07:03:00-04:00,AGN,neutral
44467.0,UPDATE: Valeant Urgers Board To Take Control Of Process Of Improving Offer,2014-10-27 07:00:00-04:00,AGN,positive
44468.0,Valeant Letter Says Prepared to Improve Offer and Provide Value of at Least $200/Share to Allergan Shareholders,2014-10-27 06:57:00-04:00,AGN,positive
44469.0,"Earnings Scheduled For October 27, 2014",2014-10-27 05:06:00-04:00,AGN,neutral
44470.0,"Keep an Eye on These 7 Stocks for October 27, 2014",2014-10-27 04:21:00-04:00,AGN,neutral
44471.0,Meister on CNBC Says Passive Holder of Allergan Stock; Wants Company to Sell for Highest Price Possible; Says Ultimately Valeant Will Raise their Bid,2014-10-21 12:44:00-04:00,AGN,positive
44472.0,"Allergan Says No Evidence to Support Valeant, Pershing Square's Counterclaims in Insider Trading Lawsuit",2014-10-21 10:32:00-04:00,AGN,negative
44473.0,"Report: Actavis, Sanofi To Bid On Over-The-Counter Drug Maker",2014-10-20 20:15:00-04:00,AGN,neutral
44474.0,"IBM's Report Weighs On The Dow, Apple Helps Boost The Nasdaq, S&P 500 Extends Winning Streak",2014-10-20 16:57:00-04:00,AGN,positive
44475.0,"From Conf Call: Valeant CEO Confident Allergan Bid Will be Worth $200+/Share Once Stock Rises, Plus With Cash Added",2014-10-20 10:13:00-04:00,AGN,positive
44476.0,From Conf Call: Valeant CEO Says Not Walking Away from Allergan Bid,2014-10-20 09:04:00-04:00,AGN,neutral
44477.0,From Conf Call: Valeant CFO Says Would Be Willing to Raise Offer for Allergan,2014-10-20 08:47:00-04:00,AGN,neutral
44478.0,From Conf Call: Valeant Says Completely Focused on Completing Allergan Transaction,2014-10-20 08:38:00-04:00,AGN,positive
44479.0,Will Actavis Win Competition For Allergan's Affection?,2014-10-16 11:10:00-04:00,AGN,positive
44480.0,Pershing Square's Bill Ackman Tells Reporters His Lawyers Saw Documents Showing Allergan Board Knowingly Released Misleading Statements Regarding Valeant -Reuters,2014-10-16 11:06:00-04:00,AGN,negative
44481.0,Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest Revenue,2014-10-13 05:22:00-04:00,AGN,positive
44482.0,UPDATE: Fidelity is Actavis' Largest Shareholder; Fidelity Increased Allergan Stake by ~2M Shares from End June-End August,2014-10-10 10:00:00-04:00,AGN,positive
44483.0,Reuters Reports Fidelity Supports Actavis-Allergan Merger,2014-10-10 09:57:00-04:00,AGN,positive
44484.0,"Dow Suffers Worst One-Day Performance In 2014, Volatility Returns To The Markets",2014-10-09 16:55:00-04:00,AGN,negative
44485.0,Salix Pharma Spikes to High,2014-10-09 14:21:00-04:00,AGN,neutral
44486.0,"Allergan, Inc. Shares Get A Bump Following Update On Performance Outlook",2014-10-09 09:41:00-04:00,AGN,positive
44487.0,Allergan Says Benefits from Previously Announced Restructuring Program to be Reflected in Actual Results Beginning Q4 2014,2014-10-09 06:50:00-04:00,AGN,positive
44488.0,"Allergan, Inc. Sees FY2014 EPS $6.20-6.25 vs $5.81 Est",2014-10-09 06:48:00-04:00,AGN,neutral
44489.0,"Allergan, Inc. Sees FY2015 EPS ~$8.60 vs $8.25 Est",2014-10-09 06:47:00-04:00,AGN,neutral
44490.0,"Allergan, Inc Up As Deutsche Bank Initiates Coverage With Buy Rating",2014-10-09 06:34:00-04:00,AGN,neutral
44491.0,"Deutsche Bank Initiates Coverage on Allergan, Inc. at Buy, Announces $25.00 PT",2014-10-09 05:57:00-04:00,AGN,neutral
44492.0,"Deutsche Bank Initiates Coverage on Allergan, Inc. at Buy, Announces $215.00 PT",2014-10-08 16:40:00-04:00,AGN,neutral
44493.0,"#PreMarket Primer: Wednesday, October 8: IMF Cuts Global Growth Prospects, Puts A Damper On Wall Street",2014-10-08 08:19:00-04:00,AGN,positive
44494.0,CNBC's Stock Pops & Drops From October 7,2014-10-08 07:40:00-04:00,AGN,neutral
44495.0,"Allergan Filed Motion for Preliminary Injunction Seeking Order to Enjoin Pershing from Exercising Privileges Of 9.7% Ownership In Co, Enjoin Pershing Square, Valeant from Voting Any Proxies Solicited By Them",2014-10-08 06:12:00-04:00,AGN,positive
44496.0,"Benzinga's M&A Chatter for Tuesday October 7, 2014",2014-10-07 20:16:00-04:00,AGN,neutral
44497.0,"Ackman's Pershing Square Could Raise Allergan Takeover Bid, WSJ Reports",2014-10-07 18:08:00-04:00,AGN,neutral
44498.0,"Ackman's Pershing Square, Valeant May Be Planning to Raise Allergan Bid by $15/Share",2014-10-07 17:47:00-04:00,AGN,neutral
44499.0,"Dow Suffers Largest Daily Decline Since July, S&P 500 At 8-Week Lows On Global Growth Concerns",2014-10-07 16:52:00-04:00,AGN,negative
44500.0,"Allergan, Inc. Spikes On Renewed Interest From Actavis PLC",2014-10-07 15:50:00-04:00,AGN,positive
44501.0,UPDATE: Actavis Could Reiterate Takeover Interest in Allergan; Sources Say Allergan Would Consider Bid of $200 or More -Rueters,2014-10-07 15:01:00-04:00,AGN,positive
44502.0,Reuters Reports Actavis Could Acquire Allergan for $200/Share -Sources,2014-10-07 14:59:00-04:00,AGN,neutral
44503.0,"Edwards Lifesciences Reports David Pyott, Allergan Chair, CEO, Has Resigned from Board",2014-10-03 16:02:00-04:00,AGN,negative
44504.0,Salix Shares Rise 4.5% Premarket Following Announcement of Termination of Merger Agreement with Cosmo,2014-10-03 05:16:00-04:00,AGN,positive
44505.0,Salix Pharma Spikes Higher; In Talks to Sell to Actavis -Bloomberg,2014-10-02 18:09:00-04:00,AGN,neutral
44506.0,"Shares of Allergan, Salix Pharma Volatile as CNBC's David Faber Suggesting Talks Between Cos. Have 'Cooled'",2014-10-02 09:52:00-04:00,AGN,positive
44507.0,"CNBC's David Faber Reports Salix to Terminate Inversion Deal with Cosmo, According to Sources",2014-10-02 09:50:00-04:00,AGN,neutral
44508.0,"Reuters Reports ISS Urges Allergan to Allow Shareholders to Vote on Any Large Deals, According to Sources",2014-10-01 10:21:00-04:00,AGN,positive
44509.0,Filing from Valeant Shows 'Rebuttal to Sept. 29th Allergan 8-K',2014-09-30 10:06:00-04:00,AGN,neutral
44510.0,Allergan Reports FDA Has Approved Revised Indication for OZURDEX,2014-09-29 09:03:00-04:00,AGN,positive
44511.0,"UPDATE: Allergan Board Offers Statement, Says Valeant's Bid 'Grossly Inadequate'",2014-09-29 08:05:00-04:00,AGN,negative
44512.0,"Allergan Board Offers Statement, Says Valeant's Bid 'Grossly Inadequate'",2014-09-29 08:04:00-04:00,AGN,negative
44513.0,Jackson Square Partners Joins Investors Opposing Allergan Bid for Salix,2014-09-28 11:05:00-04:00,AGN,neutral
44514.0,"UPDATE: T. Rowe Price Says Allergan Board Should Refrain from Approving Significant, Irreversible Commitments from Now Until Decemeber 18 Meeting Without Shareholder Approval",2014-09-26 14:44:00-04:00,AGN,negative
44515.0," T. Rowe Price Says Over Past Several Months, Have Been Watching With Growing Concern, Corporate Governance Practices of Allergan's Board",2014-09-26 14:41:00-04:00,AGN,positive
44516.0,"Benzinga's M&A Chatter for Wednesday September 24, 2014",2014-09-24 21:09:00-04:00,AGN,neutral
44517.0,"UPDATE: Valeant Letter Shows Co. Continues to be Willing to Negotiate with Allergan, Will Pursue Proxy Contest If Necessary",2014-09-24 09:07:00-04:00,AGN,neutral
44518.0,"Valeant Announces Letter Sent to Allergan, 'Extends Olive Branch;' Expecting Q3 Results to Beat Street Views",2014-09-24 09:06:00-04:00,AGN,positive
44519.0,CNBC's David Faber Says Actavis and Salix in Early Stage Discussions Regarding Potential Deal,2014-09-24 09:04:00-04:00,AGN,neutral
44520.0,"#PreMarket Primer: Wednesday, September 24: US Economy Looking Strong In The Third Quarter",2014-09-24 07:13:00-04:00,AGN,positive
44521.0,"Benzinga's M&A Chatter for Tuesday September 23, 2014",2014-09-23 18:35:00-04:00,AGN,neutral
44522.0,Dow Finishes Down 100+ Points For Second Consecutive Day,2014-09-23 16:57:00-04:00,AGN,neutral
44523.0,Amended 13D Filing from Ackman's Pershing Square on Allergan Shows Updated Letter to Board Which Was Disclosed Earlier Tues. Morn,2014-09-23 16:18:00-04:00,AGN,neutral
44524.0,Dow Down 0.6%; CarMax Shares Fall After Q2 Results,2014-09-23 15:13:00-04:00,AGN,positive
44525.0,Ascena Retail Drops On Downbeat Earnings; CF Industries Shares Gain,2014-09-23 12:43:00-04:00,AGN,positive
44526.0,Markets Mixed; Carnival Profit Tops Street View,2014-09-23 11:20:00-04:00,AGN,positive
44527.0,Benzinga's Volume Movers,2014-09-23 10:25:00-04:00,AGN,neutral
44528.0,"Allergan Spokeperson Says Board Thinks Valeant's Offer for Allergan is Grossly Inadequate, Substantially Undervalues Co -Reuters",2014-09-23 10:22:00-04:00,AGN,negative
44529.0,Stocks Hitting 52-Week Highs,2014-09-23 10:10:00-04:00,AGN,neutral
44530.0,Morning Market Movers ,2014-09-23 09:38:00-04:00,AGN,neutral
44531.0,Benzinga's Top #PreMarket Gainers,2014-09-23 08:14:00-04:00,AGN,positive
44532.0,Salix Shares Rise 9% Premarket on Report of Takeover Talks with Allergan,2014-09-23 07:53:00-04:00,AGN,positive
44533.0,Pershing Square Sends Letter to Allergan Board Regarding Salix Deal; Threatens Suit Against Allergan is Deal Doesn't Require Board Vote -DJ,2014-09-23 07:45:00-04:00,AGN,negative
44534.0,"#PreMarket Primer: Tuesday, September 23: First Airstrikes In Syria Begin",2014-09-23 07:28:00-04:00,AGN,neutral
44535.0,US Stock Futures Fall Ahead Of Economic Data,2014-09-23 07:16:00-04:00,AGN,neutral
44536.0,"Stocks To Watch For September 23, 2014",2014-09-23 05:24:00-04:00,AGN,neutral
44537.0,"Salix Pharmaceuticals, Ltd. Set To Be Acquired By Allergan, Inc.",2014-09-22 22:50:00-04:00,AGN,neutral
44538.0,"Benzinga's M&A Chatter for Monday September 22, 2014",2014-09-22 18:17:00-04:00,AGN,neutral
44539.0,"Dow Jones Reports Allergan Rejected Takeover Bid from Actavis in August; Actavis Still Interested in Allergan Deal; Allergan in Talks to Acquire Salix, According to Sources",2014-09-22 17:43:00-04:00,AGN,negative
44540.0,"Court Denies Allergan's Request for Protective Order in Allergan vs Valeant Pharma, Pershing Case -Reuters",2014-09-22 16:18:00-04:00,AGN,negative
44541.0,"Pershing Square, Valeant and Allergan Settle Pending Litigation; Allergan Agrees to Special Meeting on December 18, 2014",2014-09-16 05:33:00-04:00,AGN,positive
44542.0,"Pershing Square Submiterd Additional Special Meeting Requests On Friday, Total Submitted Represents 35.68% Of Allergan Shares",2014-09-15 11:57:00-04:00,AGN,positive
44543.0,Ackman's Pershing Square Issues Added Special Meeting Requests Representing 35% of Allergan Shares,2014-09-12 08:01:00-04:00,AGN,positive
44544.0,Allergan Comments On Pershing Square's Delivery Of Additional Requests From Stockholders Owning 1.5% Of Allergan's Shares,2014-09-11 20:46:00-04:00,AGN,positive
44545.0,"Reuters Reports Ackman Close to Signing Up Allergan Investors with Combines 35% to Call Special Meeting, According to Sources",2014-09-11 09:58:00-04:00,AGN,positive
44546.0,"Bill Ackman Rips Allergan, Inc. In Letter",2014-09-10 11:56:00-04:00,AGN,neutral
44547.0,"Ackman Alleges Allergan Board Has ""Shown A Remarkable Lack Of Understanding About Valeant's Business""",2014-09-09 15:58:00-04:00,AGN,positive
44548.0,William Ackman Sends Letter To Allergen Board,2014-09-09 15:56:00-04:00,AGN,neutral
44549.0,"Jazz Pharmaceuticals Up On Allergan, Inc. Rumor",2014-09-05 15:53:00-04:00,AGN,neutral
44550.0,Hearing Deal Reporter Says Jazz Takeover Target of Allergan,2014-09-05 10:57:00-04:00,AGN,neutral
44551.0,Allergan Provides Update Regarding Validity of Written Requests from Pershing Square for Special Meeting of Stockholders ,2014-09-04 20:05:00-04:00,AGN,positive
44552.0,Valeant And Bill Ackman Deliver Another 2.8% Conesent Vote To Allergan,2014-09-04 09:58:00-04:00,AGN,neutral
44553.0, US Appeals Court Revives Shareholder Lawsuit Against Allergan Over Botox Marketing -Reuters ,2014-09-02 12:01:00-04:00,AGN,positive
44554.0,"Allergan Reports Filing of Answer in Federal Court Related to Valeant, Pershing Square's Counterclaims",2014-09-02 09:04:00-04:00,AGN,neutral
44555.0,"Delaware Judge Grants Valeant, Pershing Square Request For Expedited Proceedings In Special Meeting Dispute",2014-08-27 11:38:00-04:00,AGN,positive
44556.0,Valeant Short Seller Bronte Capital Releases Update to Report ,2014-08-27 10:26:00-04:00,AGN,neutral
44557.0,Allergan to Request Injunction Against Valeant and Pershing Square for Violation of Insider Trading Laws ,2014-08-26 21:08:00-04:00,AGN,negative
44558.0,"S&P 500 Closes Above 2,000; Dow Hits New All-Time High As Markets Continue To Rally",2014-08-26 16:42:00-04:00,AGN,neutral
44559.0,Valeant and Bill Ackman's Pershing Square Have Asked a Delaware Judge to Expedite Case - Bloomberg,2014-08-26 16:36:00-04:00,AGN,neutral
44560.0,3 Pharma Companies That Could Deliver Breakthroughs In 'Plantibody' Technology,2014-08-24 20:08:00-04:00,AGN,neutral
44561.0,Allergan Confirms Receipt of Written Requests from Pershing Square Regarding Special Meeting of Stockholders ,2014-08-22 20:06:00-04:00,AGN,positive
44562.0,WSJ Reporting Valeant and Bill Ackman May Be Now Preparing the Final Stage for Allergan Meeting,2014-08-22 17:11:00-04:00,AGN,neutral
44563.0,"Yellen's Speech Not Enough To Keep Dow, S&P 500 In Positive Territory",2014-08-22 16:36:00-04:00,AGN,positive
44564.0,UPDATE: Allergan Says Intends to Proceed Along Path Outlined by the Court for Quick Resolution Once Pershing Square Delivers Special Meeting Requests,2014-08-22 09:27:00-04:00,AGN,positive
44565.0,Allergan Says Fully Supports Right of Stockholders to Vote on Value Proposition Offered by Valeant at Appropriate Time,2014-08-22 09:26:00-04:00,AGN,positive
44566.0,UPDATE: Salix Shares Fall 2.5% Premarket Following Report Talks with Allergan have Stalled,2014-08-21 07:55:00-04:00,AGN,positive
44567.0,"Allergan Talks to Buy Salix 'Dormant,' Co. Exploring Options Other Than Salix - Bloomberg",2014-08-20 17:30:00-04:00,AGN,neutral
44568.0,"Benzinga's M&A Chatter for Tuesday August 19, 2014",2014-08-19 19:31:00-04:00,AGN,neutral
44569.0,"Dow Flirts With 19,000, S&P 500 Approaches 2,000 & NASDAQ Trading At 14-Year Highs ",2014-08-19 16:35:00-04:00,AGN,positive
44570.0,Allergan Declines Comment on Rumor of Potential Deal with Salix,2014-08-19 15:10:00-04:00,AGN,neutral
44571.0,Allergan On The Acquisition Hunt,2014-08-19 14:11:00-04:00,AGN,neutral
44572.0,JP Morgan Says Jazz Pharmaceuticals Positioned For 'Organic Growth And Acquisition',2014-08-19 14:02:00-04:00,AGN,positive
44573.0,"UPDATE: Valeant, Jazz Shares Move Higher on WSJ Report of Potential Allergan Deal for Salix",2014-08-19 13:12:00-04:00,AGN,positive
44574.0,"UPDATE: Allergan Could Announce Deal with Salix or Another Co as Early as Next Month, According to Sources; Would Make Acquisition by Valeant More Difficult",2014-08-19 13:09:00-04:00,AGN,negative
44575.0,"Dow Jones Reports Allergan Has Approached Salix Pharmaceuticals About Acquisition, Acording to Sources",2014-08-19 13:04:00-04:00,AGN,neutral
44576.0,"UPDATE: Allergan's Jeff Edwards Stepped Down, Citing Family Committmenets",2014-08-18 09:06:00-04:00,AGN,neutral
44577.0,Allergan Announces Jim Hindman CFO,2014-08-18 09:01:00-04:00,AGN,neutral
44578.0,Valeant Reports Extension of Offer to Buy Allergan to Dec. 31st,2014-08-15 17:08:00-04:00,AGN,neutral
44579.0,Allergan Takes In 13 New Hedge Fund Investments In Q2,2014-08-15 13:20:00-04:00,AGN,neutral
44580.0,Notable Hedge Funds Disclose Additions And Reductions To Holdings,2014-08-15 07:23:00-04:00,AGN,neutral
44581.0,"13F Filing from Paulson & Co. Shows New Stakes in Covidien, DirecTV, Allergan, Questcor, Liquidated Stakes in Hess Corp. GM, Capital One, Raised Stakes in Family Dollar, Dollar General, Lowered Stakes in Freeport-McMoRan, CBS",2014-08-14 16:56:00-04:00,AGN,negative
44582.0,"Markets Gather Some Momentum As Volume Remains Light, Geopolitical Tension Improving",2014-08-14 16:37:00-04:00,AGN,positive
44583.0,"Pershing Square Says Welcoming of the SEC's Review of Allergan Facts, Says Nothing Illegal in Toehold Allergan Position - Bloomberg",2014-08-14 14:25:00-04:00,AGN,positive
44584.0,"SEC Probe in Early Stage, May Not Lead to Enforcement Action  - DJ Reports",2014-08-14 13:25:00-04:00,AGN,neutral
44585.0,"UPDATE: Valeant Shares Off Lows, as Dow Jones Reports SEC Investigating Valeant And Pershing Square's Joint Bid for  Allergan, According to Sources",2014-08-14 13:24:00-04:00,AGN,positive
44586.0,SEC Investigating Valeant And Pershing Square's Joint Pursuit Of Allergan - DJ Reports,2014-08-14 13:24:00-04:00,AGN,neutral
44587.0,Valeant Spikes Lower,2014-08-14 13:20:00-04:00,AGN,negative
44588.0,"Allergan Announces Acquisition of LiRIS Program Form RARIS Biomedical For $67.5M, Will Pay Up To $295M in Development Milestones and $225M In commercial Milestones",2014-08-13 16:31:00-04:00,AGN,negative
44589.0,"Benzinga's M&A Chatter for Monday August 11, 2014",2014-08-11 19:11:00-04:00,AGN,neutral
44590.0,Valeant Says It Has Received Request For Additional Information From FTC For Acquisition of Allergan,2014-08-11 17:31:00-04:00,AGN,neutral
44591.0,"Allergan Announces Has Received Second Request from FTC Related to Valeant Deal, Says Intends to Respond Fully, Cannot Predict How Long Investigation Will Take",2014-08-11 12:50:00-04:00,AGN,neutral
44592.0,UPDATE: Valueact Says Prolonged War for Allergan is Costly to Valeant; Should Look at Other Potential Deals,2014-08-11 12:23:00-04:00,AGN,negative
44593.0,UPDATE: Valueact Says Believes In Standalone Plan for Valeant; Sees Stock Rising to $130-$140 in a Year,2014-08-11 12:22:00-04:00,AGN,neutral
44594.0,Valueact Says Valeant Does Not Need to Buy Allergan -Reuters,2014-08-11 12:21:00-04:00,AGN,neutral
44595.0,Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest Dividend Yield,2014-08-11 05:20:00-04:00,AGN,positive
44596.0,Benzinga's Top Upgrades,2014-08-08 08:41:00-04:00,AGN,positive
44597.0,Leerink Swann Upgrades Allergan To Outperform,2014-08-08 07:48:00-04:00,AGN,neutral
44598.0,Fast Money Picks For August 8,2014-08-08 07:18:00-04:00,AGN,neutral
44599.0,"Leerink Swann Upgrades Allergan, Inc. to Outperform, Maintains $184.00 PT",2014-08-08 06:33:00-04:00,AGN,neutral
44600.0,Pershing Square to File Copy of Confidentiality Agreement Between It And Valeant Pharmaceuticals With Bank Counterparty; Also File Copies of Agreements for Call Options and Forward Purchase Contracts,2014-08-06 17:12:00-04:00,AGN,positive
44601.0,UPDATE: Filing from Pershing Square Shows Material Terms of Allergan Deal Were Disclosed,2014-08-06 17:05:00-04:00,AGN,neutral
44602.0,Amended 13D Filing from Ackman's Pershing Square on Allergan Shows Confidentiality Pact with SEC,2014-08-06 17:04:00-04:00,AGN,neutral
44603.0,ISS Issues Release Recommending Allergan Holders Call Special Meeting,2014-08-06 15:14:00-04:00,AGN,positive
44604.0,"Allergan Issues Comment on ISS, Glass Lewis Suggestions",2014-08-06 12:55:00-04:00,AGN,neutral
44605.0,Glass Lewis Recommends Allergan Shareholders Support Pershing Square's Call for Special Meeting of Shareholders ,2014-08-05 09:56:00-04:00,AGN,positive
44606.0,Allergan Says Valeant's Earnings Report Had Numerous Inconsistencies,2014-08-05 08:22:00-04:00,AGN,neutral
44607.0,Thursday's Selling Momentum Continues Into Friday,2014-08-01 16:33:00-04:00,AGN,neutral
44608.0,US M&A Announced Deals Surpass $1 Trillion For 2014,2014-08-01 15:21:00-04:00,AGN,neutral
44609.0,"Valeant, Ackman's Pershing Square Issue Response to 'Frivolous Allergan Lawsuit'",2014-08-01 15:02:00-04:00,AGN,negative
44610.0,"UPDATE: Allergan Has Filed Federal Suit Against Pershing, Valeant Pharma, Cites Violations of Federal Securities Laws",2014-08-01 11:31:00-04:00,AGN,negative
44611.0,"Allergan Files Lawsuit In Federal Court Against Valeant, Pershing Square For Violations Of Federal Securities Laws",2014-08-01 11:31:00-04:00,AGN,negative
44612.0,Dow Suffers 300 Point Drop; S&P 500 And NASDAQ Also Tumble,2014-07-31 16:49:00-04:00,AGN,negative
44613.0,Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest EPS,2014-07-31 04:40:00-04:00,AGN,positive
44614.0,Allergan Announces Positive Opinion For Ozurdex in Europe,2014-07-25 07:55:00-04:00,AGN,positive
44615.0,Valeant Pharmaceuticals Files Official Complaint With Autorite Des Marches Financiers Regarding Allergan's False And Misleading Statements,2014-07-24 08:06:00-04:00,AGN,negative
44616.0,Earnings Season Boosts Confidence; S&P Trades At Record Highs ,2014-07-22 16:40:00-04:00,AGN,positive
44617.0,BTIG: Valeant Must Sweeten Allergan Bid To More Than $200/Share,2014-07-22 16:33:00-04:00,AGN,neutral
44618.0,UPDATE: UBS Securities Upgrades Allergan On Conference Call Takeaways,2014-07-22 09:33:00-04:00,AGN,positive
44619.0,"UBS Upgrades Allergan, Inc. to Buy",2014-07-22 06:50:00-04:00,AGN,neutral
44620.0,"Filing from Allergan Shows Comment 'Allergan stands by its comments. We call on Valeant to report complete and transparent details on its business on an ongoing basis. At the end of the day, investors will make their own decisions.'",2014-07-21 17:27:00-04:00,AGN,neutral
44621.0,"Ackman Believes Allergan Earnings, Call Bring Deal 'Materially Closer to Happening,' Says Look at Spread, Action in VRX",2014-07-21 12:45:00-04:00,AGN,neutral
44622.0,Ackman Believes Jim Chanos is Wrong on Valeant,2014-07-21 12:42:00-04:00,AGN,negative
44623.0,Ackman Says Allergan Offer Open for Negotiation If Board Engages Right Now,2014-07-21 12:41:00-04:00,AGN,positive
44624.0,Ackman Bringing Up 'Credibility Issues',2014-07-21 12:36:00-04:00,AGN,neutral
44625.0,Ackman Says Today's Allergan's Earnings Report Does Not Mean Valeant has to Raise Offer,2014-07-21 12:35:00-04:00,AGN,neutral
44626.0,Pershing Square's Bill Ackman Discussing Potential Valeant-Allergan Deal on CNBC,2014-07-21 12:34:00-04:00,AGN,neutral
44627.0,"From Allergan Earnings Conference Call: If No Deal with Valeant is Done, Co. Could Decide to Do Buyback or Special Dividend",2014-07-21 11:14:00-04:00,AGN,positive
44628.0,"UPDATE: Allergan Posts Upbeat Q2 Earnings, Plans To lower 13% Of Workforce",2014-07-21 09:06:00-04:00,AGN,negative
44629.0,"Allergan, Inc. Sees FY2015 EPS $8.20-8.40, FY16 EPS ~$10",2014-07-21 08:09:00-04:00,AGN,neutral
44630.0,"Allergan, Inc. Raises FY2014 EPS Guidance from $5.64-5.73 to $5.74-5.80 vs $5.70 Est",2014-07-21 08:05:00-04:00,AGN,neutral
44631.0,"Allergan Announces Will Restructure, Expecting to Cut Headcount by 1,500 Positions",2014-07-21 08:01:00-04:00,AGN,negative
44632.0,"Allergan, Inc. Sees FY2014 Sales $6.90B-7.05B vs $6.98B Est",2014-07-21 08:01:00-04:00,AGN,neutral
44633.0,"Allergan, Inc. Sees Q3 Sales $1.68B-1.75B vs $1.72B Est",2014-07-21 08:01:00-04:00,AGN,neutral
44634.0,"Allergan, Inc. Reports Q2 EPS of $1.51 vs $1.44 Est",2014-07-21 08:00:00-04:00,AGN,neutral
44635.0,UPDATE: Valeant Complains to SEC Regarding Allergan Claims ,2014-07-21 07:16:00-04:00,AGN,negative
44636.0,Valeant Complains to SEC Regarding Allergan Claims -CNBC,2014-07-21 07:09:00-04:00,AGN,negative
44637.0,"Earnings Scheduled For July 21, 2014",2014-07-21 05:06:00-04:00,AGN,neutral
44638.0,"Stocks To Watch For July 21, 2014",2014-07-21 04:06:00-04:00,AGN,neutral
44639.0,Ackman Says Ultimately Valeant-Allergan Deal Happens,2014-07-16 17:41:00-04:00,AGN,neutral
44640.0,Ackman Says Valeant has Offered a 50% Premium to Allergan; Board of Allergan has Called Valeant an Accounting Fraud,2014-07-16 17:39:00-04:00,AGN,negative
44641.0,Ackman Says Icahn Was Supportive on Valeant-Allergan Deal,2014-07-16 17:19:00-04:00,AGN,positive
44642.0,Paulson Says He Will Talk to Ackman Regarding Potentisl Valeant-Allergan Deal,2014-07-16 14:35:00-04:00,AGN,neutral
44643.0,Paulson Says Valeant is a Serious Acquirer,2014-07-16 14:32:00-04:00,AGN,negative
44644.0,UPDATE: Pershing Square Says Will Hold 8:30 a.m. EDT Webcast on Jul. 17th to Discuss Potential Special Meeting with Allergan,2014-07-16 09:16:00-04:00,AGN,positive
44645.0,"Pershing Square Releases Letter To Allergan's Board Of Directors, Fund Actively Seeking Hold Support",2014-07-16 09:15:00-04:00,AGN,positive
44646.0,Valeant Submits HSR Filing Related to Proposed Allergan Deal,2014-07-14 08:05:00-04:00,AGN,neutral
44647.0,Allergan Issues Comment on Pershing's Definitive Proxy Statement,2014-07-11 16:46:00-04:00,AGN,neutral
44648.0,Apple And 4 Other Environmentally Responsible Companies,2014-07-11 08:22:00-04:00,AGN,positive
44649.0,"Benzinga's M&A Chatter for Wednesday July 9, 2014",2014-07-09 20:15:00-04:00,AGN,neutral
44650.0,Bloomberg Headlines Highlighting FT Story 'Investors press Allergan to find deal;' Article Suggests Holders Encouraging Board to Seek Fast Acquisition,2014-07-09 17:25:00-04:00,AGN,positive
44651.0,Allergan CEO Says Looking at Potential Acquisitions -DJ,2014-07-09 16:14:00-04:00,AGN,neutral
44652.0,Markets Marginally Lower Ahead Of Earnings Season,2014-07-07 16:37:00-04:00,AGN,negative
44653.0,"Pershing Square Issues Release Proposing Independent Slate for Allergan's Board, Slate Includes Atkins, Black, Eshelman, Shulman, Wilson, Zillmer",2014-07-07 12:48:00-04:00,AGN,neutral
44654.0," Pershing Square, Valeant Reveal Nominees for Allergan Board, Including Betsy Atkins, Cathleen Black, Steven Shulman, David Wilson, John Zillmer, Fredric Eshelman",2014-07-07 12:48:00-04:00,AGN,neutral
44655.0,Filing from Allergan Shows Bill Ackman's Pershing Square Has Filed to Request a Special Meeting,2014-07-07 12:38:00-04:00,AGN,positive
44656.0,Pershing Square Hires Credit Suisse as Banker for Allergan Campaign -DJ,2014-07-01 12:56:00-04:00,AGN,positive
44657.0,"FDA Approves Allergan's Ozurdex, Rejects Levadex",2014-06-30 12:08:00-04:00,AGN,negative
44658.0,Allergan Says Darpin Would Be Less Valuable if Valeant Owns,2014-06-30 11:51:00-04:00,AGN,positive
44659.0,Sterne Agee Feels More Positive On Allergan Following Recent Call With CEO,2014-06-30 10:23:00-04:00,AGN,positive
44660.0,Allergan Announces Positive Phase 2 Data for Abicipar Pegol,2014-06-30 08:11:00-04:00,AGN,positive
44661.0,Benzinga's Weekend M&A Chatter,2014-06-29 22:01:00-04:00,AGN,neutral
44662.0,Stocks Mildly Higher To End The Week,2014-06-27 16:33:00-04:00,AGN,neutral
44663.0,"UPDATE: Pershing Square Says Settlement Resolves Poison Pill Litigation, Paves Way for Pershing to Solicit Proxies to Call Special Meeting",2014-06-27 12:49:00-04:00,AGN,negative
44664.0,"Allergan Shares Selling Off After Spiking Higher on Ackman Headline, Last up 0.62%",2014-06-27 12:48:00-04:00,AGN,positive
44665.0,Pershing Square and Allergan Settle Delaware Court of Chancery Lawsuit Confirming that Allergan's Rights Plan is Not Triggered by Efforts to Call a Special Meeting ,2014-06-27 12:46:00-04:00,AGN,positive
44666.0,Pershing Square And Allergan Settle Delaware Court Of Chancery Lawsuit Confirming That Allergan's Rights Plan Is Not Triggered By Efforts To Call A Special Meeting,2014-06-27 12:44:00-04:00,AGN,positive
44667.0,Top 4 Stocks In The Drug Manufacturers-Other Industry With The Highest Dividend Yield,2014-06-27 05:44:00-04:00,AGN,positive
44668.0,"Benzinga's M&A Chatter for Thursday June 26, 2014",2014-06-26 19:09:00-04:00,AGN,neutral
44669.0,Valeant Pharmaceuticals CEO Says Delighted Paulson & Co Has Acquired Allergan Stake -Reuters,2014-06-26 12:36:00-04:00,AGN,positive
44670.0,"Benzinga's M&A Chatter for Wednesday June 25, 2014",2014-06-25 20:25:00-04:00,AGN,neutral
44671.0,Rumor: Big Stake In Allergan Acquired By Valeant Supporter Paulson,2014-06-25 16:49:00-04:00,AGN,positive
44672.0,Markets Close Higher Despite A Contraction In GDP,2014-06-25 16:47:00-04:00,AGN,neutral
44673.0,"Reuters Reports Paulson & Co Acquires 6M+ Shares of Allergan, in Support of Deal With Valeant, According to Sources ",2014-06-25 15:37:00-04:00,AGN,positive
44674.0,Valeant Files Prelim. Proxy Statement for Special Meeting,2014-06-25 08:01:00-04:00,AGN,positive
44675.0,"Benzinga's M&A Chatter for Tuesday June 24, 2014",2014-06-24 17:53:00-04:00,AGN,neutral
44676.0,UPDATE: Pearson Says Valeant Isn't Pursuing Other Big Deals While Bidding for Allergan,2014-06-24 15:34:00-04:00,AGN,neutral
44677.0,Valeant CEO Pearson Says Most of Allergan's Biggest Shareholders Support the $53B Bid,2014-06-24 15:31:00-04:00,AGN,positive
44678.0,Bulls Take A Break As Dow's Winning Streak Ends At 7 Days,2014-06-23 16:40:00-04:00,AGN,positive
44679.0,"Share of Allergan Resume Trading at ~$164.62/Share, Down 0.45%",2014-06-23 15:00:00-04:00,AGN,positive
44680.0,Shares of Allergan Expected to Resume Trading at 3:00PM EDT,2014-06-23 14:58:00-04:00,AGN,positive
44681.0,"'Merger Monday' Deals, Offers And Rejections",2014-06-23 13:46:00-04:00,AGN,negative
44682.0,"Allergan Shares Halted, Code 'Equipment Changeover'",2014-06-23 10:22:00-04:00,AGN,positive
44683.0,Allergan Board Rejects Unsolicited Exchange Offer From Valeant,2014-06-23 08:08:00-04:00,AGN,negative
44684.0,Valeant Has Posted Responses to Allergan's 'Misleading Assertions' on Website,2014-06-23 08:05:00-04:00,AGN,negative
44685.0,"Filing from Allergan Shows Board Urging Holders Not to Tender Shares, Unanimous Decision Valeant Offer is Inadequate",2014-06-23 07:59:00-04:00,AGN,negative
44686.0,"Valeant, Allergan Shares Seeing Delayed Response Following WSJ Headline Pershing Square's Suit on Allergan's Poison Pill Has Been Fast Tracked",2014-06-19 14:20:00-04:00,AGN,negative
44687.0,Dow Jones Reports Delaware Judge Sets Fast Timetable for Pershing Square Suit Over Allergan Poison Pill; Pershing Square Seeking Clarification of Allergan Poison Pill,2014-06-19 13:06:00-04:00,AGN,negative
44688.0,"Benzinga's M&A Chatter for Wednesday June 18, 2014",2014-06-18 17:50:00-04:00,AGN,neutral
44689.0,Market Wrap For June 18: Markets Rally On Fed Comments And Tapering,2014-06-18 16:34:00-04:00,AGN,neutral
44690.0,5-Star Biotech Stock Watch: Synta Pharmaceuticals,2014-06-18 15:26:00-04:00,AGN,neutral
44691.0,"Allergan Announces Board Will Review Exchange Offer from Valeant, Urges Holders to Take No Action at This Time",2014-06-18 11:30:00-04:00,AGN,negative
44692.0,"UPDATE: Valeant has Filed Offer $72/Share in Cash, 0.83 Valeant Shares per Allergan Share",2014-06-18 09:31:00-04:00,AGN,positive
44693.0,Valeant Commences Exchange Offer For Allergan ,2014-06-18 09:31:00-04:00,AGN,neutral
44694.0,"UPDATE: Valeant Has Filed Offer for $72/Share in Cash, 0.83 VRX Share per AGN Share",2014-06-18 09:26:00-04:00,AGN,positive
44695.0,S-4 Filing from Valeant Pharma Shows Registration of 242M Shares for Allergan,2014-06-18 09:25:00-04:00,AGN,positive
44696.0,Shire Shares Edge Higher Following SunTrust Note Suggesting Allergan Could Make 'Imminent' Bid for Co.,2014-06-18 07:48:00-04:00,AGN,positive
44697.0,Valeant Pharmaceuticals CEO Sees No Need to Adjust Proposal for Allergan,2014-06-17 09:26:00-04:00,AGN,negative
44698.0,"Benzinga's M&A Chatter for Monday June 16, 2014",2014-06-16 20:53:00-04:00,AGN,neutral
44699.0,Shire Up On Report It Proactively Hired Investment Bank ,2014-06-16 15:26:00-04:00,AGN,neutral
44700.0,Allergan Says Valeant's Business Model is Unsustainable,2014-06-16 07:02:00-04:00,AGN,neutral
44701.0,"Market Wrap For June 13: Despite Rising, Dow And S&P 500 Lower For The Week",2014-06-13 16:39:00-04:00,AGN,negative
44702.0,"Allergan Files Letter From General Counsel to Pershing Chief Legal Officer With SEC, Offerings Response to June 6 Pershing Letter",2014-06-13 13:36:00-04:00,AGN,positive
44703.0,Valeant Will Hold Conference Call on June 17 To Correct Assertions Made by Allergan,2014-06-13 12:05:00-04:00,AGN,neutral
44704.0,UPDATE: Bill Ackman's Pershing Square Files Lawsuit in Delaware Court of Chancery Over Allergan's Rights Plan ,2014-06-13 06:04:00-04:00,AGN,negative
44705.0,Pershing Square Files Lawsuit In Delaware Court Of Chancery Seeking Confirmation That Allergan's Rights Plan Is Not Triggered By Efforts To Call A Special Meeting,2014-06-13 06:01:00-04:00,AGN,positive
44706.0,"Benzinga's M&A Chatter for Tuesday June 10, 2014",2014-06-10 17:57:00-04:00,AGN,neutral
44707.0,Market Wrap For June 10: Stocks Showed Little Change On Light Volume,2014-06-10 16:41:00-04:00,AGN,neutral
44708.0, DAVID FABER Tweet: 'Valeant hires Morgan Stanley as advisor in its hostile pursuit of Allergan- sources.',2014-06-10 16:15:00-04:00,AGN,negative
44709.0,"Allergan Patents on Latisse Invalidated by US Appeals Court, Actavis, Sandoz Have Won Right to Sell Generic Eyelash Drug - Bloomberg",2014-06-10 11:18:00-04:00,AGN,positive
44710.0,UPDATE: Allergan CEO Says He's Prepared for Long Battle With Valeant -Reuters,2014-06-10 11:08:00-04:00,AGN,negative
44711.0,Valeant Spokesperson Says Allergan Statement Leaves Valeant No Choice But to Take Offer Straight to Shareholders -Reuters,2014-06-10 10:57:00-04:00,AGN,positive
44712.0,Bronte Capital Short Valeant Pharmaceuticals,2014-06-10 10:56:00-04:00,AGN,neutral
44713.0,"Allergan Says Will Offer Update on Near-Term Value-Driving Efforts, Expecting Double-Digit Sales Growth Over Next Five Years",2014-06-10 08:26:00-04:00,AGN,positive
44714.0,Release from Allergan Confirms Board's Unanimous Rejection of Latest Valeant Offer,2014-06-10 08:21:00-04:00,AGN,negative
44715.0,Filing from Allergan Shows Board Unanimously Rejects Bid from Valeant,2014-06-10 08:16:00-04:00,AGN,negative
44716.0,UPDATE: Ackman Says Valeant Was Working On Allergan Takeover Bid For 18 Months,2014-06-09 08:03:00-04:00,AGN,neutral
44717.0,"Pershing Square's Ackman on CNBC Defends Valeant, Says Not a Bad Roll-Up",2014-06-09 07:23:00-04:00,AGN,positive
44718.0,Market Wrap For June 5: Markets Positive Before Friday's Employment Report,2014-06-05 16:35:00-04:00,AGN,positive
44719.0,Market Wrap For June 3: Markets Run Out Of Steam,2014-06-03 16:44:00-04:00,AGN,neutral
44720.0,UPDATE: Credit Suisse Downgrades Allergan,2014-06-03 11:00:00-04:00,AGN,positive
44721.0,Benzinga's Top Downgrades,2014-06-03 07:45:00-04:00,AGN,positive
44722.0,"Credit Suisse Downgrades Allergan, Inc. to Neutral",2014-06-03 06:22:00-04:00,AGN,positive
44723.0,"Benzinga's Weekend M&A Chatter for Monday June 2, 2014",2014-06-02 18:48:00-04:00,AGN,neutral
44724.0,Ackman's Pershing Files Amended 13D on Allergen With Update to Show Letter From Board,2014-06-02 12:50:00-04:00,AGN,neutral
44725.0,"Allergan Says Will Review, Consider Re-Revised Offer from Pershing, Valeant, Tells Holders to Take No Action At This Time",2014-06-02 11:09:00-04:00,AGN,negative
44726.0,Pershing Square's Ackman Says Launching Process to Solicit Special Meeting of Allergan Shareholders,2014-06-02 08:16:00-04:00,AGN,positive
44727.0,"Stocks To Watch For June 2, 2014",2014-06-02 04:04:00-04:00,AGN,neutral
44728.0,Benzinga's Weekend M&A Chatter,2014-06-01 16:39:00-04:00,AGN,neutral
44729.0,"Allergan Announces Acknowledgement of Revised Offer from Valeant, Ackman's Pershing",2014-05-30 16:55:00-04:00,AGN,neutral
44730.0,Market Wrap For May 30: 'Sell In May And Go Away' Proves To Be Bad Advice,2014-05-30 16:30:00-04:00,AGN,negative
44731.0,"Allergan Shares Rally Amid Revised $72/Share in Cash, 0.83 in Valeant Shares Offer From Valeant, Ackman's Pershing Square",2014-05-30 15:26:00-04:00,AGN,positive
44732.0,"Valeant Shares Spiked to Session Low at $125.61, Spiked to Intraday High at $136.38, Now Around $130",2014-05-30 15:01:00-04:00,AGN,neutral
44733.0,"Shares of Allergan Resume, Now Up ~7%",2014-05-30 14:49:00-04:00,AGN,positive
44734.0,UPDATE: Release from Valeant Shows Pershing Square Has Taken 9.7% Stake in Allergan,2014-05-30 14:41:00-04:00,AGN,neutral
44735.0,"UPDATE: Valeant, Pershing Square Have Made Revised Offer for Allergan, $72/Share in Cash, 0.83 VRX Shares",2014-05-30 14:39:00-04:00,AGN,positive
44736.0,"UPDATE: Pershing Square Will Forego All Cash, Accept 100% Consideration VRX Shares, Pershing Will Receive $20.75/Share Less Than Other Holders",2014-05-30 14:38:00-04:00,AGN,positive
44737.0,"UPDATE: Pershing, Valeant Offer Contingent on Good Faith Talks",2014-05-30 14:37:00-04:00,AGN,positive
44738.0,"Valeant, Pershing Square Have Made Revised Offer for Allergan, $72/Share in Cash, 0.83 VRX Shares",2014-05-30 14:36:00-04:00,AGN,positive
44739.0,UPDATE: Shares of Valeant Now Down 2.3%,2014-05-30 14:32:00-04:00,AGN,positive
44740.0,Valeant Shares Spike Lower Following Allergan Halt,2014-05-30 14:30:00-04:00,AGN,neutral
44741.0,Allergan Shares Halted News Pending,2014-05-30 14:29:00-04:00,AGN,positive
44742.0,Market Wrap For May 28: Markets Take A Breather As Treasury Yields Fall,2014-05-28 16:34:00-04:00,AGN,positive
44743.0,Mid-Afternoon Market Update: Markets Mixed As Twitter Rallies,2014-05-28 15:44:00-04:00,AGN,neutral
44744.0,Moody's Says Valeant's Revised Offer for Allergan is Credit Positive,2014-05-28 14:14:00-04:00,AGN,positive
44745.0,UPDATE: Valeant CEO Says May Present Offer Directly to Allergan Shareholders,2014-05-28 11:17:00-04:00,AGN,neutral
44746.0,Valeant CEO Pearson Asks Allergan Board and Management to Engage in Discussions with Valeant,2014-05-28 11:16:00-04:00,AGN,positive
44747.0,Allergan Confirms Receiving Unsolicited Proposal From Valeant,2014-05-28 08:52:00-04:00,AGN,neutral
44748.0,US Stock Futures Signal Higher Start On Wall Street,2014-05-28 07:17:00-04:00,AGN,neutral
44749.0,Valeant to Invest Up to $400M In DARPin,2014-05-28 06:07:00-04:00,AGN,neutral
44750.0,UPDATE: Valeant Increases Cash Consideration for Allergan by $10.00/Share to $58.30/Share ,2014-05-28 06:04:00-04:00,AGN,neutral
44751.0,UPDATE: Valeant Increases Allergan Cash Consideration by $10/Share To $58.30,2014-05-28 06:02:00-04:00,AGN,neutral
44752.0,Valeant Substantially Increases Merger Proposal For Allergan,2014-05-28 06:00:00-04:00,AGN,neutral
44753.0,Market Wrap For May 27: S&P 500 Closes At New Record High After Holiday Weekend,2014-05-27 16:48:00-04:00,AGN,positive
44754.0,Allergen Rejects Valeant Offer,2014-05-27 10:30:00-04:00,AGN,negative
44755.0,"Buckingham Research Upgrades Allergan, Inc. to Buy",2014-05-27 08:26:00-04:00,AGN,neutral
44756.0,Allergan Says Concerned About Valeant Pharma Int Business Model,2014-05-27 08:16:00-04:00,AGN,neutral
44757.0,"Market Wrap For May 23: Markets Marginally Higher; S&P 500 Closes Above 1,900",2014-05-23 16:39:00-04:00,AGN,neutral
44758.0,"Form 8-K from Allergan Shows Confirmation of Receipt from Pershing's Latest Letter, Board Will Review Any Revised Bid from Valeant",2014-05-21 17:59:00-04:00,AGN,neutral
44759.0,UPDATE: Allergan: Entire Board Will 'Carefully Review' Any Revised Proposal That Valeant Makes,2014-05-21 17:33:00-04:00,AGN,positive
44760.0,UPDATE: Allergan Says Letter Has Been Distributed to Entire Board,2014-05-21 17:31:00-04:00,AGN,neutral
44761.0,Allergan Confirm Receipt of Latest Letter From Ackman/Pershing Square Capital,2014-05-21 17:31:00-04:00,AGN,neutral
44762.0,"Pershing Square Letter Says Allergan Battle May Continue Through 2014, 2015",2014-05-21 11:36:00-04:00,AGN,negative
44763.0,"UPDATE: Ackman's Letter to Allergan Director Urges Co. Board to Retain Counsel, Advisors",2014-05-21 10:58:00-04:00,AGN,neutral
44764.0,UPDATE: Ackman Issues Letter to Allergan's Lead Director Michael Gallagher,2014-05-21 10:55:00-04:00,AGN,neutral
44765.0,"UPDATE: Filing from Ackman on Allergan Shows 9.7% Stake, Includes Letter to Allergan's Lead Director Michael Gallagher",2014-05-21 10:54:00-04:00,AGN,neutral
44766.0,Amended 13D from Bill Ackman's Pershing Square on Allergan Just Filed,2014-05-21 10:53:00-04:00,AGN,neutral
44767.0,"Top Ex-Dividend Stocks For May 21, 2014",2014-05-21 10:16:00-04:00,AGN,positive
44768.0,"Market Wrap For May 20: Markets Sharply Lower On Fed Talk, Disappointing Earnings",2014-05-20 16:42:00-04:00,AGN,negative
44769.0,"Analysts See Allergan Bid Of Over $180, Possibility of 'Hostile' Bid",2014-05-20 16:19:00-04:00,AGN,neutral
44770.0,"Allergan's Physician Customers Show Support for Allergan's Rejection from Valeant, Affirms FY15, Five-Year Guidance",2014-05-20 09:02:00-04:00,AGN,negative
44771.0,Valeant Says Will Discuss Allergan Offer at May 28th Investor Meeting,2014-05-20 08:07:00-04:00,AGN,neutral
44772.0,Valeant Pharmaceuticals to Announce Improved Bid for Allergan Shareholders on May 28,2014-05-20 08:04:00-04:00,AGN,positive
44773.0,"UPDATE: Allergan Sends Letter to Ackman Confirming Receipt of Letter, Separate Letter to All Allergan Employees",2014-05-19 17:31:00-04:00,AGN,neutral
44774.0,"Form 8-K from Allergan Confirms Receipt of Ackman Letter, Board Says Disagrees with Ackman's Comments",2014-05-19 17:29:00-04:00,AGN,negative
44775.0,"Pershing Square Sends Letter To Allergan, Comments On Poor Governance",2014-05-19 09:03:00-04:00,AGN,negative
44776.0,"UPDATE: Pershing Square Files Amended 13D on Allergan, Includes Letter to Allergan's Michael Gallagher",2014-05-19 08:43:00-04:00,AGN,neutral
44777.0,"Pershing Square Files Amended 13D on Allergan, Includes Letter to Allergan's Michael Gallagher, Shows Concern About Governance Failures",2014-05-19 08:41:00-04:00,AGN,negative
44778.0,Bill Ackman Picks 4 New Stocks In 13F,2014-05-16 15:15:00-04:00,AGN,neutral
44779.0,Ackman's 13F Shows New ~597K Share Stake in Allergan,2014-05-15 17:09:00-04:00,AGN,positive
44780.0,"Jim Chanos of Kynikos Currently on CNBC Talking Allergan, Valeant Deal, Says He is Long Allergan",2014-05-15 12:37:00-04:00,AGN,neutral
44781.0,Sterne Agee Believes Allergan Is In Stronger Position Than Originally Thought,2014-05-14 10:30:00-04:00,AGN,positive
44782.0,"Benzinga's M&A Chatter for Tuesday May 13, 2014",2014-05-13 17:58:00-04:00,AGN,neutral
44783.0,Market Wrap For May 13: Markets Close Again At Record Highs,2014-05-13 16:36:00-04:00,AGN,neutral
44784.0,UPDATE: Allergan Spokesperson Says Pershing Square Meeting of Allergan Shareholders is a Self-Serving Exercise,2014-05-13 13:45:00-04:00,AGN,neutral
44785.0,Pershing Square's Bill Ackman Files Proxy Statement Related to Allergan's Meeting of Shareholders,2014-05-13 12:48:00-04:00,AGN,neutral
44786.0,Morgan Stanley Sees Compelling Standalone EPS Growth For Allergan,2014-05-13 10:14:00-04:00,AGN,positive
44787.0,Valeant Pharmaceuticals Responds to Allergan's Rejection of Merger Proposal,2014-05-13 08:02:00-04:00,AGN,negative
44788.0,"Benzinga's M&A Chatter for Monday May 12, 2014",2014-05-12 18:18:00-04:00,AGN,neutral
44789.0,Market Wrap For May 12: Dow And S&P Close At Record Highs,2014-05-12 16:37:00-04:00,AGN,neutral
44790.0,Bill Ackman's Pershing Square Says It Requested Stockholder List from Allergan Following Rejection of Valeant's Takeover Proposal,2014-05-12 13:06:00-04:00,AGN,negative
44791.0,UPDATE: Allergan Board Rejects Valeant Latest Proposal,2014-05-12 07:01:00-04:00,AGN,negative
44792.0,Allergan Board Rejects Valeant Latest Proposal,2014-05-12 07:01:00-04:00,AGN,negative
44793.0,Benzinga's Weekend M&A Chatter,2014-05-11 22:28:00-04:00,AGN,neutral
44794.0,Valeant Pharmaceuticals Spikes to High,2014-05-09 14:08:00-04:00,AGN,neutral
44795.0,"UPDATE: Allergan Rumored to Contact Glaxo, Novartis About Possible Interest",2014-05-09 14:04:00-04:00,AGN,positive
44796.0,"Sanofi Rumored Not to Be Interested in Allergan, J&J Said to Demur on Co.'s Breast Implant Business - Bloomberg",2014-05-09 14:03:00-04:00,AGN,negative
44797.0,FT Reporting Allergan Rumored to Prepare Rejection of Valeant's Offer,2014-05-09 11:36:00-04:00,AGN,negative
44798.0,Market Wrap For May 8: Tesla Helps Extend Nasdaq's Losing Streak To 3 Straight Days,2014-05-08 16:32:00-04:00,AGN,positive
44799.0,"JP Morgan Maintains Overweight on Allergan, Inc., Maintains $190.00 PT",2014-05-08 06:48:00-04:00,AGN,neutral
44800.0,"Jefferies Maintains Hold on Allergan, Inc., Raises PT to $160.00",2014-05-08 06:48:00-04:00,AGN,neutral
44801.0,"William Blair Maintains Outperform on Allergan, Inc.to Outperform",2014-05-08 06:47:00-04:00,AGN,neutral
44802.0,"Piper Jaffray Maintains Neutral on Allergan, Inc., Raises PT to $170.00",2014-05-08 06:47:00-04:00,AGN,neutral
44803.0,Allergan CEO Says Evaluating 'Strategic Plan Which Began Nine Months Ago -DJ,2014-05-07 12:15:00-04:00,AGN,neutral
44804.0,From Allergan Earnings Conf. Call: Co. Has Had No Talks with Valeant,2014-05-07 11:09:00-04:00,AGN,negative
44805.0,"Allergan, Inc. Sees FY2014 EPS $5.64-5.73 vs $5.47 Est; Sees Sales $6.78B-7.0B vs $6.87B Est",2014-05-07 09:01:00-04:00,AGN,neutral
44806.0,"Allergan, Inc. Sees Q2 EPS $1.41-1.44 vs $1.37 Est; Sees Sales $1.73B-1.80B vs $1.74B Est",2014-05-07 09:01:00-04:00,AGN,neutral
44807.0,"Allergan, Inc. Reports Q1 EPS of $1.18 vs $1.13 Est; Revenue of $1.62B vs $1.60B Est",2014-05-07 09:01:00-04:00,AGN,neutral
44808.0,"Earnings Scheduled For May 7, 2014",2014-05-07 05:15:00-04:00,AGN,neutral
44809.0,"Ackman Sends Letter to Allergan's Lead Independent Director, Suggests Valeant Bid Superior to Standalone, Sees Best Interest as Beginning Talks 'Very Soon'",2014-05-05 12:55:00-04:00,AGN,positive
44810.0,Amended 13D from Ackman's Pershing Square on Allergan Just Hitting EDGAR's Site,2014-05-05 12:50:00-04:00,AGN,neutral
44811.0,"Doug Kass On Bubbles, Forecasting, Social Media And More",2014-05-02 17:12:00-04:00,AGN,neutral
44812.0,"Bill Ackman's Pershing Square Receives Permission from FTC to Turn Allergan Options into Shares, According to Source -Reuters",2014-05-02 10:30:00-04:00,AGN,positive
44813.0,"Benzinga's M&A Chatter for Tuesday April 29, 2014",2014-04-29 20:07:00-04:00,AGN,neutral
44814.0,Market Wrap For April 29: Dow Approaches Record Highs Despite Ongoing Ukraine Tension and Upcoming Fed Meeting ,2014-04-29 16:43:00-04:00,AGN,positive
44815.0,Icahn And Ackman Kiss And Make Up,2014-04-29 13:39:00-04:00,AGN,positive
44816.0,"UPDATE: JNJ, Sanofi Spokespersons Decline Comment on Rumored Contact from Allergan",2014-04-29 10:02:00-04:00,AGN,neutral
44817.0,"Allergan Could Explore Sale to Sanofi, J&J Instead of Valeant - Bloomberg",2014-04-29 09:23:00-04:00,AGN,neutral
44818.0,Market Wrap For April 28: Apple Hits New 52-Week Highs In a Volatile Start To the Trading Week,2014-04-28 16:34:00-04:00,AGN,neutral
44819.0,"Reuters Reports Allergan to Approach Shire About Potential Takeover, According to Sources",2014-04-28 14:49:00-04:00,AGN,neutral
44820.0,UPDATE: Stifel Downgrades Allergan as Company is Now on the Defensive,2014-04-28 10:27:00-04:00,AGN,neutral
44821.0,Benzinga's Top Downgrades,2014-04-28 07:52:00-04:00,AGN,positive
44822.0,"Stifel Nicolaus Downgrades Allergan, Inc. to Hold, Removes $125.00 PT",2014-04-28 07:10:00-04:00,AGN,neutral
44823.0,"Mylan Raises Bid for Meda to 145 Kroner/Share, Shares Gain 3%",2014-04-25 14:34:00-04:00,AGN,positive
44824.0,"Benzinga's M&A Chatter for Wednesday April 23, 2014",2014-04-23 20:34:00-04:00,AGN,neutral
44825.0,"Market Wrap For April 23: S&P 500 Ends Winning Streak, Apple Announces 7-for-1 Stock Split",2014-04-23 16:46:00-04:00,AGN,positive
44826.0,Fitch Places Allergan's Ratings On Negative Watch,2014-04-23 15:09:00-04:00,AGN,negative
44827.0,Ackman Says Valeant is a Better Choice Now for an Investor than Allergan; Says Valeant is Easily a $200 Stock When Deal Closes,2014-04-23 10:43:00-04:00,AGN,positive
44828.0,Ackman Says Valeant has Made a Lot of Acquisitions but has Not Overpaid,2014-04-23 10:40:00-04:00,AGN,neutral
44829.0,Bill Ackman on Bloomberg TV Says Never Invested in Healthcare Co Before Because its a Difficult Industry; Says Valeant-Allergan Combination is More Like a P&G than a Biotech Co,2014-04-23 10:33:00-04:00,AGN,positive
44830.0,"Edward Jones Downgrades Allergan, Inc. to Sell",2014-04-23 09:51:00-04:00,AGN,neutral
44831.0,Bill Ackman Talks Partnership With Valeant For Allergan Deal ,2014-04-23 09:38:00-04:00,AGN,neutral
44832.0,"Ackman Reassuring Confidentiality Agreement in Valeant, Allergan Deal Should Effectively Quiet Any Front-Running Allegations",2014-04-23 07:56:00-04:00,AGN,positive
44833.0,Bill Ackman Says Valeant was Capable of doing Allergan Deal Alone,2014-04-23 07:51:00-04:00,AGN,positive
44834.0,"Valeant Chair, CEO Pearson on CNBC Describing Bill Ackman's Helpfulness with the Deal, Believes Ackman's Involvement Makes Deal More Likely",2014-04-23 07:51:00-04:00,AGN,positive
44835.0,"Bill Ackman on CNBC Discussing Insider Trading Related to Valeant, Allergan Deal",2014-04-23 07:49:00-04:00,AGN,neutral
44836.0,Ackman Says Allergan Poison Pill Not Necessarily Bad,2014-04-23 07:41:00-04:00,AGN,negative
44837.0,Bill Ackman Says Allergan Poison Pill is OK if it's there fro Co to Look at Other Opportunities,2014-04-23 07:41:00-04:00,AGN,positive
44838.0,Valeant CEO Says Thinks Deal will Get Done Despite 'Poison Pill' Adopted by Allergan Board,2014-04-23 07:39:00-04:00,AGN,positive
44839.0,Valeant CEO on CNBC Says Allergan Has Great Durable Assets,2014-04-23 07:38:00-04:00,AGN,positive
44840.0,Benzinga's Top Upgrades,2014-04-23 07:26:00-04:00,AGN,positive
44841.0,"JP Morgan Upgrades Allergan, Inc. to Overweight, Raises PT to $190.00",2014-04-23 07:23:00-04:00,AGN,neutral
44842.0,Allergan Adopts One-Year Stockholder Rights Plan ,2014-04-22 22:35:00-04:00,AGN,positive
44843.0,"Benzinga's M&A Chatter for Tuesday April 22, 2014",2014-04-22 18:19:00-04:00,AGN,neutral
44844.0,"Market Wrap For April 22: S&P Rises For Sixth Straight Day, Dow & Nasdaq Also Positive",2014-04-22 16:52:00-04:00,AGN,positive
44845.0,Mid-Afternoon Market Update: Revance Therapeutics Continues to Rally as Markets Hang onto Early Strength,2014-04-22 16:01:00-04:00,AGN,positive
44846.0,"Argus Research Downgrades Allergan, Inc. to Hold, Maintains $130.00 PT",2014-04-22 15:20:00-04:00,AGN,neutral
44847.0,"Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)",2014-04-22 13:24:00-04:00,AGN,neutral
44848.0,Moody's Revises Allergan's Outlook to Negative,2014-04-22 12:56:00-04:00,AGN,negative
44849.0,Moody's Affirms Ratings on Allergan; Outlook Revised Lower to Negative,2014-04-22 12:55:00-04:00,AGN,negative
44850.0,Mid-Day Market Update: Allergan Surges On Buyout Offer; Lexmark Shares Slip,2014-04-22 12:14:00-04:00,AGN,positive
44851.0,"From Valent Conference Call Related to Allergan Purchase: Ackman's Pershing Square Will Not Be Treated Preferentially, Co. Already in Discussions with FTC",2014-04-22 11:14:00-04:00,AGN,neutral
44852.0,"UPDATE: Allergan Confirms Receipt of Unsolicited Proposal from Valeant, Will Review Offer",2014-04-22 11:02:00-04:00,AGN,neutral
44853.0,Allergan Confirms Receipt of Unsolicited Proposal from Valeant,2014-04-22 11:01:00-04:00,AGN,neutral
44854.0,Mid-Morning Market Update: Markets Gain; McDonald's Posts Lower Profit,2014-04-22 10:46:00-04:00,AGN,positive
44855.0,Stocks Hitting 52-Week Highs,2014-04-22 10:29:00-04:00,AGN,neutral
44856.0,michelle celarier Tweet: 'Ackman visited Valeant's Poland operations 2 weeks ago as part of DD on the $AGN deal; bid $45.6B for the Botox maker #nyp',2014-04-22 10:08:00-04:00,AGN,neutral
44857.0,Morning Market Movers ,2014-04-22 09:43:00-04:00,AGN,neutral
44858.0,Sterne Agee Expects Allergan to Resist Hostile Takeover by Valeant,2014-04-22 09:30:00-04:00,AGN,negative
44859.0,Benzinga's Top #PreMarket Gainers,2014-04-22 08:09:00-04:00,AGN,positive
44860.0,"ETF Outlook For Tuesday, April 22, 2014 (PBS, IHE, IYT, EIRL, VRX, AGN, NFLX)",2014-04-22 07:42:00-04:00,AGN,neutral
44861.0,"UPDATE: Valeant Proposes to Combine with Allergan at $48.30/Cash, 0.83 Shares",2014-04-22 07:32:00-04:00,AGN,positive
44862.0,"Valeant Proposes to Combine with Allergan at $48.30/Cash, 0.83 Shares",2014-04-22 07:31:00-04:00,AGN,positive
44863.0,Allergan Responds to Public Filings by Valeant and Pershing Square ,2014-04-22 05:41:00-04:00,AGN,neutral
44864.0,"Benzinga's M&A Chatter for Monday April 21, 2014",2014-04-21 20:16:00-04:00,AGN,neutral
44865.0,Allergan and Valeant Rally on News of Potential Three Way Deal With Pershing Square,2014-04-21 17:22:00-04:00,AGN,neutral
44866.0,Pershing's AGN Position Includes Call Options; Pershing to Buy $400M Shares of Valeant Stake at 15% Discount; May Have Right to End Pact if no Valeant Offer Before May 2,2014-04-21 17:05:00-04:00,AGN,neutral
44867.0,UPDATE: Pershing Square Reports Cash Component Will be Around $15B for Allergan ,2014-04-21 17:03:00-04:00,AGN,neutral
44868.0,"UPDATE: Pershing Square to Propose Merger In Which Allergan Shareholders to Receive Combination of Cash, Valeant Shares",2014-04-21 17:02:00-04:00,AGN,positive
44869.0,UPDATE: Ackman's Pershing Square Says Intends to Engage In Discussions With Allergan -Filing,2014-04-21 17:00:00-04:00,AGN,positive
44870.0,Pershing Filing Reports 9.7% Beneficial Ownership in Allergan ,2014-04-21 17:00:00-04:00,AGN,positive
44871.0,David Faber Reports Valeant to Make a Hostile $45B+ Bid for Allergan by Tuesday; Deal to be 1/3 Cash,2014-04-21 16:43:00-04:00,AGN,negative
44872.0,UPDATE: Pershing Has Built Up a 10% Stake in Allergan Dow Jones Reports,2014-04-21 16:38:00-04:00,AGN,neutral
44873.0,"UPDATE: Allergan Spikes Higher 19% to $169 Following Rumor Ackman, Valeant Team Up for Possible Bid of Company",2014-04-21 16:33:00-04:00,AGN,neutral
44874.0,"Dow Jones Reporting Ackman, Valeant Team up For Possible bid for Allergan",2014-04-21 16:30:00-04:00,AGN,neutral
44875.0,"UPDATE: Valeant shares Rise 16% After-Hours on Rumor of Allergan Bid, Allergan Shares Rise 18%",2014-04-21 16:28:00-04:00,AGN,positive
44876.0,"Jefferies Initiates Coverage on Allergan, Inc. at Hold",2014-04-21 16:24:00-04:00,AGN,neutral
44877.0,"Dow Jones Reports Ackman, Valeant Pursuing Takeover Of Allergan, Accoording to Sources",2014-04-21 16:24:00-04:00,AGN,neutral
44878.0,Market Wrap For April 16: Markets Hold On To Gains On Positive Yellen Comments And Economic Data,2014-04-16 16:50:00-04:00,AGN,positive
44879.0,"Sterne Agee Initiates Coverage on Allergan, Inc. at Buy, Announces $142.00 PT",2014-04-16 08:14:00-04:00,AGN,neutral
44880.0,Benzinga's Volume Movers,2014-04-15 11:31:00-04:00,AGN,neutral
44881.0,Market Wrap For March 28: Markets Still Positive Despite Giving Up Early Gains,2014-03-28 16:27:00-04:00,AGN,positive
44882.0,Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest EPS,2014-03-10 05:56:00-04:00,AGN,positive
44883.0,Market Wrap For March 7: Markets Cap Off Positive Week With Small Gains,2014-03-07 16:31:00-05:00,AGN,positive
44884.0,Fitch Affirms A+ IDR Rating on Allergan; Outlook Stable,2014-03-05 11:08:00-05:00,AGN,positive
44885.0,Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest Operating Margin,2014-02-14 04:30:00-05:00,AGN,positive
44886.0,Morgan Stanley Says Allergan Management is Still Optimistic,2014-02-11 09:16:00-05:00,AGN,positive
44887.0,"Credit Suisse Maintains Outperform on Allergan, Inc., Raises PT to $140.00",2014-02-11 06:38:00-05:00,AGN,positive
44888.0,"Allergan, Inc. Sees FY2014 EPS $5.36-5.48 vs $5.46 Est",2014-02-05 09:01:00-05:00,AGN,neutral
44889.0,"Allergan, Inc. Sees Q1 EPS $1.09-1.12 vs $1.21 Est",2014-02-05 09:01:00-05:00,AGN,neutral
44890.0,"Allergan, Inc. Reports Q4 EPS of $1.35 vs $1.34 Est; Revenue of $1.66B vs $1.65B Est",2014-02-05 09:00:00-05:00,AGN,neutral
44891.0,"Earnings Scheduled For February 5, 2014",2014-02-05 04:21:00-05:00,AGN,neutral
44892.0,UPDATE: Allergan Upgraded by Citigroup on Strong Fundamentals,2014-02-04 11:02:00-05:00,AGN,positive
44893.0,"Citigroup Upgrades Allergan, Inc. to Buy, Raises undefined to $130.00",2014-02-04 07:03:00-05:00,AGN,neutral
44894.0,UPDATE: Allergan to Vigorously Enforce Intellectual Property Rights Relating to Restasis,2014-01-22 09:12:00-05:00,AGN,positive
44895.0,Allergan Received Letter Stating Watson Labs Has Filed Abbreviated NDA Seeking Approval to Market a Generic Version of Restasis-- Filing,2014-01-22 09:11:00-05:00,AGN,positive
44896.0,Benzinga's Top Upgrades,2014-01-17 07:47:00-05:00,AGN,positive
44897.0,"SunTrust Robinson Humphrey Upgrades Allergan, Inc. to Buy, Raises PT to $150.00",2014-01-17 07:37:00-05:00,AGN,neutral
44898.0,Bloomberg First Word Reporting Patent for Allergan's Restasis Listed in FDA Orange Book,2014-01-16 14:13:00-05:00,AGN,neutral
44899.0,"Susquehanna Lifts Price Target on Allergan from $122 to $145, Maintains Positive Rating",2014-01-15 09:07:00-05:00,AGN,positive
44900.0,"Morgan Stanley Maintainson Allergan, Changes PT",2014-01-15 08:12:00-05:00,AGN,neutral
44901.0,"Morgan Stanley Maintains Equal-weight on Allergan, Inc.to Equal-weight, Removes $94.00 PT",2014-01-15 07:19:00-05:00,AGN,neutral
44902.0,Market Wrap For January 14: Markets Rebound On Earnings Season Kickoff,2014-01-14 17:19:00-05:00,AGN,neutral
44903.0,"UPDATE: Allergan Apr $125 Call Rises Almost 100% from Monday's Report by Benzinga of 6,000 Contract Buy; Was $2.85, High Today $5.60",2014-01-14 11:25:00-05:00,AGN,neutral
44904.0,UPDATE: Allergan Has Won a Ruling Blocking Generics of Lumigan Until 2027,2014-01-14 11:21:00-05:00,AGN,positive
44905.0,"Bloomberg Reporting Allergan Wins Suit Against Actavis, Novartis Related to Lumigan",2014-01-14 11:20:00-05:00,AGN,positive
44906.0,Allergan Shares Extremely Volatile Today as Traders Digesting News US PTO Issued a New Patent for Restasis,2014-01-14 10:38:00-05:00,AGN,positive
44907.0,"Option Alert: Allergan Apr $125 Call; 6,000 Contract Trade at Ask @$2.85; Currently $114.77",2014-01-13 13:23:00-05:00,AGN,positive
44908.0,"Allergan, Medytox Close Licensing Agreement ",2014-01-07 09:07:00-05:00,AGN,positive
44909.0,Benzinga's Top Upgrades,2013-12-24 08:44:00-05:00,AGN,positive
44910.0,"Wells Fargo Upgrades Allergan, Inc. to Outperform",2013-12-24 07:38:00-05:00,AGN,positive
44911.0,Cowen Suggests Truth to Allergan Rumors,2013-12-21 17:00:00-05:00,AGN,positive
44912.0,"UPDATE: Allergan Spokesperson Says No News to Cause Spike in Share Price, Not Aware of Pending Event",2013-12-19 15:09:00-05:00,AGN,neutral
44913.0,UPDATE: Hearing Chatter Allergan Spiking on Rumor of Patent for Restasis,2013-12-19 15:05:00-05:00,AGN,neutral
44914.0,Allergan Spikes Higher; May be Attributed to Takeover Chatter,2013-12-19 15:03:00-05:00,AGN,neutral
44915.0,Merger Monday Lives Up To Its Name: More Than $33B In Deals Announced,2013-12-16 15:41:00-05:00,AGN,neutral
44916.0,"Allergan Shares Up 3+% to Near $100 Amid Pharma M&A; Cowen Sees Co. as Ideal Candidate for Purchase of Galderma, RBC Says Could Be Counterbidder for Solta",2013-12-16 10:48:00-05:00,AGN,positive
44917.0,UPDATE: Credit Suisse Raises PT on Allergan on Compelling Turnaround Story Heading into 2014,2013-12-12 10:30:00-05:00,AGN,positive
44918.0,"Credit Suisse Maintains Outperform on Allergan, Inc., Raises PT to $112.00",2013-12-12 06:54:00-05:00,AGN,positive
44919.0,UPDATE: BTIG Research Initiates Coverage on Allergan as Lots of Shots on Goal Could Cause a Bounce,2013-12-06 08:12:00-05:00,AGN,neutral
44920.0,"BTIG Research Initiates Coverage on Allergan, Inc. at Buy, Announces $115.00 PT",2013-12-05 16:28:00-05:00,AGN,neutral
44921.0,"BTIG Research Initiates Coverage on Allergan, Inc. at Buy, Announces $115.00 PT",2013-12-05 16:26:00-05:00,AGN,neutral
44922.0,"Allergan, Inc. Sees Q4 EPS $1.31-1.33 vs $1.36 Est; Sees Sales $1.59B-1.66B vs $1.63B Est",2013-10-29 09:01:00-04:00,AGN,neutral
44923.0,"Allergan, Inc. Reports Q3 EPS of $1.23 vs $1.21 Est; Revenue of $1.53B vs $1.53B Est",2013-10-29 09:00:00-04:00,AGN,neutral
44924.0,"Credit Suisse Starts Pfizer, Bristol-Myers, AbbVie, Allergan at Outperform, Merck, Eli Lilly, Forest Labs at Neutral",2013-10-08 16:57:00-04:00,AGN,positive
44925.0,"Weatherford, Copart And Others Insiders Have Been Buying (AYR, CPRT, OPK, WFT)",2013-10-01 14:40:00-04:00,AGN,neutral
44926.0,"Allergan, Medytox to Enter Licensing Agreement ",2013-09-25 18:43:00-04:00,AGN,positive
44927.0,Allergan Confirms FDA Approval for BOTOX for Temporary Improvement of Moderate to Severe Crow's Feet in Adults,2013-09-11 14:56:00-04:00,AGN,positive
44928.0,Top 4 Large-Cap Stocks In The Drug Manufacturers-Other Industry With The Highest Cash,2013-09-04 04:12:00-04:00,AGN,positive
44929.0,"Reuters Reported India Has Revoked Patents on Allergan's Eye Drugs Ganfort, Combigan",2013-08-08 16:57:00-04:00,AGN,neutral
44930.0,"Allergan, Inc. Sees FY2013 EPS $4.72-4.76 vs $4.74 Est; Sees Sales $6.05B-6.20B vs $6.18B Est",2013-07-31 09:04:00-04:00,AGN,neutral
44931.0,"Allergan, Inc. Sees Q3 EPS $1.18-1.20 vs $1.20 Est; Sees Sales $1.50B-1.57B vs $1.52B Est",2013-07-31 09:04:00-04:00,AGN,neutral
44932.0,"Allergan, Inc. Reports Q2 EPS of $1.22 vs $1.20 Est; Revenue of $1.58B vs $1.56B Est",2013-07-31 09:03:00-04:00,AGN,neutral
44933.0,"Weekly Preview: Earnings Season Continues, Fed In Focus, Economic Maelstrom Expected",2013-07-26 16:05:00-04:00,AGN,neutral
44934.0,"Recent Insider Buying at Navistar, Walgreen (NAV, OPK, WAG)",2013-07-20 12:16:00-04:00,AGN,neutral
44935.0,"Benzinga's M&A Chatter for Friday July 12, 2013",2013-07-13 20:10:00-04:00,AGN,neutral
44936.0,"First Round Bids for Elan due Next Week, Allergan, Forest Labs Among Drugmakers Still Involved: Reuters",2013-07-12 15:39:00-04:00,AGN,neutral
44937.0,RBC Says New Dosing for Allergan's DARPin Could Be Positive for Regeneron's Eylea,2013-07-03 12:33:00-04:00,AGN,positive
44938.0,"Chesapeake Energy, Weyerhaeuser and Other Stocks Insiders Are Buying (CHK, WY)",2013-06-30 20:34:00-04:00,AGN,positive
44939.0,UPDATE: Canaccord Genuity Lowers PT on Allergan on Disappointments Hitting Sentiment,2013-06-25 14:14:00-04:00,AGN,negative
44940.0,Benzinga's Volume Movers,2013-06-25 10:22:00-04:00,AGN,neutral
44941.0,"Wells Fargo Downgrades Allergan, Inc. to Market Perform",2013-06-25 08:16:00-04:00,AGN,positive
44942.0,Benzinga's Top Downgrades,2013-06-25 07:25:00-04:00,AGN,positive
44943.0,"Citigroup Downgrades Allergan, Inc. to Neutral, Lowers PT to $95.00",2013-06-25 06:27:00-04:00,AGN,negative
44944.0,Allergan Names Douglas Ingram Pres,2013-06-24 17:15:00-04:00,AGN,neutral
44945.0,"Market Wrap for Monday, June 24: Stocks Continue Slide to Start Trading Week ",2013-06-24 16:19:00-04:00,AGN,neutral
44946.0,"Citigroup Downgrades Allergan, Inc. to Neutral",2013-06-24 12:35:00-04:00,AGN,neutral
44947.0,UPDATE: Piper Jaffray Lowers PT on Allergan Following FDA Draft Guidance,2013-06-24 10:50:00-04:00,AGN,negative
44948.0,"Piper Jaffray Maintains Neutral on Allergan, Inc., Lowers PT to $79.00",2013-06-24 10:01:00-04:00,AGN,negative
44949.0,"Leerink Swann Downgrades Allergan, Inc. to Market Perform",2013-06-24 08:53:00-04:00,AGN,neutral
44950.0,UPDATE: Deutsche Bank Downgrades Allergan Following FDA Draft Guidance,2013-06-24 08:24:00-04:00,AGN,neutral
44951.0,"Deutsche Bank Downgrades Allergan, Inc. to Hold, Lowers PT to $98.00",2013-06-24 06:24:00-04:00,AGN,negative
44952.0,UPDATE: Goldman Sachs Downgrades Allergan on Removal from America's Buy List,2013-06-21 08:44:00-04:00,AGN,neutral
44953.0,Benzinga's Top Downgrades,2013-06-21 07:29:00-04:00,AGN,positive
44954.0,"Goldman Sachs Downgrades Allergan, Inc. to Neutral, Maintains $110.00 PT",2013-06-21 07:26:00-04:00,AGN,neutral
44955.0,"Jefferies Says Analysis on Elan Supports $19/Share Takeover Bid, Lifts Price Target to $19",2013-06-18 10:39:00-04:00,AGN,positive
44956.0,ACADIA Pharmaceuticals Announces Advancement by Allergan of Novel Glaucoma Compound into Preclinical Development ,2013-06-03 09:05:00-04:00,AGN,positive
44957.0,Valeant Pharmaceuticals to Buy Bausch & Lomb,2013-05-28 12:20:00-04:00,AGN,neutral
44958.0,Benzinga's Top Initiations,2013-05-10 08:50:00-04:00,AGN,positive
44959.0,"BMO Capital Initiates Coverage on Allergan, Inc. at Outperform, Announces $118.00 PT",2013-05-10 08:23:00-04:00,AGN,neutral
44960.0,"Starbucks, Huntington Bancshares and Other Stocks Insiders Are Buying",2013-05-04 10:25:00-04:00,AGN,neutral
44961.0,FDA Advisory Committee Unanimously Recommends JUVÉDERM VOLUMA™ XC as a Safe and Effective Treatment Option for Cheek Augmentation to Correct Age-Related Volume Deficit in the Mid-Face ,2013-05-02 16:54:00-04:00,AGN,positive
44962.0,"Lazard Capital Markets Upgrades Allergan, Inc. to Buy",2013-05-02 08:19:00-04:00,AGN,neutral
44963.0,Regeneron Pharmaceuticals: The Stock That Only Goes Up?,2013-05-01 16:42:00-04:00,AGN,neutral
44964.0,"Market Wrap for Wednesday, May 1: Stocks Fall as Employment Data Weakens in April ",2013-05-01 16:16:00-04:00,AGN,negative
44965.0,Mid-Afternoon Market Update: Markets Remain Down as Allergan Continues to Fall,2013-05-01 15:39:00-04:00,AGN,neutral
44966.0,"Bank of America Maintains Buy on Allergan, Inc., Lowers PO to $110.00",2013-05-01 15:30:00-04:00,AGN,negative
44967.0,"Morgan Stanley Downgrades Allergan, Inc. to Equal-weight",2013-05-01 14:30:00-04:00,AGN,neutral
44968.0,"RBC's Malhotra Says Buy the Dip in Allergan, Calls Reaction to DARPin-Related News Overreaction, Maintains Outperform",2013-05-01 11:53:00-04:00,AGN,negative
44969.0,"Allergan Says DARPin Data Do Not Support Phase 3 Trials, Will Delay Study -Bloomberg",2013-05-01 11:22:00-04:00,AGN,negative
44970.0,"Allergen Combigan Patent to Expire in 2023 is Invalid, Gets Mixed Rulings in Combigan Appeal -Bloomberg",2013-05-01 11:17:00-04:00,AGN,neutral
44971.0,Allergen Resumes Trading After Tripping a Circuit Breaker Earlier this Morning,2013-05-01 11:13:00-04:00,AGN,neutral
44972.0,AGN Price Indication of 99-103,2013-05-01 11:09:00-04:00,AGN,neutral
44973.0,Allergan Spikes Lower,2013-05-01 11:06:00-04:00,AGN,negative
44974.0,"Allergan, Inc. Sees FY2013 Sales $5.98B-6.20B vs $6.16B Est",2013-05-01 09:00:00-04:00,AGN,neutral
44975.0,"Allergan, Inc. Sees Q2 Sales $1.50B-1.58B vs $1.57B Est",2013-05-01 09:00:00-04:00,AGN,neutral
44976.0,"Allergan, Inc. Reports Q1 EPS of $0.98 vs $0.96 Est; Revenue of $1.43B vs $1.44B Est",2013-05-01 09:00:00-04:00,AGN,neutral
44977.0,Allergan Receives Complete Response Letter from the FDA for LEVADEX ,2013-04-16 09:03:00-04:00,AGN,neutral
44978.0,Allergan Receives CRL from FDA for LEVADEX NDA,2013-04-16 09:02:00-04:00,AGN,neutral
44979.0,"UBS Maintains Buy on Allergan, Inc., Raises PT to $128.00",2013-04-10 09:42:00-04:00,AGN,neutral
44980.0,These Are the 100 Highest-Paid CEOs in Business Today,2013-04-08 16:30:00-04:00,AGN,neutral
44981.0,"Apache, Windstream and Other Stocks Insiders Are Buying",2013-04-06 12:26:00-04:00,AGN,neutral
44982.0,"Allergan Wins Appeal of Delaware Holder-Suit, Allergan Doesn't Have to Face Investor Claims",2013-04-05 11:17:00-04:00,AGN,positive
44983.0,13 Drugs Pending FDA Approval in 2013,2013-03-26 13:19:00-04:00,AGN,positive
44984.0,Johnson & Johnson's Quest to Knock Botox off the Pedestal ,2013-03-22 14:51:00-04:00,AGN,neutral
44985.0,"Three 'Elite' Oil and Gas Stocks (HAL, PSX, TSO)",2013-03-20 12:04:00-04:00,AGN,neutral
44986.0,"Unusual Options Alert: Allergan Inc. April 105/100 Put Spread Trades 1,066 Times Over Open Interests of 424 and 368, Respectively. ",2013-03-13 11:22:00-04:00,AGN,positive
44987.0,"Icahn Enterprises, Sears Holdings and Other Stocks Insiders Are Buying",2013-03-09 14:55:00-05:00,AGN,neutral
44988.0,"Buckingham Research Downgrades Allergan, Inc. to Neutral, Maintains $120.00 PT",2013-03-07 08:20:00-05:00,AGN,neutral
44989.0,"Allergan Announces Intent to Exercise Top-Up Option, Expiration of Offer of MAP Pharma Shares, Says 30.5M Shares Validly Tendered, Not Properly Withdrawn",2013-03-01 09:02:00-05:00,AGN,positive
44990.0,Allergan Settles Oklahoma Botox Case,2013-02-26 14:32:00-05:00,AGN,neutral
44991.0,FDA Approves Allergan's Natrelle 410 Implants ,2013-02-20 17:36:00-05:00,AGN,positive
44992.0,"Akamai, Murphy Oil and Other Stocks Insiders Are Buying",2013-02-16 13:57:00-05:00,AGN,neutral
44993.0,2013: Year of the Mega Deal,2013-02-15 07:22:00-05:00,AGN,neutral
44994.0,Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest Dividend Yield,2013-02-11 01:51:00-05:00,AGN,positive
44995.0,"Allergan, Map Pharma Announce FTC Grants Early Termination of Waiting Period Under HSR Act",2013-02-07 09:07:00-05:00,AGN,positive
44996.0,UPDATE: Stifel Nicolaus Raises PT to $118 on Allergan on Solid 2013 Outlook,2013-02-06 13:48:00-05:00,AGN,positive
44997.0,UPDATE: Jefferies Raises PT on Allergan on Q4 EPS,2013-02-06 12:52:00-05:00,AGN,neutral
44998.0,UPDATE: Deutsche Bank Raises PT on Allergan on Q4 EPS,2013-02-06 10:45:00-05:00,AGN,neutral
44999.0,"JMP Securities Upgrades Allergan, Inc. to Market Outperform, Announces $135.00 PT",2013-02-06 08:58:00-05:00,AGN,positive
45000.0,"Stifel Nicolaus Maintains Buy on Allergan, Inc., Raises PT to $118.00",2013-02-06 08:27:00-05:00,AGN,neutral
45001.0,"Jefferies Maintains Hold on Allergan, Inc., Raises PT to $100.00",2013-02-06 08:11:00-05:00,AGN,neutral
45002.0,Delaware Supreme Court Reserves Ruling in Allergan Case,2013-02-05 12:28:00-05:00,AGN,positive
45003.0,"From Allergan Call: Sees 2013 Cash Flow from Operations Over $1B, Sees CapEx $250M",2013-02-05 11:35:00-05:00,AGN,neutral
45004.0,"Allergan, Inc. Sees FY2013 EPS $4.75-4.83 vs $4.74 Est; Sees Sales $5.90B-6.20B vs $6.27B Est",2013-02-05 09:03:00-05:00,AGN,neutral
45005.0,"Allergan, Inc. Sees Q1 EPS $0.94-0.96 vs $1.02 Est; Sees Sales $1.38B-1.45B vs $1.48B Est",2013-02-05 09:02:00-05:00,AGN,neutral
45006.0,"Allergan, Inc. Reports Q4 EPS of $1.15 vs $1.18 Est; Revenue of $1.51B vs $1.51B Est",2013-02-05 09:00:00-05:00,AGN,neutral
45007.0,Allergan Wins Appeal to Uphold Patent for Lumigan Eye Treatment,2013-01-28 15:27:00-05:00,AGN,positive
45008.0,"Benzinga's M&A Chatter for Wednesday January 23, 2013",2013-01-23 18:43:00-05:00,AGN,neutral
45009.0,"UPDATE: Bank of America Merrill Lynch Reiterates Buy Rating, Raises PT on Allergan",2013-01-23 14:45:00-05:00,AGN,neutral
45010.0,"Bank of America Maintains Buy on Allergan, Inc., Raises PO to $110.00",2013-01-23 14:05:00-05:00,AGN,negative
45011.0,MAP Skyrockets Off the Map on Allergan Acquisition,2013-01-23 12:23:00-05:00,AGN,neutral
45012.0,Allergan to Acquire MAP Pharmaceuticals for $25.00/Share,2013-01-22 20:55:00-05:00,AGN,neutral
45013.0,"Stocks To Watch For January 22, 2013",2013-01-22 01:05:00-05:00,AGN,neutral
45014.0,"Adobe, Darden and Other Stocks Insiders Are Buying",2013-01-20 13:17:00-05:00,AGN,neutral
45015.0,BOTOX Wins FDA Approval for Treatment of Overactive Bladder for Adults,2013-01-18 17:01:00-05:00,AGN,positive
45016.0,"Allergan Raises Board Size to 10, Adds Peter McDonnel",2013-01-17 16:47:00-05:00,AGN,neutral
45017.0,"Deutsche Bank Maintains Buy on Allergan, Inc., Raises PT to $108.00",2013-01-14 08:23:00-05:00,AGN,neutral
45018.0,"Citi Initiates Coverage on Allergan, Inc. at Buy, Announces $106.00 PT",2012-11-29 16:22:00-05:00,AGN,neutral
45019.0,"SunTrust Initiated Coverage on Allergan at Buy, Announced PT to $103",2012-11-16 10:03:00-05:00,AGN,neutral
45020.0,Allergan to Acquire SkinMedica For $350M Up-Front and Up to an Additional $25M,2012-11-16 09:03:00-05:00,AGN,neutral
45021.0,Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest Cash,2012-11-16 01:41:00-05:00,AGN,positive
45022.0,Allergan Reports Q3 EPS $1.06 vs $1.04 Est; Revenues $1.41B vs $1.43B Est,2012-10-30 09:14:00-04:00,AGN,neutral
45023.0,Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest Operating Margin,2012-10-24 03:31:00-04:00,AGN,positive
45024.0,"BlackRock, Cracker Barrel and Other Stocks Insiders Are Buying",2012-10-23 13:39:00-04:00,AGN,neutral
45025.0,CORRECTION: Earlier Headline on Agrium Was Tagged Under Allergan's Ticker,2012-10-01 14:56:00-04:00,AGN,neutral
45026.0,"Esterline, Janus Capital and Other Stocks Insiders Are Buying",2012-10-01 06:58:00-04:00,AGN,neutral
45027.0,Benzinga's Top Upgrades ,2012-09-24 07:16:00-04:00,AGN,positive
45028.0,"UPDATE: Canaccord Genuity Initiates Coverage on Allergan with Hold Rating, $101 PT",2012-09-19 09:59:00-04:00,AGN,neutral
45029.0,Benzinga's Top Initiations,2012-09-19 07:33:00-04:00,AGN,positive
45030.0,"Canaccord Initiates Coverage on Allergan at Hold, Announces PT of $101",2012-09-19 05:48:00-04:00,AGN,neutral
45031.0,PREVIEW: Jim Cramer to Interview CEO David  Pyott of Allergan on Mad Money,2012-09-07 12:30:00-04:00,AGN,negative
45032.0,"E*Trade, Cheesecake Factory and Other Stocks Insiders are Buying",2012-08-20 11:53:00-04:00,AGN,neutral
45033.0,"Goldman Sachs Maintains Allergan at Buy, Lowers PT from $106 to $104",2012-08-02 10:01:00-04:00,AGN,negative
45034.0,"Allergan Guides FY EPS $4.15-4.19, Had Seen $4.13-4.19 vs $4.17",2012-08-01 09:02:00-04:00,AGN,neutral
45035.0,Allergan Reports Q2 EPS $1.07 vs $1.06 Est; Revenues $1.49B vs $1.50B Est,2012-08-01 09:02:00-04:00,AGN,neutral
45036.0,"Yahoo!, Radio Shack and Other Stocks Insiders Are Buying",2012-07-30 14:29:00-04:00,AGN,neutral
45037.0,"CVS, Navistar and Other Stocks Insiders Are Buying",2012-07-12 12:37:00-04:00,AGN,neutral
45038.0,Earnings Scheduled For July 2,2012-07-02 02:14:00-04:00,AGN,neutral
45039.0,"Medtronic, Snyder's-Lance and Other Stocks Insiders Are Buying",2012-06-26 10:13:00-04:00,AGN,neutral
45040.0,Allergan Loses Appeal Over Patents for Sanctura XR Drug -Bloomberg,2012-06-18 11:21:00-04:00,AGN,negative
45041.0,Judge Says Allergan Holders Can Proceed with Botox Suit -Bloomberg,2012-06-11 13:04:00-04:00,AGN,neutral
45042.0,"Hewlett-Packard, Yahoo! and Other Stocks Insiders Are Buying",2012-06-05 07:01:00-04:00,AGN,neutral
45043.0,UPDATE: Jefferies Raises PT to $95 on Allergan; Promotional Timing Clouds Q1  ,2012-05-03 08:13:00-04:00,AGN,neutral
45044.0,"Jefferies & Company Maintains Allergan at Hold, Raises PT from $82 to $95",2012-05-03 06:38:00-04:00,AGN,neutral
45045.0,Allergan Reports Q1 EPS $0.86 vs $0.87 Est; Revenues $1.39B vs $1.38B Est,2012-05-02 09:01:00-04:00,AGN,neutral
45046.0,"Netflix, Akamai and Other Stocks Insiders are Buying",2012-05-02 07:19:00-04:00,AGN,neutral
45047.0,S&P: Bullish On Pharma ETFs Long-Term,2012-04-19 14:45:00-04:00,AGN,neutral
45048.0,Allergan Rises Almost A Point After-Hours on Jim Cramer/Mad Money Mention,2012-04-12 19:05:00-04:00,AGN,neutral
45049.0,Allergan Receives Positive Mad Money/Jim Cramer Mention -CNBC,2012-04-12 18:26:00-04:00,AGN,positive
45050.0,UPDATE: Bank of America Raises Allergan's PT,2012-04-10 10:01:00-04:00,AGN,neutral
45051.0,"Bank of America Maintains Allergan at Buy, Raises PO from $100 to $106",2012-04-10 07:57:00-04:00,AGN,negative
45052.0,Cracker Barrel and Other Stocks Insiders Are Buying,2012-04-06 06:19:00-04:00,AGN,neutral
45053.0,Watson Confirms LUMIGAN and LATISSE Patent Challenges ,2012-04-03 09:16:00-04:00,AGN,positive
45054.0,UPDATE: Stifel Nicolaus Increases Target to $110 on Allergan,2012-03-29 10:23:00-04:00,AGN,neutral
45055.0,"UBS Maintains Allergan at Buy, Raises PT from $100 to $107",2012-03-29 10:17:00-04:00,AGN,neutral
45056.0,UPDATE: Credit Suisse Raises Allergan's PT,2012-03-29 08:54:00-04:00,AGN,positive
45057.0,"Stifel Nicolaus Maintains Allergan at Buy, Raises PT from $90 to $110",2012-03-29 08:06:00-04:00,AGN,neutral
45058.0,"Credit Suisse Maintains Allergan at Outperform, Raises PT from $102 to $104",2012-03-29 06:11:00-04:00,AGN,positive
45059.0,"Morgan Stanley Maintains Allergan at Overweight, Raises PT from $98 to $106",2012-03-29 06:05:00-04:00,AGN,negative
45060.0,Allergan CEO Expects $600-800M in Sales Through New Programs -CNBC,2012-03-28 15:48:00-04:00,AGN,neutral
45061.0,UPDATE: Allergan Submitted SBLA with FDA Application in EU; Trial Shows Botox Significantly Cut Incontinence,2012-03-28 09:04:00-04:00,AGN,negative
45062.0,Allergan Announces Positive Top-Line Results from Phase III BOTOX Overactive Bladder Program  ,2012-03-28 09:00:00-04:00,AGN,positive
45063.0,UPDATE: MAP Pharma Will Request FDA Meeting Today; Believes It Has Strong Support from Allergan; FDA May Take 60-75 Days to Have Meeting; DA Issue Has No Effect on Allergan Contract,2012-03-27 08:28:00-04:00,AGN,positive
45064.0,MAP CEO Says Approval Milestone with Allergan $50M,2012-03-27 08:25:00-04:00,AGN,positive
45065.0,UPDATE: Citigroup Raises Target on Allergan to $110,2012-03-27 07:04:00-04:00,AGN,neutral
45066.0,"Citigroup Maintains Allergan at Buy, Raises PT from $94 to $110",2012-03-27 06:01:00-04:00,AGN,neutral
45067.0,"Fresh Del Monte, BlackRock and Other Stocks Insiders Are Buying",2012-03-08 06:41:00-05:00,AGN,positive
45068.0,Allergan Trading 2.1% Higher on Heavy Volume; Currently at $90.29,2012-03-07 14:12:00-05:00,AGN,neutral
45069.0,ACADIA Pharmaceuticals Announces Extension of Drug Discovery Collaboration with Allergan,2012-03-05 09:02:00-05:00,AGN,neutral
45070.0,ACADIA Pharmaceuticals Announces Extension of Drug Discovery Collaboration with Allergan,2012-03-05 09:00:00-05:00,AGN,neutral
45071.0,UPDATE: Morgan Stanley Raises Allergan's PT,2012-02-08 09:15:00-05:00,AGN,neutral
45072.0,"Morgan Stanley Maintains Allergan at Overweight, Raises PT from $90 to $98",2012-02-08 08:45:00-05:00,AGN,negative
45073.0,UPDATE: Deutsche Bank Lowers Target on Allergan to $95,2012-02-03 07:51:00-05:00,AGN,negative
45074.0,Allergan Guides Q1 EPS $0.84-0.86 vs $0.91 Est,2012-02-02 09:02:00-05:00,AGN,neutral
45075.0,Allergan Reports Q4 EPS $1.00 vs $1.00 Est; Revenues $1.38B vs $1.40B Est	 				,2012-02-02 09:00:00-05:00,AGN,neutral
45076.0,Allergan Hits 52-Week High of $89.51,2012-01-25 15:41:00-05:00,AGN,neutral
45077.0,Best Specialty Pharma Stocks Picked by UBS,2012-01-20 18:27:00-05:00,AGN,positive
45078.0,"Democrats Seeks Hearing on Hazardous Medical Devices; Says Studies Show Risks wit J&J, Allergan Devices",2012-01-20 13:27:00-05:00,AGN,negative
45079.0,Allergan Hits 52-Week High of $89.42,2012-01-17 09:50:00-05:00,AGN,neutral
45080.0,Allergan Hits 52-Week High of $89.38,2012-01-12 11:05:00-05:00,AGN,neutral
45081.0,Allergan Hits 52-Week High of $89.37,2012-01-11 09:42:00-05:00,AGN,neutral
45082.0,ETF Showdown: Fun With Pharma,2011-12-30 16:10:00-05:00,AGN,positive
45083.0,Notable Call Options Activity in Allergan,2011-12-13 14:09:00-05:00,AGN,neutral
45084.0,"Deutsche Bank Reiterates Ratings, Price Targets On Several Pharma Firms",2011-12-07 11:24:00-05:00,AGN,neutral
45085.0,"Hearing Seagate, Allergan Upgraded to Buy at Argus",2011-12-01 07:34:00-05:00,AGN,neutral
45086.0,Piper Jaffray Maintains Neutral Rating and $87 PT on Allergan,2011-12-01 07:16:00-05:00,AGN,neutral
45087.0,Disclosure Insight Maintains Medium Risk Rating on Allergan ,2011-11-17 07:02:00-05:00,AGN,negative
45088.0,Health Canada Approves BOTOX as Prophylactic Treatment for Chronic Migraine  ,2011-11-14 09:09:00-05:00,AGN,positive
45089.0,Allergan Spiking Lower on Heavy Volume,2011-11-10 15:14:00-05:00,AGN,negative
45090.0,ExonHit Extends Strategic Collaboration with Allergan  ,2011-11-02 06:54:00-04:00,AGN,positive
45091.0,A Look at The New DRGS ETN,2011-10-31 13:34:00-04:00,AGN,neutral
45092.0,UPDATE: Piper Jaffray Lowers PT to $87 on Allergan ,2011-10-27 08:03:00-04:00,AGN,negative
45093.0,Goldman Sachs Reiterates Buy on Allergan,2011-10-27 07:53:00-04:00,AGN,neutral
45094.0,Deutsche Bank Has Buy on Allergan,2011-10-27 07:38:00-04:00,AGN,neutral
45095.0,Piper Jaffray Lowers PT on Allergan to $87,2011-10-27 06:30:00-04:00,AGN,negative
45096.0,"Allergan CEO Pyott: 'Ophthalmics was Below Expectations, but there is No Need to Worry Going Forward'",2011-10-26 23:26:00-04:00,AGN,negative
45097.0,Jim Cramer Interviews CEO David Pyott of Allergan,2011-10-26 23:23:00-04:00,AGN,neutral
45098.0,"End-of-Day Market Summary for October 26, 2011",2011-10-26 16:17:00-04:00,AGN,neutral
45099.0,Allergan Tops Earnings Estimates,2011-10-26 10:07:00-04:00,AGN,positive
45100.0,Allergan Reports Q3 EPS $0.92 vs $0.90 Est; Revenues $1.31B vs $1.33B Est				,2011-10-26 09:00:00-04:00,AGN,neutral
45101.0,"Allergan Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-25 18:02:00-04:00,AGN,neutral
45102.0,J.P. Morgan Publishes 3Q/11 Preview on Specialty Pharmaceuticals ,2011-10-17 08:08:00-04:00,AGN,neutral
45103.0,Deutsche Bank Reports Earnings on Specialty Pharmaceuticals,2011-10-11 09:37:00-04:00,AGN,neutral
45104.0,Allergan Spiking Lower on Heavy Volume,2011-10-10 14:57:00-04:00,AGN,negative
45105.0,Deutsche Bank Initiates Coverage On Allergan With Buy Rating,2011-09-16 08:16:00-04:00,AGN,neutral
45106.0,Deutsche Bank Coverage Initiations 9/16/2011,2011-09-16 06:03:00-04:00,AGN,neutral
45107.0,Morgan Stanley Reiterates Overweight Rating On Allergan,2011-09-14 08:16:00-04:00,AGN,negative
45108.0,Allergan's Latisse Being Tested As Treatment for Baldness; Latisse Was Approved for Eyelashes in 2008,2011-09-12 16:53:00-04:00,AGN,positive
45109.0,Piper Jaffray Reviews Allergan After FDA Action,2011-08-25 06:58:00-04:00,AGN,neutral
45110.0,UPDATE: BOTOX® (onabotulinumtoxinA) Receives U.S. FDA Approval for the Treatment of Urinary Incontinence in Adults with Neurological Conditions Including Multiple Sclerosis and Spinal Cord Injury,2011-08-24 13:47:00-04:00,AGN,positive
45111.0,FDA Clears Allergan's Botox for Urinary Incontinence,2011-08-24 12:38:00-04:00,AGN,positive
45112.0,Allergan Spiking Higher on Heavy Volume,2011-08-24 12:37:00-04:00,AGN,neutral
45113.0,Credit Suisse Upgrading Allergan ,2011-08-16 09:30:00-04:00,AGN,positive
45114.0,Benzinga's Top Upgrades,2011-08-16 07:37:00-04:00,AGN,positive
45115.0,"Credit Suisse Upgrades Allergan To Outperform, Raises PT To $91",2011-08-16 05:50:00-04:00,AGN,positive
45116.0,Allergan's BOTOX Receives A Positive Opinion in Fourteen European Countries for Urinary Incontinence in Patients with MS or Spinal Cord Injury ,2011-08-08 06:41:00-04:00,AGN,positive
45117.0,Piper Jaffray Downgrades Allergan To Neutral,2011-08-04 08:04:00-04:00,AGN,neutral
45118.0,"News Summary for August 4, 2011",2011-08-04 07:51:00-04:00,AGN,neutral
45119.0,Benzinga's Top Downgrades,2011-08-04 07:45:00-04:00,AGN,positive
45120.0,"Piper Jaffray Downgrades Allergan To Neutral, Lowers PT To $89",2011-08-04 06:40:00-04:00,AGN,negative
45121.0,Allergan Reports Rise in Profit,2011-08-03 11:16:00-04:00,AGN,positive
45122.0,Allergan Reports Q2 EPS $0.96 vs $0.95 Est; Revenues $1.42B vs $1.34B Est  			,2011-08-03 09:00:00-04:00,AGN,neutral
45123.0,Earnings Expectations for the Week of August 1,2011-07-31 10:02:00-04:00,AGN,neutral
45124.0,"Earnings Preview: Allergan's EPS, Revenue Expected to Rise",2011-07-29 10:05:00-04:00,AGN,neutral
45125.0,Morgan Stanley Comments on Allergan After Migraine Survey,2011-07-26 08:57:00-04:00,AGN,neutral
45126.0,"Allergan to Acquire Privately Held Dermatologic Company, Vicept Therapeutics ",2011-07-19 09:01:00-04:00,AGN,neutral
45127.0,Piper Jaffray Overweight On Allergan ,2011-07-01 07:43:00-04:00,AGN,negative
45128.0,Allergan Reports New Study Finds That Gastric Banding Pays For Itself In Approximately Two Years For Patients With Diabetes And Four Years For Patients Without Diabetes ,2011-06-22 09:05:00-04:00,AGN,neutral
45129.0,"S&P Sector Update: Financials Leading 0.6%, Oil and Gas Lagging (0.4%)",2011-06-13 11:55:00-04:00,AGN,negative
45130.0,Bank of America Comments on Expert Call Regarding AGN's Botox,2011-06-13 07:48:00-04:00,AGN,neutral
45131.0,Bank Of America Reports On Botox Headache Treatment From AGN,2011-06-08 08:21:00-04:00,AGN,neutral
45132.0,Bank of America Merrill Lynch Maintains Buy on Allergan,2011-06-07 07:33:00-04:00,AGN,neutral
45133.0,GlaxoSmithKline and Isis Pharmaceuticals partnership shouldn't be overlooked as a long-term,2011-05-18 06:29:00-04:00,AGN,neutral
45134.0,Citi Reviews Allergan 1Q11,2011-05-16 07:35:00-04:00,AGN,neutral
45135.0,J.P. Morgan Maintain Neutral Rating But Increases Price Target On Allergan To $83.00 From $80.00 (AGN),2011-05-05 07:24:00-04:00,AGN,neutral
45136.0,Piper Jaffray Raises PT On Allergan To $91,2011-05-05 06:46:00-04:00,AGN,neutral
45137.0,JP Morgan Raises PT On Allergan To $83,2011-05-05 06:26:00-04:00,AGN,positive
45138.0,"Top 10 Most Popular Stock Picks on 5/5/11- ERTS, NWSA, WFMI, BMC, FRE, GRMN, FNMA, D,VSEA, AGN",2011-05-05 05:52:00-04:00,AGN,positive
45139.0,Allergan and Molecular Partners Enter into an Exclusive License Agreement For MP0112 For the Treatment of Retinal Diseases   ,2011-05-04 13:53:00-04:00,AGN,positive
45140.0,Allergan Guides Q2 EPS $0.93-0.95 vs $0.92 Estimate; Guides Revenues $1.31-1.36B vs. $1.32B Estimate (AGN),2011-05-04 09:04:00-04:00,AGN,neutral
45141.0,Allergen Guides FY 2011 $3.56-3.62 vs. $3.61 Estimate; Revenues $5050-5250M (AGN),2011-05-04 09:03:00-04:00,AGN,neutral
45142.0,Allergan Reports EPS of $0.77 vs. $0.74 Estimate; Revenues $1.27B vs. $1.22B Estimate (AGN),2011-05-04 09:02:00-04:00,AGN,neutral
45143.0,"Earnings Scheduled For May 4 (PCG, WFMI, TWX, BUD, MET, MGM, ERTS, AOL, RIG, AGN, JDSU, NWSA, TSLA, ACE, GG, CSC, K, KKR, BMC, MMC, PRU, RRD, VG)",2011-05-04 02:20:00-04:00,AGN,positive
45144.0,New Clinical Studies Reinforce the LAP-BAND System is a Safe and Effective Weight-Loss Treatment for Obese Adults with Obesity (AGN),2011-04-13 09:04:00-04:00,AGN,positive
45145.0,Morgan Stanley Maintains Overweight on Allergan (AGN),2011-04-11 09:19:00-04:00,AGN,negative
45146.0,"Morgan Stanley Reaffirms AGN Recommendation, $85 PT",2011-04-11 08:21:00-04:00,AGN,neutral
45147.0,"LifeTech Capital Comments On Merck Acquisition (MRK, ISPH)",2011-04-07 08:42:00-04:00,AGN,neutral
45149.0,Piper Jaffray Reports On AGN's Upcoming Conference Call,2011-04-04 09:25:00-04:00,AGN,neutral
45150.0,ACADIA Pharmaceuticals Announces Extension of Drug Discovery Collaboration with Allergan,2011-04-01 09:04:00-04:00,AGN,neutral
45151.0,"Benzinga's Top Upgrades (AGN, HBAN, CMCO, ALEX)",2011-04-01 08:17:00-04:00,AGN,positive
45152.0,Citi Comments On Allergan's Over Active Bladder Data,2011-03-21 07:41:00-04:00,AGN,positive
45153.0,Allergan To Discuss Phase III Data On Botox 3/22,2011-03-17 08:51:00-04:00,AGN,neutral
45154.0,Goldman Removes Allergan From Conviction Buy (AGN),2011-03-03 07:52:00-05:00,AGN,neutral
45155.0,Allergan Posts Earnings Increase - Analyst Blog,2011-02-02 15:01:00-05:00,AGN,positive
45156.0,Allergan Posts Earnings Increase - Analyst Blog,2011-02-02 14:30:00-05:00,AGN,positive
45157.0,Allergan Reports Q4 EPS of $.88 vs. $.89,2011-02-02 09:01:00-05:00,AGN,neutral
45158.0,US Stock Futures Up As Investors Await Earnings Reports,2011-02-02 06:43:00-05:00,AGN,positive
45159.0,"Earnings Scheduled For February 2 (YUM, MAT, V, AGN, MRO, HSY, NWS, NDAQ, GNW, AOL, TWX, TMO, AMP, WHR, BMC, ACE, HIG)",2011-02-02 03:51:00-05:00,AGN,neutral
45160.0,Jefferies Maintains Hold on Allergan (AGN),2011-02-01 07:23:00-05:00,AGN,neutral
45161.0,"Piper Jaffray Remains Bullish On AGN; Maintains OW Rating, $81 PT",2011-01-31 09:30:00-05:00,AGN,neutral
45162.0,"Options Brief: Allergan, Inc. (AGN)",2011-01-19 10:48:00-05:00,AGN,neutral
45163.0,"Insiders Trading PTY, AGN, PZG, MKSI",2010-12-29 09:24:00-05:00,AGN,neutral
45164.0,Solta Medical Reaches Milestone - Analyst Blog,2010-12-17 17:06:00-05:00,AGN,positive
45165.0,Solta Medical Reaches Milestone - Analyst Blog,2010-12-17 16:33:00-05:00,AGN,positive
45166.0,ISPH's Eye Drug Hits Japan - Analyst Blog,2010-12-14 10:33:00-05:00,AGN,neutral
45167.0,ISPH's Eye Drug Hits Japan - Analyst Blog,2010-12-14 10:00:00-05:00,AGN,neutral
45168.0,Orexigen Therapeutics: FDA Panel Live Blog,2010-12-07 07:47:00-05:00,AGN,neutral
45169.0,Allergan's Lap-Band Finds Support - Analyst Blog,2010-12-06 14:08:00-05:00,AGN,positive
45170.0,Allergan's Lap-Band Finds Support - Analyst Blog,2010-12-06 13:06:00-05:00,AGN,positive
45171.0,Collins Stewart Comments On Allergan's Lap Band Vote,2010-12-06 08:27:00-05:00,AGN,neutral
45172.0,Allergan: FDA Approves Broading Of Lap-Band Label,2010-12-06 07:12:00-05:00,AGN,positive
45173.0,Piper Jaffray Reiterates Overweight Rating on Allergan (AGN),2010-12-02 09:35:00-05:00,AGN,negative
45174.0,Citi Discusses Allergan's Earnings (AGN),2010-11-19 07:03:00-05:00,AGN,neutral
45175.0,"Mad Money Lightning Round OT: Cramer Is A Buyer Of BBY (GLD, EGO, SLW, BIDU, GOOG, BBY, AGN, SMT, GSK, RFMD, AMAT)",2010-11-17 20:03:00-05:00,AGN,negative
45176.0,Unconfirmed Rumors that Abbott Laboratories (ABT) is in talks to acquire Allergan Inc. (AGN) at $100.00 a share,2010-11-15 09:49:00-05:00,AGN,positive
45177.0,Botox Treatments Help Allergan,2010-11-12 07:53:00-05:00,AGN,positive
45178.0,"Calls Purchased on Allergan, Inc. (AGN)",2010-11-11 12:40:00-05:00,AGN,neutral
45179.0,In-Line Quarter for Allergan - Analyst Blog,2010-11-02 09:35:00-04:00,AGN,neutral
45180.0,In-Line Quarter for Allergan - Analyst Blog,2010-11-02 09:35:00-04:00,AGN,neutral
45181.0,Goldman Sees Significant Upside In Allergan (AGN),2010-11-02 08:06:00-04:00,AGN,positive
45182.0,Allergan Meets Earnings Estimates (AGN),2010-11-01 09:16:00-04:00,AGN,neutral
45183.0,Allergan Reports Third Quarter EPS of $(2.21),2010-11-01 09:01:00-04:00,AGN,neutral
45184.0,"Earnings Scheduled For November 1 (BHI, APC, AGN, PTV, GLW, HUM, VMC, NU, CNA, PFG, ED, L, ICE, SPG)",2010-11-01 05:49:00-04:00,AGN,neutral
45185.0,Jefferies Reiterates Hold Rating on Intercontinental Exchange (ICE),2010-10-19 09:51:00-04:00,AGN,neutral
45186.0,Jefferies Raises Price Target on Allergan (AGN),2010-10-19 09:46:00-04:00,AGN,neutral
45187.0,"Benzinga's Top Downgrades (INTC, AGAM, AGN, INFN)",2010-10-19 07:29:00-04:00,AGN,positive
45188.0,"Market Roundup (AAPL, IBM, STX, PETS, AGN, HAL)",2010-10-18 12:35:00-04:00,AGN,neutral
45189.0,"New CM Treatment A Positive Development For Allergan, Wells Fargo Reports",2010-10-18 11:44:00-04:00,AGN,positive
45190.0,Goldman Raises Earnings Estimates And Price Target On Allergan (AGN),2010-10-18 10:00:00-04:00,AGN,neutral
45191.0,"RBC Capital Reiterates Ratings On AME, MIDD, OIS, GPC, GDI, FTR, FHN, AGN",2010-10-18 09:37:00-04:00,AGN,neutral
45192.0,Botox Approved for Migraine As Well - Analyst Blog,2010-10-18 09:36:00-04:00,AGN,positive
45193.0,"Company News for October 18, 2010 - Corporate Summary",2010-10-18 09:36:00-04:00,AGN,neutral
45194.0,"Stocks To Watch For October 18 (C, AAPL, AGN, IBM, HAS)",2010-10-18 04:48:00-04:00,AGN,neutral
45195.0,Piper Jaffray Reiterates Allergan Rating And Price Target Amid Botox Migraine Approval,2010-10-15 07:33:00-04:00,AGN,positive
45196.0,Oppenheimer Maintains Perform On Allergan (AGN),2010-10-13 07:27:00-04:00,AGN,neutral
45197.0,"Calls Sold on Allergan, Inc. (AGN)",2010-09-29 10:27:00-04:00,AGN,neutral
45198.0,Allergan Receives FDA Approval for OZURDEX as Treatment Option for Non-Infectious Uveitis Affecting the Posterior Segment of the Eye ,2010-09-24 16:31:00-04:00,AGN,positive
45199.0,"Cramer Talks About The Best Of Breed Stocks AGN, MRX, TIF, COH, MO, PMI, WYNN, LVS, BUD",2010-09-10 07:55:00-04:00,AGN,positive
45200.0,New Dosages of Solodyn Approved - Analyst Blog,2010-08-31 14:06:00-04:00,AGN,positive
45201.0,"Goldman Sachs’ Specialty Pharma Playlist (MYL, AGN, PRGO)",2010-08-31 10:20:00-04:00,AGN,neutral
45202.0,"Medicis Beats, Provides Outlook - Analyst Blog",2010-08-11 19:14:00-04:00,AGN,neutral
45203.0,William Blair Reiterates Outperform Rating on Allergan (AGN),2010-08-03 10:37:00-04:00,AGN,neutral
45204.0,Allergan Beats Zacks Estimates - Analyst Blog,2010-08-02 17:36:00-04:00,AGN,neutral
45205.0,Clues World Economies May Be Healthier Than Anticipated  08-02-2010,2010-08-02 14:44:00-04:00,AGN,neutral
45206.0,Allergan Rising On Higher Q2 Profit,2010-08-02 10:27:00-04:00,AGN,positive
45207.0,"Biotech Love Quarrel On Takeover Reports (BIIB, AGN)",2010-07-23 14:02:00-04:00,AGN,positive
45208.0,Puts Sold on Allergan Inc. (AGN),2010-07-23 13:31:00-04:00,AGN,neutral
45209.0,"Company News for July 13, 2010 - Corporate Summary",2010-07-13 12:41:00-04:00,AGN,neutral
45210.0,"Company News for July 9, 2010 - Corporate Summary",2010-07-09 09:39:00-04:00,AGN,neutral
45211.0,Calls Purchased on Allergan Inc. (AGN),2010-07-06 10:41:00-04:00,AGN,neutral
45212.0,"Stocks To Watch For July 6 (AGN, BIIB, GENZ, SNY, AAPL, PCS, MDR)",2010-07-06 07:24:00-04:00,AGN,neutral
45213.0,"Market Closes Lower Ahead of July 4th Holiday (SPY, AA, VIX, BIIB, SNY, GENZ) ",2010-07-02 16:21:00-04:00,AGN,positive
45214.0,Gainers And Losers On July 2 ,2010-07-02 15:49:00-04:00,AGN,negative
45215.0,"AGN, BIIB And GENZ Advance On Takeover Speculation",2010-07-02 12:50:00-04:00,AGN,neutral
45216.0,"Calls Sold on Allergan (AGN, SNY)",2010-07-02 10:35:00-04:00,AGN,neutral
45217.0,Calls Purchased on Allergan (AGN),2010-06-29 13:09:00-04:00,AGN,neutral
45218.0,Difference Between an ETF & Index  05-28-2010,2010-06-02 15:28:00-04:00,AGN,neutral
45219.0,Upside Purchased on Allergan (AGN),2010-05-28 11:17:00-04:00,AGN,neutral
45220.0,Goldman Sachs Calls Allergan (AGN) Top Idea,2010-05-25 16:38:00-04:00,AGN,positive
45221.0,"AGN Swings To Q1 Profits On Decline In Charges, Sales Down",2010-05-12 08:57:00-04:00,AGN,positive
45222.0,"Earnings Roundup (AGN, NDAQ, NWL, CVH)",2010-04-30 14:12:00-04:00,AGN,neutral
45223.0,"Stocks To Watch On April 30, 2010 (CVX, NDAQ, AVP, CEG, AGN)",2010-04-30 06:11:00-04:00,AGN,neutral
45224.0,Personal Spending Strengthens the Market and Heavy Options Activity in Citigroup (C) and MEMC Electronic Materials (WFR),2010-03-29 16:18:00-04:00,AGN,positive
45225.0,S&P 500 Could Reach 1200 By Mid-April,2010-03-24 14:50:00-04:00,AGN,neutral
45226.0,Before Jumping Into A Single Health Care Stock Consider This ETF,2010-03-23 23:22:00-04:00,AGN,positive
45227.0,Heavy Options Activity in Vale (VALE) and a Brief Lesson in Risk Reversals,2010-03-23 17:27:00-04:00,AGN,negative
45228.0,High Options Volume in Teva Pharmaceuticals (TEVA): Are Investors Reacting to the Health care Reform Bill?,2010-03-22 17:17:00-04:00,AGN,positive
45229.0,Investors Flock To Healthcare ETFs On Historic Reform,2010-03-22 16:13:00-04:00,AGN,neutral
45230.0,How Will Obama-Care Play Into The Markets And ETFs?,2010-03-21 21:50:00-04:00,AGN,positive
45231.0,"Jim Cramer's Lightning Round OT Comments (ACL, AGN, NTES, BIDU, DPM, KMP)",2010-03-15 20:04:00-04:00,AGN,neutral
45232.0,Heavy Options Activity in Amylin Pharmaceuticals (AMLN) and Allergan (AGN),2010-03-15 15:17:00-04:00,AGN,neutral
45233.0,Aesthetics Market Improving Gradually,2010-03-10 13:09:00-05:00,AGN,positive
45234.0,"Pre-Market Outlook; U.S. Equity Market (AVAV, AGN, AEO, PSS, FACT)",2010-03-09 21:30:00-05:00,AGN,neutral
45235.0,FDA Approves Botox In Treatment Of Muscle Spasms,2010-03-09 17:16:00-05:00,AGN,positive
45236.0,"Company News for March 5, 2010 - Corporate Summary",2010-03-05 09:25:00-05:00,AGN,neutral
45237.0,"Bristol-Myers Signs A Pact With Allergan Inc. (BMY, AGN)",2010-03-03 15:19:00-05:00,AGN,neutral
45238.0,Bristol Myers Squibb And Allergan Enters Into Global Agreement,2010-03-03 08:37:00-05:00,AGN,positive
45239.0,Stock Portfolio Update,2010-03-02 23:47:00-05:00,AGN,neutral
45240.0,29 Stocks Worth Shorting with Stops,2010-02-23 22:40:00-05:00,AGN,positive
45241.0,Weekly Wrap-Up,2010-02-21 14:13:00-05:00,AGN,neutral
45242.0,"Stopped out of 2, Shorted 3 More",2010-02-17 13:43:00-05:00,AGN,negative
45243.0,"Stopped out of 2, Shorted 3 More",2010-02-17 12:51:00-05:00,AGN,negative
45244.0,3 More Solid Short Setups,2010-02-16 23:26:00-05:00,AGN,positive
45245.0,3 More Solid Short Setups,2010-02-16 22:34:00-05:00,AGN,positive
45246.0,"AGN Posts Solid Q4 Results, Guidance Conservative",2010-02-05 12:49:00-05:00,AGN,positive
45247.0,"Company News for February 4, 2010 - Corporate Summary",2010-02-04 09:51:00-05:00,AGN,neutral
45248.0,"Stock Market News for February 4, 2010 - Market News",2010-02-04 09:49:00-05:00,AGN,neutral
45249.0,"Benzinga's Earnings Roundup (PCG, AGN)",2009-10-30 07:42:00-04:00,AGN,neutral
45250.0,Allergen Increase Profit With Increased Sales Of BOTOX (AGN),2009-10-29 12:14:00-04:00,AGN,positive
45251.0,"Cramer likes HBAN,AGN,FNFG and dislikes JEC,TNP",2009-10-05 07:45:00-04:00,AGN,neutral
45252.0,"RothmanResearch.com Stock Review for DAN, PG, MON, DDR, PNR and AGN",2009-08-14 06:59:00-04:00,AGN,neutral
45253.0,"RothmanResearch.com Stock Review for DAN, PG, MON, DDR, PNR and AGN",2009-08-14 06:59:00-04:00,AGN,neutral
